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The crystallization of free haem (ferriprotoporphyrin IX) into haemozoin within the parasitic 
food vacuole is a vital detoxification process in the life cycle of the malaria parasite. 
Quinoline antimalarial drugs achieve their mechanism of action by adsorbing onto the fastest 
growing face of haemozoin, which brings about inhibition of further crystal growth. 
Therefore, an in-depth study of the adsorption of quinoline antimalarial drugs and structurally 
related non-quinoline compounds to β-haematin (synthetic haemozoin) was undertaken in 
order to assess this hypothesis. 
Adsorption of clinically-relevant quinoline drugs onto both the fastest and the second fastest 
growth faces of β-haematin was evaluated using molecular mechanics simulations. The 
adsorption geometries obtained were consistent with those previously reported in literature. 
When applying a multiple correlation that takes into account both the percentage speciation at 
pH 4.8 (pH in the food vacuole), as well as the adsorption onto both the fastest growing 
crystal faces, a significant linear correlation was found when comparing the calculated 
adsorption energies (Eads (kcal.mol
-1
)) and the determined β-haematin growth inhibition 
activities (Lipid BHIC50), where an R
2
 value of 0.78 and a P value of 0.004 are found. This 
observation greatly supported the above mentioned hypothesis. 
The study was further extended to evaluate the adsorption of a set of non-quinoline 
compounds onto the two fastest growing crystal faces. A new adsorption geometry was 
observed where the inhibitors were able to adsorb over two adjacent unit cells, thereby 
forming π-π interactions to two neighbouring porphyrin structures. This is the first time that 
this adsorption geometry has been observed. Therefore, following the successful synthesis of 
a small set of quinoline inhibitors, it was demonstrated that an improved adsorption and a 





subsequent enhanced β-haematin growth inhibition activity is dependent on the formation of 
a larger number of intermolecular interactions between the inhibitor and the crystal surface.  
Finally, by combining all compounds investigated (25 in total) and thereby evaluating a more 
comprehensive data set, an exponential relationship is found when comparing the calculated 
adsorption energy (Eads (kcal.mol
-1
)) and the determined β-haematin growth inhibition 
activity (NP40 BHIC50), when applying the multiple correlation equation, and upon 
considering both the percentage speciation at pH 4.8 as well as the adsorption onto both the 
fastest growing crystal faces. An R
2
 value of 0.73 with a P value of <0.0001 are obtained. 
These results add merit to the argument that antimalarial drugs adsorb onto β-haematin to 
inhibit further crystal growth. Moreover, by determining the necessary intermolecular 
interactions required for improved adsorption onto these crystal faces, this information could 










Die kristallisering van vrye heem (ysterprotoporfirien IX) na hemozoin binne in die 
parasitiese voedsel vakuool, is ‘n belangrikke ontgiftigings proses in die lewenssiklus van die 
malaria parasiet. Kinolien anti-malaria geneesmiddelle verrig hul meganisme van aksie deur 
op die vinnigste groeiende kristalvlak van hemozoin te adsorbeer, wat dan lei tot die inhibisie 
van verdere kristal groei. Daarom, was ‘n in-diepte studie van die adsorpsie van kinolien en 
strukturele verwante nie-kinolien verbindings op β-hematien (sintetiese hemozoin) 
uitegevoer, om dus hierdie hipotese te ondersoek. 
Adsorpsie van klinies-relevante kinolien geneesmiddele op beide die vinnigste en die tweede 
vinnigste groei vlakke van β-hematien was geëvalueer deur gebruik te maak van molekulêre 
meganiese simulasies. Die adsorpsie geometrieë wat verkry was, is oorenstemmend met dié 
wat voorheen in die literatuur gepubliseer is. Met die toepassing van ‘n meervoudige 
korrelasie wat beide die persentasie spesiasie by ‘n pH van 4.8 (pH in die voedsel vakuool) 
sowel as die adsorpsie op beide die twee vinigste groeiende kristalvlakke in ag neem, was ‘n 
beduidende liniêre verband tussen die berekende adsorpsie energieë (Eads (kcal.mol
-1
)) en die 
bepaalde β-hematien groei inhibisie aktiwiteite (Lipied BHIC50) gevind, met ‘n R
2
 waarde 
van 0.78 en ‘n P waarde van 0.004. Hierdie observasie ondersteun dus die bogenoemde 
hipotese. 
Die studie was verder uitgebrei om die adsorpsie van ‘n stel nie-kinolien verbindings op die 
twee vinnigste groeiende kristalvlakke te ondersoek. ’n Nuwe adsorpsie geometrie was 
waargeneem, waar die verbindings oor twee aanligende seleenhede adsorbeer, en waar die 
vorming van π-π interaksies na die twee aanliggende porfirien strukture bevorder word. Dit is 
die eerste keer dat hierdie adsorpsie geometrie waargeneem was. Daarom, gevolg deur die 





sintese van ‘n klein stel kinolien verbindings, was dit gedemonstreer dat verbeterde adsorpsie 
en dus ook ‘n verbeterde β-hematien inhibisie aktiwiteit afhanklik is van die vorming van ‘n 
vermeerderde aantal intermolekulêre interaksies tussen die verbinding en die 
kristaloppervlakte. 
 As ‘n finale bydrae, deur al die verbindings wat ondersoek was saam te evalueer (25 in 
totaal) en gevolglik ‘n meer voledige data stel te ondersoek, was ‘n eksponensiële verhouding 
verkry wanneer die berekende adsorpsie energieë (Eads (kcal.mol
-1
)) en die bepaalde β-
hematien groei inhibisie aktiwiteite (NP40 BHIC50) vergelyk was deur die meervoudige 
korrelasie toe te pas, en sodoende ook die persentasie spesiasie by ‘n pH van 4.8 en die 
adsorpsie op beide die vinnigste groeiende kristalvlakke in ag te neem. ‘n R
2
 waarde van 0.73 
met ‘n P waarde van <0.0001 was verkry. 
Hierdie resultate voeg meriete tot die argument dat anti-malaria geneesmiddelle adsorbeer op 
β-hematien wat lei tot die inhibisie van verdere kristal groei. Ook, deur die belangrikke 
intermolekulêre interaksies wat noodsaak is vir ‘n verbeterde adsorpsie te identifiseer, kan 
hierdie inliging toegepas word in verdere geneesmiddel ontwikkeling, waar nuwe 
anti-malaria geneesmiddelle met verbeterde aktiwiteit rasioneel ontwerp kan word. 
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CHAPTER 1  
MALARIA AND β-HAEMATIN 
Malaria, one of the most prevalent diseases known to humanity, is a tropical disease which is 
spread by the Anopheles mosquito and is mainly caused by the protozoan parasite of the 
genus Plasmodium.
1
 With more than 214 million people infected and with an estimated 
438 000 deaths annually, malaria greatly contributes to both social and economic challenges.
2
 
The areas affected are the tropics, with the sub-Saharan African countries affected the worst. 
Pregnant women and children are more susceptible to this disease, where malaria is 




In a comprehensive attempt to eradicate malaria, the World Health Organisation (WHO) 
reported a decrease of 37% in the annual amount of cases reported and a decrease of 60% in 
the annual mortality rate since the turn of the millennium.
2
 This result has mainly been 
attributed to the mass distribution of insecticide treated mosquito nets, the intermittent 
chemoprevention treatment in pregnant women, and the chemo treatment of malaria cases.
3
 
Current treatments involve artemisinin-based combination therapies (ACT) for the treatment 
of uncomplicated Plasmodium falciparum and uncomplicated Plasmodium vivax malaria.
3
 In 
the rare case of non-chloroquine resistant uncomplicated Plasmodium vivax malaria, 
chloroquine (CQ) is still the recommended drug for treatment. 
However, even with great progress made in combatting malaria, with the development of 
resistant strains towards current treatments (including ACTs in Thailand and Cambodia),
2
 and 
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with the exact mechanism of action of these antimalarial drugs still unknown, malaria is still 
considered a threat to humanity.  This thus emphasises the need for further research in 
understanding the mechanism of antimalarial drug action and thereby the development of 
new antimalarial drugs. 
 
1.1 MALARIA: AN ACCOUNT OF THE DISEASE FROM DISCOVERY TO PRESENT 
1.1.1 The extent of the malaria problem 
Malaria is not a modern disease, as ancient manuscripts dating back as far as 3000 BC, found 
in ancient China, Egypt, Greece, and Italy, describe similar symptoms associated with this 
disease, where it was mainly observed in areas in close proximity to marshes and rivers.
4,5
  
The earliest indication of malaria is found in ancient China and Egypt. The Chinese medical 
classic Nei Ching (ca. 2700 BC) describes the symptoms of the disease and the accompanied 
formation of an enlarged spleen.
4
 It was believed that the symptoms of headaches, chills and 
fever were instigated by three demons. Each demon carried an object which was associated 
with these undesirable symptoms. It is said that one demon carried a hammer, one a vessel of 
water, and the last one, a stove.
4
 In Egypt, more direct evidence of malaria was found. Here, 
mummies were discovered with enlarged spleens, and with modern technology available, 
malaria antigens were detected in the skin and lung samples of these historic ancestors 
(ca. 3200 and 1304 B.C.).
4
 Additionally, various herbal treatments of the time, as well as the 
symptoms of the disease were well documented in an Egyptian medical papyrus, known as 
the Ebers Papyrus (ca. 1570 BC).
4
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More of these manuscripts, describing this fever-causing disease, were found in ancient 
communities of Greece and Rome. Even though the Greeks tended not to talk about their 
illnesses, both Plato and Hippocrates (ca. 400 BC) clearly described the symptoms of the 
disease referred to as the “burning disease”, accompanied by the enlargement of the spleen.
5
 
This disease was mostly dominant in summer and in autumn. The first reference to malaria in 
Italy was described by Celsus (ca. 50 AD).
5
 However, with the natural landscape of Italy not 
being optimal for the breeding of the mosquito, writings indicate that Rome was mostly 
affected by this disease during war periods. It became known as the “Roman fever” which 
later led to the Italian word mal’aria, meaning “bad air”.
4
  
Throughout Europe, other than seasonal outbreaks amongst the wetlands, the occurrence of 
malaria was mainly associated with travellers, merchants, and soldiers during war times. 
With no previous indication of malaria, it is believed that malaria was only introduced to the 
New World by European travellers, accompanied by the importation of goods and slaves.
4
 
Finally, aside from herbal and folk medicine used for the treatment of malaria, it was not until 
the discovery of quinine (QN), extracted from the bark of the Cinchona tree, that a treatment 
was developed by more modern medicinal practices and was finally distributed commercially 
for the treatment of malaria.
6,7
  
According to legend, this discovery originated when a native Indian remedy, named “fever 
bark”, was introduced to the Countess of Chinchon during her stay in Peru in 1629, after 
which it became known as cinchona and Countess’ powder.
6,7
 Eleven years later she returned 
to Spain, where the treatment was introduced to, and widely spread across Europe. Almost 
200 years later, in 1820, a French chemist, Pelletier, successfully extracted QN, the active 
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compound in the Cinchona tree bark for the use as the first antimalarial drug.
6
 This drug 
became the main treatment against malaria for more than a century. However, as with most 
modern antimalarial drugs, this treatment had its shortcomings and was not active against all 
strains of malaria.  
For the duration of World War II, the United States army suffered a tremendous loss of 
soldiers during the invasion of South East Asia, where this fired a new interest in finding 
active treatments against malaria.
6,7
 Subsequently, increased funding was directed towards 
malaria research, which led to the development of more active treatments against this disease. 
It was at this stage, that Chloroquine (CQ), which was developed by Johann “Hans” 
Andersag in 1934, became used as the first-line treatment against malaria.
8
 
In the 1950’s, a campaign was initiated to stop the spread of malaria by eradicating the 
malaria mosquito with the excessive use of the insecticide, dichlorodiphenyltrichloroethane 
(DDT).
9
 This limited the spread of malaria mainly to a large part of Africa. Unfortunately, 
not only did this colourless insecticide destroy the malaria mosquito, but it had a devastating 
environmental impact, destroying both plant and animal life in the areas affected. With the 
ban of the use of DDT in large parts of the globe in the 1970’s, the spread of malaria 
resumed, again causing the deaths of millions worldwide.
10
  
It was not until 1972 that artemisinin (AR) was extracted from ‘qinghao’, an ancient Chinese 
herbal remedy also known as Artemisia annua, or sweet wormwood.
4
 AR was widely used 
throughout China by the 1980’s, where artemisinin-based drugs, together with 
quinoline-based drugs form the foundation of modern antimalarial treatment.  
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The breakthrough in the understanding of the cause of malaria was aided by the development 
of the microscope and with the progression of the idea that diseases are caused by microbes. 
In 1716, an Italian physician, Giovanni M. Lancisi, first observed black granules in the spleen 
of corpses.
4
 However, it was only in 1847 that the German pathologist, Johann H. Meckel, 
associated this brown pigment found in the spleen, blood and liver of patients who had 
succumbed to malaria, with the cause of the disease. He referred to this brown pigment as 
haemozoin.
4,6
 Even though his understanding that haemozoin is the cause of the disease was 
not entirely accurate, his observation created a new focal point in malaria research. Finally, 
this led to the finding in 1880, by a French pathologist, Charles L.A. Laveran, that this 
pigment was in fact accompanied by a parasite in the blood, which he referred to as 
Oscillaria malariae.
4,11
 Laveran observed and clearly described four different forms of the 
parasite: crescents, spherical bodies with actively moving flagella, motionless spherical 




Today, with more research performed on the parasite, it is believed that these bodies that 
Laveran had described were indeed the different life stages of Plasmodium falciparum as it is 
known today. This greater understanding of the malaria parasite’s life cycle was a remarkable 
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1.1.2 The malaria parasite and its life cycle 
The malaria parasite is carried by the Anopheles mosquito and is transferred to the human 
host during feeding.
12
 The disease is caused by five different protozoa parasite types of the 
same genus: Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium 
malariae, and less common, Plasmodium knowlesi.
13
 Even though Plasmodium vivax is the 
most widespread, Plasmodium falciparum is still the leading cause of malaria on the African 
continent and is considered the deadliest of the protozoa parasites.
3
  
As the parasite’s life cycle is highly complex, a large amount of research has been performed 




The parasite’s life cycle progresses in three stages: a sexual stage in the mosquito and two 
asexual stages in the human host, the latter occurring in hepatocytes (liver cells) and 
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Figure 1: The life cycle of Plasmodium falciparum.  
This image was created with information obtained from images published by Bautista
15
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The cycle is initiated when the parasite, in the form of sporozoites, is transmitted to the 
human in the saliva of the mosquito during feeding. These sporozoites then pass to the liver 
by means of the blood stream to initiate the asymptomatic liver stage, where they would 
invade the liver cells, named hepatocytes, and develop into schizonts. Within a period of  
5-15 days, daughter parasites, called merozoites, are formed within the schizonts. Finally the 
schizonts will rupture and release the merozoites back into the blood stream.  
The symptomatic blood stage is initiated when these merozoites invade the red blood 
cells (RBCs). At this stage of the life cycle, the human host will start to show symptoms and 
pathologic signs of malaria infection. The merozoites develop through ring, trophozoite and 
schizont forms. During the trophozoite form, the parasite modifies the host cell, allowing for 
the transportation of molecules in and out of the cell. Here, haemoglobin is digested as the 
main nutrient source within the parasite’s food vacuole.
16
 The trophozoite will finally 
develop into the schizont, where the schizont will again rupture and release new daughter 
merozoites to invade other red blood cells. A cycle in the blood stage typically lasts 48 hours. 
Finally, some of these merozoites develop into dimorphic gametocytes, with a male to female 
ratio of 1:4.
14
  These are ingested by the mosquito during feeding. Finally, the sexual 
reproduction stage is initiated, where further development of the parasites lead to the 
formation of new sporozoites. These then migrate into the mosquito’s salivary glands, and are 
ready to infect another human host. 
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1.1.3 Haemoglobin degradation 
Host haemoglobin is a major nutrient source for the malaria parasite, where it is broken down 
to provide valuable amino acids for parasite growth.
18
 Even though the exact mechanism of 
haemoglobin digestion is still unknown, both cysteine and aspartic proteases have been 




During the trophozoite stage in the red blood cell, an estimate of 25-80% of host 
haemoglobin is digested.
25–27
 The parasite ingests the haemoglobin into the cytostome, where 
after it is pinched off into small vesicles (Figure 3).
28
 These vesicles migrate into the food 
vacuole (digestive vacuole), where haemoglobin is digested at a low pH (4.8-5.2).
29
 At this 
stage, the iron centre is oxidised, whereupon toxic free haem (ferriprotoporphyrin IX 
(Fe(III)PPIX)) (Figure 2), is released.
20
 Finally, the toxic free haem is crystallised into an 
ordered non-toxic form, previously referred to as haemozoin.  
 
Figure 2: Free haem (ferriprotoporphyrin IX (Fe(III)PPIX)) 
This brown pigment (haemozoin) is characteristic of infected red blood cells. It is at this 
trophozoite stage that the disease becomes symptomatic, with the occurrence of aches, fever, 
and chills. This concurrence led to the previous incorrect understanding that the formation of 
haemozoin is the major cause of the disease.
4,6
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Figure 3: An electron micrograph of a whole parasitised erythrocyte collected by Goldberg et al.
19
 
In this image the cytostome (c) is visible, as well as a haemoglobin containing vesicle (v) in the cytoplasm, 
which moves towards the digestive vacuole (dv). The haemozoin crystals are clearly visible inside the digestive 
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1.2 HAEMOZOIN AND β-HAEMATIN 
1.2.1 Chemical composition of haemozoin and β-haematin  
In 1987, Fitch and Kanjananggulpan were the first to report the chemical composition of 
haemozoin. The crystalline material was purified from infected mouse erythrocytes, where 
they found that it consists of ferriprotoporphyrin IX (Fe(III)PPIX).
30
 A few years later, 
in 1991, Slater and co-workers were the first to show insight into the structural composition 
of haemozoin and β-haematin (synthetic haemozoin). They confirmed by means of elemental 
analysis, that haemozoin solely consists of Fe(III)PPIX and that it is chemically identical to 
β-haematin, which is subsequently known as synthetic heamozoin.
31
 
By performing Fourier transform infrared spectroscopy studies, strong absorbance was 
observed between 1720 and 1650 cm
-1
, which is consistent with C=O stretching vibrations 
(Figure 4).
31
 It was suggested that similar to acetato[deuteroporphyrin IX dimethyl 
ester]iron(III), a ferric ion with a unidentate acetate coordination must be present, which 
would give rise to one of the C-O bonds having double-bond character. This argument was 
then further strengthened by means of extended X-ray adsorption fine structure spectroscopy 
(EXAFS) analysis,
31
 where the obtained bond lengths were compared to that of a theoretical 
model. 
From these findings, it was suggested, and assumed for many years thereafter, that 
haemozoin is a polymer, in which the molecules are linked through the propionate group of 
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Figure 4: The FTIR spectra reported by Slater et al.
31
 
The FTIR spectrum of  a m   i     ) was compared to that of haematin (---) in a,  
a d β-haematin (···) in b. 
 
1.2.2 Proposed methods for β-haematin formation 
In 1990, Goldberg et al. investigated the degradation of haemoglobin in Plasmodium 
falciparum, where the haemozoin crystals were observed to line up along a single axis in the 
food vacuole.
19
 Resultantly, it was proposed that haemozoin formation is an ordered process, 
which is most likely promoted by the paramagnetic properties of this structure. It was later 
suggested by Slater et al., that haemozoin growth might be catalysed by an enzyme that they 
referred to as “haem polymerase”.
32
 Thereafter, it was believed for an extensive period of 
time, that haemozoin is a polymer. 
It was also proposed that haemozoin grows in the presence of histidine-rich proteins II and III 
(HRPII and III), with it being an abundant protein in Plasmodium falciparum.
33,34
 However, 
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evidence has indicated that HRPII is exported from the parasite to the red blood cell, leaving 
only small amounts of the protein present in the food vacuole.
35,36
 Furthermore, Noland et al. 
observed haemozoin formation in parasite clones in which HRPII and HRPIII were absent.
37
 
Therefore, these findings strongly suggest that HRPII and III might not play an important role 
in haemozoin formation. 
Dorn et al. were the first to suggest that the process of haemozoin formation might be solely 
chemical in nature, after β-haematin (synthetic haemozoin) crystals were grown in an acidic 
buffer solution.
38
 Since this discovery, β-haematin crystals have been grown from acidic 




More recently, it is proposed that haemozoin growth might be promoted by neutral lipid 
bodies in the cell.
41–45
 By using Nile red labelling and thin layer chromatography, 
Jackson et al. were able to isolate triacylglycerol (TAG) and diacylglycerol (DAG) neutral 
lipids from the parasitic food vacuole, where enhanced concentrations were isolated from 
more mature erythrocytes.
41
 It was previously found that the accumulation of TAG is only 
observed in infected erythrocytes.
46–48
 Pisciotta et al. observed the formation of haemozoin 
within neutral lipid bodies inside the food vacuole by means of transmission electron 
microscopy (TEM) (Figure 5), where it was suggested that these lipid bodies could also 
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Figure 5: TEM images of the parasitic food vacuole collected by Pisciotta et al.
43
 
A TEM image of early trophozoite stages, indicating the haemozoin crystals in the lipid bodies, is shown (left), 
as w ll as a TEM imag   f a matur  tr p    it s, c  tai i g larg r  a m   i  crystals  rig t). Scal  bar, 1 μm. 
 
With β-haematin crystals commonly obtained from acidic acetate or phosphate buffer 
solutions, improved β-haematin crystal growth was obtained in vitro at a water-octanol and 
pentanol-water interfaces, as well as in the presence of various neutral glycerol lipids.
44,49,50
 
Therefore, the current thinking is that the formation of haemozoin is a lipid-mediated process 
of biomineralisation. 
In light of the latest findings that lipid bodies promote β-haematin growth, a new focus has 
turned to obtaining larger synthetic crystals. Furthermore, by being able to mimic haemozoin 
crystal growth outside of the infected food vacuole, more research could be performed to 
improve the current understanding on the mechanism of β-haematin growth. 
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1.2.3 The β-haematin crystal structure 
A landmark discovery came as somewhat of a surprise in 1997, when Bohle et al. obtained 
and refined the first crystal structure of β-haematin by means of high resolution powder X-ray 
diffraction, since at that time, β-haematin was still believed to be a polymer (Figure 6).
40,51
  
In the study of Bohle et al., infected  late trophozoites and uninfected erythrocytes were 
isolated from the NF54 strain of Plasmodium falciparum, whereupon the samples were 
freeze-dried prior to obtaining the powder X-ray diffraction patterns thereof.
51
 Synthetic 
β-haematin was prepared from haemin (ferriprotoporphyrin IX, with a chloride ligand). 
Finally, by comparing the crystallographic patterns, it was found that the haemozoin is 
crystalline in situ and that it crystallised with the same unit cell parameters as β-haematin. In 
other words, this material is not a polymer. The β-haematin monomer units were found to be 
linked through reciprocal Fe(III)-carboxylate bonds resulting in the formation of 
centrosymmetric dimers, which hydrogen bond to one another via the free propionic acid side 
chains (Figure 6). Furthermore, it was shown that the crystalline species found in the 
trophozoites have clear Bragg diffraction spikes.
51
 This crystalline species was absent in the 
uninfected erythrocytes. 
Pagola et al. further refined the obtained crystal structure of β-haematin by means of 
simulated annealing techniques.
40
 From this study it was concluded that the β-haematin unit 
cell consists of a cyclic dimer pair (Figure 7). The observed Fe-O bond distance of 1.886 Å is 
in agreement with other high-spin ferric and ferrous complexes reported by Bominaar et al, 







were synthesised and fully characterised, followed by the determination of the crystal 
structures by means of  X-ray diffraction.
52
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More recently, in 2013, Gildenhuys et al.  (members of our research group) obtained the first 
single crystal data of β-haematin dimethyl sulfoxide solvate by means of single crystal X-ray 
diffraction.
53
 This crystal was grown in the presence of chloroquine, where it was suggested 
that the inhibitor slowed the crystal growth in order to obtain a large enough single crystal. In 
this crystal structure, the free propionic acid functional groups were found to be hydrogen 
bonded to dimethyl sulfoxide molecules. However, their finding with regards to the porphyrin 
dimer coincided with that reported by Bohle et al., which strengthened the argument that it 
most possibly represents the true crystal structure of β-haematin. 
1.2.4 β-Haematin crystal growth morphology  
With the initial crystal structure of β-haematin obtained, Buller et al. investigated the 
theoretical crystal growth morphology thereof, thus contributing in the understanding of 
β-haematin crystal growth.
54
 The calculated crystal morphology was correlated to the 
scanning electron micrographs of natural haemozoin, where it is found to be similar in habit 
(external shape) and form (Figure 8). 
By doing so, the crystal face attachment energies (Eatt (kcal.mol
-1
)) were calculated, where 
Eatt is the energy released upon the formation of a new layer. It is found that faces {100} 
and {010} had the highest calculated Eatt energies, in which case they are expressed the most, 
and a larger crystal surface is observed in the morphology. Similarly, faces {001} and {011} 
were identified as the fastest growing faces, with the lowest calculated Eatt energies. The 
latter are relatively small, and do not dominate the crystal morphology (Figure 27). 
The crystal face attachment energies and the layer energies are calculated by means of 
molecular mechanical potential energy calculations, where this information is combined to 
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determine the crystal morphology based on Hartman-Perdok principles.
55–58
 The face 
attachment energy is defined as the energy released per molecule when a new molecule is 
attached to the face, and determines the growth rate of the crystal. The layer energy is defined 
as the total energy released when a new layer is formed, and is an indication of the stability of 
the layer.
12
 The morphological importance of a crystal face is inversely proportional to the 
growth rate and directly proportional to the stability of the crystal face. Therefore, the most 





Figure 8: The theoretical growth morphology of β-haematin as proposed by Buller et al.
54
 
The crystal structure is viewed perpendicular to the {100} face (a), and perpendicular to the {011} face (b), in 
which the crystal extends. The faces are correlated to scanning electron micrographs of natural 
haemozoin isolated form P. falciparum (c), S. mansoni (d), and H. columbae (e). 
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In order to grasp a greater understanding of the crystal growth morphology, Straasø et al. 
performed further high-resolution X-ray powder diffraction studies.
60
 They have suggested 
that due to the enantio-facial symmetry of the porphyrin monomers and the disorder of the 
peripheral methyl and vinyl groups, four stereoisomers (Figure 9), of which two 
centrosymmetric (cdī1 and cdī2) and two chiral enantiomers (cd2(±)), could occur in solution. 
However, the crystal structure reported by Pagola et al. only showed one of the 
centrosymmetric dimers (cdī1). In 2011, Marom et al. further reported the calculated 
structural parameters of each of the three stereoisomers (cdī1, cdī2, and cd2) by means of van 




Figure 9: The stereoisomers of β-haematin found by Straasø et al.
60
 
The two centrosymmetric dimers cdī1 (left) and cdī2 (centre), and the chiral dimers cd2(-)(right). 
 
By understanding the crystal packing arrangement of β-haematin, it was further proposed that 
the free monomers are drawn to the crystal lattice by the interactions formed on the surface of 
the crystal. These include possible π-π interactions between the porphyrin rings, dispersion 
and van der Waals interactions to the methyl and vinyl groups, and hydrogen bonding to the 
free propionic acid groups.
60,61
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The crystals obtained by Straasø et al. reportedly consist of a major and a minor phase, where 
the major phase is constructed of the more stable cdī1 dimers, and the minor phase of cdī2 
dimers.
60
 It is suggested that the cd2(±) dimers adsorb onto the outside of the formed crystal 
faces (Figure 10). Here, they would hinder adsorption of the cdī1 or cdī2 dimers onto the 
crystal face, which would impede further crystal growth. It is considered that this might be 
the reason why only relatively small haemozoin crystals were isolated until now, and a single 
crystal X-ray structure has not yet been obtained. 
 
  
Figure 10: The packing arrangement of the major phase as proposed by Straasø et al.  
 showing face {010} and face {100}.
60
 
The adsorption of the cd2(-) dimers is shown onto face {010} (left) and face {100} (right) of the major phase, 
which  comprises an ordered array of  cd ī1 dimers. 
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1. 3 ANTIMALARIAL TREATMENTS 
1.3.1 Current antimalarial treatment 
Since the use of quinine as an extract of the Cinchona bark,
6
 more antimalarial drugs have 
been developed and subsequently approved by the Food and Drug Administration (FDA) for 
the treatment of malaria. However, with the emergence of resistant strains against these 
drugs, the WHO has stipulated recommended guidelines for the treatment of malaria in order 
to achieve the optimal results in combatting this disease.  
In general, a three day artemisinin-based combination therapy (ACT) is recommended,
62
 
where this comprises a combination treatment of more than one drug with different modes of 
action, with at least one of these drugs being an artemisinin (AR) derivative (Figure 11 and 
Figure 12). With the artemisinin derivatives having a rapid mode of action, it is combined 
with slow-clearing drugs to remove remaining parasites.
63
 As a consequence of combination 
therapy, more than one mode of action is achieved, and the risk of the development of 
resistant strains is minimised. In combination with this treatment, a single dose of 
primaquine (PQ) is administered prior to the ACT treatment, to reduce transmissibility.
62
  
Existing ACTs that are available for clinical use include arthemether (AM) and lumefantrine 
(LUM) (sold as Coartem®, distributed by Novartis),
64
 artesunate (AS) and amodiaquine 
(AQ) (sold as Coarsucam™ or Artesunate/Amodiaquine Winthrop®, distributed by 
Sanofi-Aventis),
65
 artesunate (AS)  and mefloquine (MQ), (distributed by Cipla),
66
 
dihydroartemisinin (DHA) and piperaquine (PIP) (sold as Eurartesim®, distributed by 
Sigma-Tau),
67
 or artesunate (AS) and sulfadoxine/pyrimethamine (SP).
62
 In the cases of 
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uncomplicated Plasmodium vivax, Plasmodium ovale, Plasmodium malariae, and 
Plasmodium knowlesi, ACT or chloroquine (CQ) could be administered.
62
  
It is recommended that if a patient tests positive for the human immunodeficiency 
virus (HIV) and is being treated with efavirenz or zidovudine, that artesunate (AS) and 
amodiaquine (AQ) are not administed, and if a patient is being treated with the antibiotic 
co-trimoxazole, that artesunate (AS) and sulfadoxine/pyrmethamine (SP) are not 
administered. The two main  reasons for these recommendations are related to interference, 




Furthermore, within the first trimester of pregnancy, pregnant women are treated with a 
combination of quinine (QN) and clindamycin (CL), or chloroquine (CQ). For chemo 
preventative treatment in malaria regions, sulfadoxine-pyrmethamine (SP) is administered in 
the first and second trimester of pregnancy, and to infants under the age of 12 months. 
A combination of amodiaquine (AQ) and sulfadoxine-pyrmethamine (SP) is administered to 




Figure 11: Co-drugs currently used for the treatment of malaria. 
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Figure 12: Artemisinin and quinoline-based drugs currently used for the treatment of malaria. 
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In July 2015, after 30 years of development by GlaxoSmithKline Biologicals, the world’s 
first malaria vaccine, Mosquirix™, was approved by the European Union (EU) 
regulators.
68,69
 However, with a reduction in malaria cases of only 36% in young children and 
26% in infants, an advisory group to the World Health Organisation has recommended that 
the pilot study be undertaken with caution.
70
 One of the main concerns is that the vaccine is 
ineffective if the recommended four doses are not administered.  
Even with the vaccine not being as effective as initially anticipated, the pilot study continues 
with the hope of developing a more potent vaccine in time. To date, ACTs and chloroquine 
are still the recommended treatment for malaria, but with the rapid development of resistant 
strains,
2
 the great need for the development of new antimalarial drugs still remains.  
 
1.3.2 Current drug resistance and modes of action 
Even though the exact mechanisms of antimalarial drug action are still unknown, a significant 
amount of research has been performed in understanding these modes of action. It is believed 
that drug resistance is mainly a result of incomplete clearance of the parasite from the 
patient’s blood after treatment, as well as the ineffective administering of these treatments.
62
 
Moreover, the occurrence of co-drug resistance, where the resistance of one drug results in 
the resistance of more drugs of the same family, causes more drugs to be ineffective against 
new resistant strains of malaria.
62
  
1.3.2.1 Quinoline-based drugs 
Chloroquine and related quinoline drugs are primarily active in the blood stage of the 
parasite’s life cycle, where they selectively penetrate the food vacuole. It is postulated that 
with the quinoline being a weak base, the drug could easily be protonated. One explanation is 
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that it crosses the food vacuolar membrane and concentrates within the acidic food vacuole 
where it is protonated, by means of a method known as pH trapping.
71,72
  
Studies have shown that quinoline drugs might have two possible mechanisms of action. 
During the blood stage of the parasite’s life cycle, host haemoglobin is digested and the iron 
centre is oxidised, whereupon the resulting toxic free haem, also known as 
ferriprotoporphyrin IX (Fe(III)PPIX), is released.
19
 At this point, the toxic free haem is 
crystallised into a non-toxic form, known as malaria pigment or haemozoin.  It is during this 
detoxification process that the presence of quinoline drugs brings about inhibition of 
haemozoin formation, which subsequently results in parasite death.
73
 It has been suggested 
that the quinoline drugs might adsorb onto the haemozoin crystal surface, impeding further 
crystal growth.
54,73
 Furthermore, crystal structures have been obtained of drug-haem 
complexes, indicating that the quinoline drugs complexes with the free haem, leaving a lower 
free haem concentration to crystallise into haemozoin.
74,75
  
CQ resistance was slow to develop. With an elapsed time of 20 years, the first case of 
resistance was reported in the 1960’s in Southeast Asia and South America, with another 
20 year time period before resistance spread to East Africa.
76
 In the late 1990’s the pfcrt gene 
was linked to chloroquine resistance.
77–79
 The mutant protein, the Plasmodium falciparum 
chloroquine resistance transporter (PfCRT), seems to alter the flux of CQ across the food 
vacuole membrane and thereby prevents the accumulation of the drug in the food vacuole, 
which renders the drug to be ineffective.
78
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1.3.2.2 Artemisinin-based drugs 
Artemisinin drugs are mostly active in the blood stage of the parasite, especially targeting 
membrane containing structures within the malaria infected cells, such as the plasma 
membrane, the food vacuolar membrane, the nuclear envelope, the endoplasmic reticulum, 
and the mitochondria membrane.
80
 Studies have shown activity against trophozoites, rings, 
schizonts, and gametocytes. 
81–83
 However, exactly which of the stages in the life cycle is 
targeted most, is still under debate.
84
  
Even with artemisinin-based drugs being most effective for malaria treatment, little is yet 
known about the mechanism of drug action. It is suggested that the interparasitic free haem or 
iron interacts to assist in the initial breaking of the endoperoxide bridge of the artemisinin 
drug, thereby releasing toxic free radicals to the surroundings.
85,86
 It is believed that these free 
radicals might react with parasite cell constituents (in particular membranes), or that these 




The occurrence of the world’s first artemisinin resistance was reported in 2008 in western 
Cambodia.
87,88
 Six years later, Ariey et al. were able to identify the K13-propeller 
polymorphism as a molecular marker of AR resistance from the ART-resistant F32-ART5 
parasite line.
89
 To date, more than 50 K13 mutant alleles have been identified, where each 
carries a single nucleotide polymorphism that changes the amino acids, and thus the 
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1.3.3 The development of new types of antimalarial drugs in an attempt to overcome 
drug resistance 
Great success has been achieved with the development of bis-quinoline compounds, where 
two quinoline moieties are connected via a long alkyl chain. It was shown that the length of 
this linker chain affects the activity of the molecule.
91
 Several bis-quinoline compounds with 
similar activities to that of CQ have been developed. However, these compounds were found 
to exhibit greater activity against CQ-sensitive strains, with prolonged duration of action.
92,93
 
Piperaquine and Hydroxypiperaquine are considered the most successful bis-quinolines to 
date, where these two compounds exhibited greater activity than CQ against both 
CQ-sensitive and CQ-resistant strains of malaria (Figure 13). Piperaquine is currently used in 
China as part of a short-course artemisinin-based combination treatment, trading as CV8®.
94
 
Also, with the growing sulfadoxine–pyrimethamine resistance in East and Southern Africa, it 
has been shown that dihydroartemisinin–piperaquine could be used as an alternative 





R = H, Piperaquine;  R = OH, Hydroxypiperaquine 
Figure 13: The chemical structures of Piperaquine and Hydroxypiperaquine 
Owing to the great success of artemisinin-combination treatment in overcoming new resistant 
strains of the malaria parasite, a new research focus is set on developing hybrid antimalarial 
drugs, which could interact at more than one target site.                                                            
Stellenbosch University  https://scholar.sun.ac.za





A more recent trend is the development of hybrid antimalarial drugs with vastly different 
pharmacophores.
96
 In an attempt to overcome CQ-resistance, the molecular structure of CQ 
was combined with that of clinically available drugs which is able to inhibit the activity of the 
protein responsible for the emergence of CQ resistance, the Plasmodium transmembrane 
protein, PfCRT.
97





 where these hybrid drugs were found to be active against both CQ-sensitive 




CQ-impramine hybrid drug Impramine 
 
  
CQ-astemizole hybrid drug Astemizole 
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In an attempt to promote dual mechanism of action, different classes of antimalarial drugs 
have also been combined. For instance, QN and MQ were combined with Artemether (AM) 
to obtain QN-AM and MQ-AM hybrids (Figure 15).
101,102
 These compounds were found to be 
active in vivo (comparable to ART) against CQ-resistant strains, but no substantial evidence 












1.3.4 Strategies and methods used in antimalarial drug discovery 
Current methods used in modern drug discovery, include chemical alteration of existing 
drugs, whole-cell high throughput screening of drug libraries (HTS), and the development of 
new drugs based on structure-activity pharmacophore modelling.
103–105
 In the latter case, a 
new scaffold would be preferable to currently-used scaffolds (such as quinoline) to which 
resistance is known. Of these three methods, especially since the exact modes of action of 
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antimalarial drugs are still unknown, the whole-cell HTS method is found to be the most 
promising in finding new lead compounds, where these compounds are already optimised 
with the required pharmacokinetic and pharmacodynamic properties in order to permeate cell 
membranes, as well as to interact at the desired target area. 
However, with the exact mechanism of drug action still unknown, the rational optimisation of 
these newly identified lead compounds for the treatment of malaria, is still a challenge. This 
highlights the importance of gaining a greater understanding of the mechanism of 
antimalarial drug action, for future drug development. 
Given their clinical success, quinoline antimalarial drugs have been the focus of numerous 
studies. There is substantial evidence that points to the mechanism of drug action of this class 
of compound, where inhibition of beta-haematin formation in vitro suggests inhibition of 
haemozoin formation in vivo. With the process of haemozoin formation being chemical in 
nature, it is considered an important drug target for further exploration..
106
 Furthermore, the 
mechanism of chloroquine resistance is known to be distinctly separate from the mode of 
action, and thus haemozoin remains a valuable target against which new drugs could be 
developed to overcome this obstacle in the treatment of malaria. Therefore, the understanding 
of the mechanism of haemozoin formation and quinoline drug development are still 
considered as valid research focal points. 
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1.4 β-HAEMATIN GROWTH AND INHIBITION BY QUINOLINE-BASED DRUGS 
1.4.1 Physical evidence for β-haematin growth inhibition by quinoline drugs 
With quinoline-based drugs being one of the main classes of drugs used in current ACT 
treatment, a significant amount of research has been performed to better understand their 
mechanism of action. As mentioned in Section 1.3.2.1, various studies have shown that these 
drugs inhibit haemozoin growth inside the parasitic food vacuole.  
In 2007, Solomonov et al. performed a thorough study to investigate β-haematin crystal 
growth.
73
 β-Haematin crystals were grown in two solvent systems, chloroform, and a 
methanol and dimethyl sulfoxide mixture, as well as in the presence of quinine and 
chloroquine. The resultant crystals were examined by transmission electron 
microscopy (TEM), grazing incidence X-ray diffraction (GIXD), electron diffraction (ED), 
synchrotron X-ray powder diffraction (XRPD), coherent grazing exit synchrotron X-ray 
scattering, micro-Raman spectroscopy, and infrared attenuated total reflectance (IR-ATR) 
spectroscopy. They found that the crystals grown in the presence of a drug, formed slower, 
and were cylindrically tapered at the edges (Figure 16). This indicated that the drugs most 
likely acted as inhibitors at the fastest-growing (least expressed) crystal faces, thereby 
inhibiting further crystal growth. 
Stellenbosch University  https://scholar.sun.ac.za






Figure 16: SEM images of β-haematin collected by Solomonov et al.
73
 
The crystals were grown in methanol and dimethyl sulfoxide (a-c), and chloroform (d-f), where they were also 
grown in the absence of drug (a and d),10% quinine (b and e), and 10% chloroquine (c and f).  
 
 
In a more recent study, Olafson et al. investigated β-haematin growth by means of 
time-resolved in situ atomic force microscopy (AFM) (Figure 17).
49
 A citric acid 
buffer-saturated solution of octanol, at pH 4.8, was used, since the crystals that were obtained 
from this solution best represented the morphology of haemozoin crystals extracted from 
Plasmodium falciparum. By observing a large crystal surface, a classical layer-by-layer 
growth was observed. For each layer that was formed, new layers formed on top of these, 
resulting in islands, with step-like edges. Upon nucleation of a new layer, it transformed from 
an initial isometric to an anisometric shape, where these new layers grew the fastest in the 
c direction (Figure 17 (a)). 
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Figure 17: The AFM images of β-haematin crystals collected by Olafson et al.
49
 
An AFM image is collected of a β-haematin crystal (a), viewed onto the largest face, face {100}, where the  
b and c growth directions are indicated. The newly formed islands were monitored over time (b1 and b2). An 
AFM 3D height image is also collected, showing the newly formed layers (c). 
 
During this study, it was also noticed that new layers grew slower in the presence of 
chloroquine, with more uneven edges.  
These physical findings reported by Solomonov et al. and Olafson et al., greatly strengthened 
the idea that quinoline compounds inhibits β-haematin crystal growth. As mentioned in 
Section 1.3.2.1, it is believed that these drugs act by means of two modes of inhibition, one 
where the drug adsorbs onto the β-haematin crystal surface thereby preventing further crystal 
growth, and the second being the formation of a drug-haem complex. However, to what 
extent these two processes might compete with one another, has still not been conclusively 
resolved. 
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1.4.2 Inhibition by adsorption of the drug onto the crystal surface  
One of the proposed mechanisms of drug inhibition is the adsorption of drugs onto the 
β-haematin crystal surface, whereby the growth sites are blocked and further crystal growth is 
inhibited. Even though no physical evidence for this argument, other than the slower 
β-haematin crystal growth in the presence of a quinoline drug, has been obtained, it is 
believed that this is the stronger competitor in β-haematin crystal growth inhibition.
34,107,108
 
Webster et al. performed Resonance Raman Spectroscopy on haemozoin within the food 
vacuole of Plasmodium falciparum trophozoites.
109
 Upon treating the infected cells with CQ, 
it was found that a number of bands commonly observed in the spectrum of haemozoin 
decreased in intensity, and were in some cases shifted. Strangely, the characteristic bands of 
CQ were absent. Therefore it was postulated that the quinoline moiety in CQ forms 
intermolecular π-π interactions to the porphyrin structures of haemozoin, thereby hindering 
further crystal growth. 
Olafsen et al. strengthened this argument by visually investigating the β-haematin crystal 
layer and step growth at various concentrations of chloroquine drug over time.
49
 Chloroquine 
concentrations of 0-2 μM were used, where a complete halt in layer formation was observed 
at 2 μM. It is argued that for a 1:1 chloroquine-haem complex to form, it would not be 
sufficient to totally stop layer formation at a 2 μM concentration, since there would still be a 
sufficient amount of free haem left to form new layers. However, this does not rule out the 
idea that complex formation might still occur. 
Upon investigating the theoretical crystal morphology, Buller et al. further proposed how 
clinically-relevant antimalarial quinoline drugs might adsorb onto the fastest growing face of 
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the β-haematin crystal, at pH 4.8.
54
 A Hartman-Perdok computational approach was used, 
using the Cerius2 software package, where the crystal morphology was optimised. The 
quinoline drugs structures were minimised using a universal force field, whereupon these 
were manually fitted to the crystal surface to obtain the maximum interaction, as judged 
visually. Only the monoprotic forms of the inhibitors were modelled, where the quinoline 
nitrogen atom of CQ would be neutral and the terminal amine nitrogen atom would be 
protonated. However, at pH 4.8, both the terminal and quinoline nitrogen atoms of CQ would 
in fact be protonated.
110
 
Upon viewing the crystal surface of the fastest growing face (the one being expressed the 
least), large crevices are observed where these drugs could adsorb into (Figure 18). It is 
considered that possible π-π interactions could form between the quinoline moiety and the 
porphyrin structure, where additional hydrophobic interactions between the quinoline moiety 
and methyl groups on the porphyrin structure could form. Furthermore, by including a 
bridging water molecule, the formation of hydrogen bonding interactions between amine 
group on the side-chains of the inhibitors and the trapped water molecules, and then again 
between the water molecule and a carbonyl group on the crystal face, appear to strengthen the 
adsorption of the inhibitors onto the crystal face. For the adsorption of MQ onto the crystal 
face, it is proposed that with the large -CF3 substituents, intermolecular C-F···H interactions 
form between the inhibitor and the vinyl hydrogen atoms on the porphyrin structure.
54
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Figure 18: Molecular modelling results presented by Buller et al.
54
 
The surface of the fastest growing face {001}, is shown (a), and the crevices are highlighted in green.  
The proposed adsorption onto this face for chloroquine (b),  amodiaquine (c), quinine (d), and mefloquine (e), 
in the monoprotic form is shown, indicating the measured intermolecular interaction distances. 
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Even though the molecular modelling results presented by Buller et al. were not investigated 
thoroughly by means of computational docking or adsorption methods, the study gave insight 
into how the quinoline antimalarial drugs might adsorb onto the β-haematin crystal surface, 
and which interactions might be important to promote adsorption.  
Further research was performed by Dubar et al.,
111
 where the mechanism of antimalarial drug 
action of ferroquine (FQ), a ferrocene-containing quinoline inhibitor, and analogues of 
ferroquine, were investigated (Figure 19). A similar computational approach has been used as 
discussed by Buller et al., where the adsorbed geometries of the molecules onto the fastest 
growing crystal face {001}, and the largest crystal face {100}, were adjusted to fit that of CQ 
in the adsorbed state. The adsorbed geometries were minimised and the binding energies 









Methylferroquine (Me-FQ)  Methylruthenoquine (Me-RQ) 
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For the adsorption onto the fastest growing crystal face, similar adsorption geometries were 
proposed as suggested by Buller et al., where the formation of hydrophobic interactions 
between the quinoline moiety of the inhibitor and the methyl groups on the porphyrin 
structure is found (Figure 20). However, for the adsorption of FQ in the diprotic form onto 
the most expressed crystal face (Figure 21), hydrogen bonding interactions are observed 
between the amine hydrogen atoms on the side-chain of the inhibitor and free carbonyl 
groups on the crystal surface. The formation of additional hydrophobic interactions between 







Figure 20: Adsorption of FQ onto face {001} as proposed by Dubar et al.
111
 
The adsorption of FQ onto face {001} in the monoprotic form, as viewed from the side of the crystal face(left), 
and as viewed from the top of the crystal face (right), is shown. The intermolecular interactions that form are 
indicated by green lines. 
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Figure 21: Adsorption of FQ onto face {100} as proposed by Dubar et al.
111
 
The adsorption of FQ onto face {100} in the diprotic form, as viewed form the side of the crystal face is shown. 
The intermolecular interactions that form are indicated by green lines. 
 
It is believed that the formation of radicals might play a contributing part in the breakdown of 
the parasite membrane. FQ has been reported to form hydroxyl radicals from hydrogen 
peroxide commonly found in the parasitic food vacuole.
112
 Therefore, by performing electron 
paramagnetic resonance (EPR) spin trapping experiments, Dubar et al. have shown that FQ 
and methylferroquine (Me-FQ) are able to generate hydroxyl radicals from hydrogen 
peroxide.
111
 Furthermore, by performing ultrastructural studies, the breakdown of the parasite 
membrane is seen in the presence of these two compounds. As a result, it is believed that the 
formation of radicals might play a contributing part in the breakdown of the parasite 
membrane.  However, this observation is not seen for the ruthenium analogues, 
ruthenoquine (RQ) and methylruthenoquine (Me-RQ). Therefore, the mechanism of action by 
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adsorption onto the fastest growing crystal surface of β-haematin is still a viable mechanism 
of antimalarial drug action for these compounds. 
A brief computational investigation of the adsorption of multiple artemisinin-based 
compounds onto β-haematin has been performed by Solomonov et al.
73
 However, as the 
focus of this project is on investigating the mechanism of β-haematin growth inhibition by 
quinoline-based drugs, and with the mechanism of action of artemisinin drugs considered to 
be distinctly different to that of quinoline drugs, their findings will not be discussed here. 
 
1.4.3 Complex formation 
A competing argument to that of crystal inhibition by adsorption, is the formation of a 
drug-haem complex, and thereby the removal of free haem from the food vacuole cytoplasm 
of Plasmodium falciparum. 
The idea of the drug binding to free haem was first introduced by Dorn et al., where 
isothermal titration microcalorimetry (ITC) experiments were performed to measure the heats 
of dilution and mixing, by titrating haematin in a phosphate buffer with quinoline antimalarial 
drugs.
113
 From this data, association constants (Ka values), enthalpy change (∆H°) and 
stoichiometry (n) were obtained. A good correlation between haematin polymerisation 
inhibition (common understanding at that time) and parasite growth inhibition for quinoline 
drug-containing blood schizonts were observed.  
Another breakthrough occured in 2008, when de Villiers et al. from our lab determined the 
first crystal structure of the halofantrine-Fe(III)PPIX complex by means of single X-ray 
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Figure 22: The chemical structure of halofantrine and the  halofantrine-Fe(III)PPIX complex reported by 
de Villiers et al.
74
 
The chemical structure of halofantrine (right) and the X-ray crystal structure of the halofantrine-Fe(III)PPIX 
complex (left) are shown. Only polar hydrogens are shown for clarity. The atom colours are as follow: C, grey; 
H, white; Cl, yellow; F, Prussian blue; Fe, cyan; N, blue; O, red. 
 
The de Villiers research group continued their investigation on the complex formation, where 
they were able to obtain the crystal structures of a racemic erytho mefloquine-Fe(III)PPIX 
complex (Figure 23),
114
 a quinine-Fe(III)PPIX and a quinidine-Fe(III)PPIX complex,
75
 as 
well as validate the existence of these complexes in acetonitrile, by means of electrospray 
ionisation mass spectrometry (ESI-MS), extended X-ray adsorption fine structure (EXAFS), 
and UV-vis spectroscopy.
114
 In each case the quinoline methanol compound is observed to 
coordinate to the Fe(III) centre via the deprotonated hydroxyl group. 
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Figure 23: The two enantiomeric mefloquine-Fe(III)PPIX complexes reported by Gildenhuys et al.
114
 
Showing the two mirrored enantiomers found in the racemic the erytho mefloquine-Fe(III)PPIX complex. Only 
polar hydrogens are shown for clarity. The atom colours are as follow: C, grey; H, white; F, Prussian blue; 
Fe, cyan; N, blue; O, red. 
 
More recent in vitro studies performed within our research group, by S Fitzroy, has indicated 
that a decrease in the yield of β-haematin formation is observed at high drug concentrations. 
It was therefore suggested that adsorption onto β-haematin might be relevant at low drug 
concentrations, where complexation may be relevant at high drug concentrations. 
Even though drug-complex formation might play a lesser role in β-haematin crystal growth 
inhibition at low drug concetrations, the concrete structural evidence obtained for the 
existence of these complexes could not be ignored. Therefore, this mechanism of inhibition is 
still considered relevant in the overall study of β-haematin crystal growth inhibition. 
For the purposes of this study, complexation was not considered and the primary focus was 
set on β-haematin inhibition by adsorption of antimalarial drugs onto the crystal surface. 
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1.4.4 β-Haematin growth inhibition assays 
Determining the activity of antimalarial drugs is a vital process in identifying targeted drug 
treatments for the disease. Even though many assays have been developed for the in vivo 
activity testing against malaria, such as against D10 and NF54 strains, the development of 
assays for determining β-haematin growth inhibition is still a developing process. 
Currently, three biomimetic assays are commonly used for determining the ability of 
compounds to bring about β-haematin growth inhibition, one in an acetate buffer (referred to 
as the acetate BHIC50 assay)(Table 1),
115
 and more recently, two in lipophilic detergent 
solutions, Tween 20,
116
 and Nonident P-40 (NP40) (referred to as the NP40 BHIC50 assay) 
(Table 1).
117,118
 The development of these assays has been promoted by the earlier finding of 
Ncokazi et al., that pyridine acts as a ligand and coordinates with the Fe(III) atom in free 
haem.
107
 The subsequent formation of a bis-pyridyl Fe (III)PPIX complex results in a colour 
change in the solution, which can be measured by means of UV-vis spectroscopy at 405 nm. 
This allows for the quantification of the amount of free haem left in solution after a fixed 
incubation time, in the presence of a β-haematin inhibitor. 
With the understanding that β-haematin growth is promoted in the presence of neutral lipid 
bodies,
43
 a modified assay was developed within our research group, for determining 
β-haematin growth inhibition in the presence of monopalmitoyl-rac-glycerol (MPG) 
(Table 1).
53
 For this assay, the inhibitors were dissolved in a citric acid buffer solution 
(pH 4.8), after which it is incubated for 30 minutes at 37 °C. The haematin solution (synthetic 
haem dissolved in 0.1 M aqueous sodium hydroxide, which was diluted with a 1:9 acetone-
methanol solvent), was premixed with the lipid solution (MPG lipid in the 1:9 acetone-
methanol solvent). The haematin-lipid solution was carefully added to the surface of the 
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inhibitor-citrate buffer solution, after which the system was incubated at 37 °C for 8 hours. 
During this period of time, the inhibitor was allowed to interact with the free haematin, or the 
β-haematin that forms in solution. Therefore, upon the addition of a pyridine solution (2.0 M, 
pH 7.5) and 40% acetone), the amount of unreacted free haematin was detected by means of 
UV-vis spectroscopy at 405 nm, from which an IC50 dose-response curve was obtained. This 
assay was then further optimised to a medium throughput method performed in 96-well plates 
(referred to as the lipid BHIC50 assay).
119
  
Table 1: The three BHIC50 assays used in this dissertation. 
 Acetate BHIC50 assay NP40 BHIC50 assay Lipid BHIC50 assay 
Detergent or lipid None NP40-detergent MPG lipid 
Buffer Acetate buffer Acetate buffer Citric acid 
pH 5.0 4.9 4.8 
Temperature 37° 37 °C 37 °C 
Incubation time 18 hours 4 hours 8 hours 
 
When the ability of the various assays to determine β-haematin growth inhibition was 
compared (Figure 24), the IC50 activity data of NP40 BHIC50 assay compared well to that of 
the lipid BHIC50 assay, with a significant linear correlation with an R
2
 value of 0.93 and a 
P value of <0.05.
119
 On the other hand, a non-significant linear correlation with and R
2
 value 
of 0.68 was found when comparing the IC50 data of the acetate BHIC50 assay to that of the 
lipid BHIC50 assay.
119
 A significant correlation was, however, observed between acetate 
BHIC50 values and normalised antiplasmodial activity for a range of 4-aminoquinoline 
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compounds when taking into account pH trapping.
120
 More recently, the determined IC50 
values of the lipid BHIC50 assay were also shown to be in good agreement with the IC50 
activities determined against a CQ-sensitive strain of the malaria parasite, 3D7 (Figure 24). In 
the latter case, a linear correlation with an R
2
 value of 0.91 and a P value of <0.05 was 
observed.
119
 This finding was quite significant, seeing that for a biological assay, more 
factors need to be taken into account, such as the ability of the drug to cross cell membranes 
and to permeate into the cell. 
These correlations were indicative that the newly developed lipid BHIC50 assay, as well as 
the NP40 BHIC50 assay, are more suitable to determine the abilities of compounds to bring 
about β-haematin growth inhibition. Importantly, given that these two biomimetic systems 
more closely align with the biological formation of β-haematin, they were prioritized in the 
current study where data was available. 
For the purposes of this project, only the biomimetic assays were used and in vivo testing was 
not performed, as other factors would contribute to antiplasmodial activity. By performing a 
biomimetic assay, these external factors would be eliminated. Therefore, only β-haematin 
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Figure 24: The Lipid BHIC50 assay was compared to other assays by S. Fitzroy.
119
 
The Lipid BHIC50 assay was compared to the acetate BHIC50 assay (a), the NP40 BHIC50 assay (b), as well as 
to the IC50 activities against the 3D7 CQ-sensitive strain of the malaria parasite (c). Significant linear 
correlations were found for comparing the lipid BHIC50 activities with the NP40 BHIC50 and the IC50 (3D7) 
activities, with R
2
 values of 0.93 and 0.91 respectively, and P values of <0.05. A non-significant linear 
correlation was found when comparing the lipid BHIC50 activities against the acetate BHIC50 activities, with an 
R
2
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1.5 AIMS AND OBJECTIVES OF THIS PROJECT 
In light of knowing the chemical and the structural composition of haemozoin and 
β-haematin, a new era of research has been sparked, with the focus on understanding the 
mechanism of β-haematin formation, as well as the inhibition thereof by antimalarial drugs. 
Furthermore, with growing support for the hypothesis that antimalarial drugs bring about 
β-haematin growth inhibition by adsorbing onto the crystal surface, and with the development 
of assays to determine the ability of antimalarial drugs to promote β-haematin growth 
inhibition, this information could be combined to evaluate the mechanism of β-haematin 
growth inhibition brought about by the adsorption of inhibitors onto the β-haematin crystal 
surface. 
The main strategy for this project was to investigate the adsorption of quinoline inhibitors 
onto the two fastest growing β-haematin crystal faces, faces {001} and {011}, 
computationally, where a preferred target area could be identified. Moreover, 
structure-activity relationships could be investigated between the adsorption of known 
antimalarial drugs onto the β-haematin crystal surface and their determined β-haematin 
inhibition. 
By gaining a greater understanding of the mechanism of antimalarial drug action, this 
research could be applied for future drug development, where this project fills an imperative 
role as part of a larger research strategy. Therefore, a significant contribution would be made 
in the fight against malaria. 
 
In order to achieve the goals of this project, the objectives of this thesis were to: 
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1. Identify and optimise a computational protocol in order to evaluate the adsorption of 
small compounds onto the crystal surface computationally. For this, a small subset of 
quinoline compounds with existing activity data would be considered. 
2. Evaluate the adsorption of clinically-relevant inhibitors onto the fastest and the 
second fastest growth face of β-haematin, and determine structure-activity 
relationships between the calculated adsorption energies and the determined 
β-haematin inhibition activities. 
3. Extend the adsorption study to include a set of non-quinoline compounds that were 
synthesised by our collaborator’s research group at the University of Cape Town. 
These compounds include a set of 2,4,5-triaryl substituted imidazole and benzamide 
inhibitors that were synthesised by Dr Kathryn Wicht,
121,122
 and benzimidazole 
inhibitors that were synthesised by Fabrizio L’abbate, as part of their respective PhD 
projects. 
4. Assess the theoretical computational model based on the information obtained from 
this study. The relevant molecules needed could either be synthesised or purchased, 
where after their β-haematin inhibition activities would be determined.  
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THE ADSORPTION OF INHIBITORS ONTO β-HAEMATIN 
For the first part of this project, a computational study was undertaken in order to gain a 
greater understanding of the mechanism of β-haematin growth inhibition by small molecule 
inhibiors. As mentioned earlier, we were not the first to consider this idea, as Buller et al. 
gave some insight as to how known antimalarial drugs might interact with the crystal surface 
(Section 1.4.2).
54
 However, to date, no concrete computational investigation has been 
performed to strengthen their argument.  
It is postulated that by investigating the adsorption of known antimalarial drugs onto 
β-haematin, some structure-activity correlations might be observed. The aim of the study was 
to determine whether a specific binding site is preferred and which molecular interactions are 
necessary for enhanced adsorption. Also, by considering the adsorption of these drugs onto 
multiple faces of the crystal, some insight might be gained as to why the two fastest growing 
faces, {001} and {011}, appear to be preferred over the others for inhibition, as observed by 
Solomonov et al. (Section 1.4.1).
73
 
Furthermore, with a step-like formation of new layers onto the crystal surface observed by 
Olafson et al. (Section 1.4.1),
49
 by investigating these newly formed “steps” and the 
adsorption of known antimalarial drugs thereon, a greater insight into the mechanism of 
β-haematin growth inhibition could be obtained. 
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2.1 PREPARING THE COMPUTATIONAL ENVIRONMENT 
In order to proceed with the adsorption study, the computational environment had to be 
prepared, where the adsorption of inhibitors onto a large crystal surface would be 
investigated. Therefore, the more robust molecular mechanics simulations would be ideal for 
such a large computational system, as opposed to first principle calculations. The preparation 
of the computational environment would include finding an optimum force field and atomic 
charge method, determining which computational protocol would be suitable, as well as 
preparing and optimising the molecules that would be used. 
For this study, the Accelrys Materials Studio software package was used, since a simulated 
annealing adsorption protocol was already available.
123
 Although this software package is 
typically used to study the adsorption of molecular gasses or liquids onto substrates, it is 
considered that it could be used to investigate the adsorption of small organic molecules onto 
the β-haematin crystal surface. Moreover, the morphology protocol available in the Materials 
Studio suite could be used to investigate the crystal morphology, as well as prepare the 
crystal faces needed for the adsorption study. 
By exploiting a thorough computational study, a visual insight would be obtained into how 
these inhibitors adsorb onto the crystal surface of β-haematin, and the adsorption 
energy (Eads) would be calculated as the energy difference in the system before and after 
adsorption of the inhibitors.  
This adsorption energy (Eads) would take into account the substrate-inhibitor interaction 
energy, as well as the difference in the internal energy of the inhibitor. With the crystal being 
kept rigid during the simulation, a change in the internal energy would not be included in the 
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calculation. Therefore, Eads is the difference in energy before adsorption (when the inhibitor 
and the crystal are separated) and after adsorption (when the inhibitor is adsorbed to the 
crystal). Equation 2.1 is an expression of Eads : 
                                                   
 (                  )                                                        (2.1) 
In proceeding further, the computational environment that would best represent the molecular 
system (Figure 25), had to be determined and optimised. Following this, it was necessary to 
determine the crystal morphology in order to investigate the crystal faces. Finally, by 
investigating the adsorption of a subset of quinoline molecules that are similar in shape and 
size, adsorption trends would be more easily observed and the adsorption energies (Eads) 
would be relatively similar and more easily comparable. The computational environment 
could be optimised with this subset of molecules, before investigating the adsorption of a 
more complex set of clinically-relevant antimalarial drugs.   
 
Figure 25: The computational strategy  
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2.1.1. Optimising the force field 
The first priority for this project was to choose a suitable force field that would represent all 
atoms within the computational system. While the CHARMM force field is normally deemed 
suitable for adsorption simulations,
124
 it unfortunately does not account for the high-spin 
Fe(III) centre in the β-haematin porphyrin structure, and therefore it was not considered 
optimal for this study. 
Given that the focus of the project was not the development of a new force field, but rather 
the application of an available package to provide insight to the research hypothesis, it was 
considered to optimise an existing force field in order to accommodate the high-spin Fe(III) 
centre. A more detailed discussion on the theory behind the computational techniques used, 
follows in Section 6.1. 







investigated. The cvff force field is optimised for simulations involving small organic 
molecules, where it is found to predict binding and conformational energies very well. In 
contrast, the deidring force field is rule-based, and found not to be ideal for determining 
geometries and crystal packing energies. The pcff force field is mainly optimised for 
polymers. Therefore, the cvff force field was chosen for this study, since the adsorption of 
small molecules would be investigated, where only the Fe(III) atom required additional 
parameterisation. 
Munro et al. reported the optimisation of a force field for low-spin Fe(III)-porphyrin 
complexes,
131,132
 and their procedure was utilised in the current study to optimise the cvff 
force field. For this purpose, the crystal structure of β-haematin,
40
 as well as a training set of 
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seven Fe(III)-containing porphyrin crystal structures was used, where these represented both 
the porphyrin, and the Fe(III)-O bond.
74,114,133–137
  
In preparing each of these structures, the hydrogen atoms and double bonds were manually 
added in geometrically suitable locations. The structures were then minimised using the 
DMol
3
 module in Materials Studio.
123
 The minimisation was deemed adequate when the 
geometry of the minimised structure matched that of the original crystal structure when 
overlaying the two structures. The crystal structures were minimised by means of a density 
functional theory (DFT) calculation using the generalised gradient approximation (GGA, 
PW91),
138,139
 and a double numerical basis set with polarisation (DNP),
140
 as this 
combination gave the best results. 
For the purposes of optimising the force field, the Forcefield viewer in Materials Studio was 
used to alter the cvff force field parameters, where the geometry optimisation protocol in the 




In preparation for the geometry optimisation simulation, the molecules were charged using a 
charge equilibration approach (QEq),
141
 and the atoms in the porphyrin structure were 
renamed and manually typed in order to obtain consistent results (Figure 26, Table 2), as well 





), was changed manually until the smallest root mean square 
deviations (rmsds) of bond lengths, R0 (Å), bond angles, and torsion angles,  T0 (°), were 
obtained when comparing the geometries of the optimised structures, to that of the DFT 
minimised structures.   
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Figure 26: Atom numbering used for 
the porphyrin structure 
Table 2: The atom typing and numbering of the porphyrin 




 n -nitrogen, SP2 
N
b
 np -nitrogen, SP2, aromatic 
N
c
 np -nitrogen, SP2, aromatic 
N
d







In evaluating the altered force field, a scripting protocol was used to measure all the bonds 
and angles, as well as to simplify the overall simulation process. Upon completion, the 
measured values were exported, and processed in a pre-formulated Microsoft Office Excel 
document, where the final averages of each iteration were calculated automatically.  
The final parameters were deemed optimum when for each structure, the final average bond 
angles obtained deviated by less than 1.5°, the bond lengths deviated by less than 0.015Å, 
and the torsion angles deviated by less than 4° from that of the DFT minimised structures 
(Table 3 and Table 4).
131
 However, in some cases the standard deviation was greater than the 
allowed deviation. In such an occurrence, the measured values of the individual bonds or 
angles were also evaluated. 
 
 






Table 3: Final force constants used in the optimised cvff force field, with the average optimised bond lengths and angles,  











Bond stretch (Å)  
N-Fe 2200 2.1 ± 0.01 2.1 ± 0.01 0.001 
O-Fe 300 1.9 ± 0.1 1.9 ± 0.1 0.001 
     
Angle bend (°)     
C-N-Fe 150 126.2 ± 0.9 127.4 ± 0.9 1.2 
C-O-Fe 150 126.1 ± 2.3 126.6 ± 1.8 0.5 
N-Fe-O 150 102.5 ± 2.3 102.2 ± 0.9 0.3 
N-Fe-N 480 87.3 ± 0.6 87.9 ± 2.2 0.6 
N-Fe-N 480 154.9 ± 1.8 155.5 ± 0.5 0.6 
     
Torsion angle bend (°)     
C-N-Fe-O NA 81.9 ± 5.6 81.6 ± 5.6 0.3 
C-N-Fe-O NA -81.9 ± 5.6 -81.6 ± 5.6 0.3 
C-N-Fe-N NA 174.9 ± 3.6 175.0 ± 3.9 0.1 
C-N-Fe-N NA 97.9 ± 4.9 98.0 ± 5.6 0.1 
C-N-Fe-N NA 20.3 ± 4.3 20.1 ± 5.7 0.3 
C-N-Fe-N NA -20.3 ± 4.3 -20.1 ± 5.7 0.3 
C-N-Fe-N NA -97.9 ± 4.9 -98.0 ± 5.6 0.1 
C-N-Fe-N NA -174.9 ± 3.6 -175.0 ± 3.9 0.1 
 
*
The calculated difference between the average values obtained after the geometry optimisation, by applying the 
optimised cvff force field, and the original values after the DFT optimisation. 
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Table 4: Final averages obtained after a geometry optimisation of the eight crystal structures, when applying the optimised force field. 





















Bond stretch (Å) 
N-Fe  2.1 ± 0.01 2.1 ± 0.01 2.1 ± 0.01 2.1 ± 0.01 2.1 ± 0.01 2.1 ± 0.01 2.1 ± 0.01 2.1 ± 0.01 
O-Fe        1.9        1.9       1.9       1.9       1.8        1.8        1.9        1.9 
 
Angle bend (°) 
C-N-Fe 127.6 ± 1.0 127.6 ± 0.8 127.5 ± 0.6 127.4 ± 0.8 126.9 ± 1.2 127.6 ± 0.6 127.2 ± 1.2 127.6 ± 0.8 
C-O-Fe        136.2        126.5        128.2        129.0        123.4         126.6         126.6         126.1 
N-Fe-O 102.3 ± 2.6 102.2 ± 0.2 102.3 ± 0.5 102.2 ± 1.0 102.3 ± 0.6 102.2 ± 0.7 102.2 ± 0.7 102.2 ± 0.2 
N-Fe-N 90.3 ± 6.2 87.4 ± 0.8 87.4 ± 0.5 87.4 ± 0.6 88.0 ± 1.5 87.5 ± 0.2 87.4 ± 0.5 87.4 ± 0.4 
N-Fe-N 155.4 ± 0.1 155.5 ± 0.2 155.4 ± 0.4 155.5 ± 0.4 155.4 ± 0.8 155.7 ± 0.8 155.6 ± 1.3 155.6 ± 0.2 
                         
Torsion angle bend (°) 
C-N-Fe-O 81.8 ± 7.7 81.4 ± 5.2 80.7 ± 3.7 80.7 ± 4.2 81.6 ± 8.7 82.4 ± 3.6 81.9 ± 6.8 82.6 ± 5.0 
C-N-Fe-O -81.8 ± 7.7 -81.4 ± 5.2 -80.7 ± 3.7 -80.7 ± 4.2 -81.6 ± 8.7 -82.4 ± 3.6 -81.9 ± 6.8 -82.6 ± 5.0 
C-N-Fe-N 174.9 ± 5.3 175.1 ± 3.4 176.1 ± 3.8 176.2 ± 2.6 172.8 ± 4.5 175.7 ± 3.2 173.8 ± 3.8 175.5 ± 4.9 
C-N-Fe-N 98.2 ± 5.9 98.6 ± 5.1 99.3 ± 3.5 96.6 ± 7.9 98.4 ± 8.8 97.6 ± 3.0 98.1 ± 6.4 97.4 ± 4.2 
C-N-Fe-N 20.2 ± 6.3 23.7 ± 4.2 21.3 ± 3.4 21.2 ± 3.8 20.5 ± 8.4 18.2 ± 4.1 20.0 ± 7.1 15.3 ± 4.6 
C-N-Fe-N -20.2 ± 6.3 -23.7 ± 4.2 -21.3 ± 3.4 -21.2 ± 3.8 -20.5 ± 8.4 -18.2 ± 4.1 -20.0 ± 7.1 -15.3 ± 4.6 
C-N-Fe-N -98.2 ± 5.9 -98.6 ± 5.1 -99.3 ± 3.5 -96.6 ± 7.9 -98.4 ± 8.8 -97.6 ± 3.0 -98.1 ± 6.4 -97.4 ± 4.2 
C-N-Fe-N -174.9 ± 5.3 -175.1 ± 3.4 -176.1 ± 3.8 -176.2 ± 2.6 -172.8 ± 4.5 -175.7 ± 3.2 -173.8 ± 3.8 -175.5 ± 4.9 
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With an optimised force field in hand, that could accommodate the high-spin Fe(III) atom, it 
was used in molecular mechanics simulations for investigating the crystal morphology, as 
well as the adsorption of inhibitors onto the crystal faces. 
This optimised force field was used throughout this project for all molecular mechanics 
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2.2 THE CRYSTAL MORPHOLOGY 
2.2.1 Investigating the crystal morphology 
Buller et al. and Straasø et al. gave some insight into the β-haematin crystal packing 
arrangement, as well as the crystal morphology (Section 1.2.4).
54,60
 By having a three 
dimensional model of the β-haematin crystal, a greater understanding of the crystal growth, 
as well as of the step propagation observed by Olafson et al. could be obtained.
49
   
A model of the β-haematin crystal was grown using the Morphology module within Materials 
Studio, by applying the parameterised cvff force field.
123
 In order to evaluate the crystal face 
expression, the calculated crystal face attachment energies (Eatt (kcal.mol
-1
))  for each face are 
compared to that of face {001}, where the values are also reported as a fraction of {001} 
(Table 5, Figure 27). The overall crystal morphology obtained agreed with that reported by 
Buller et al,
54
 where it is found that the fastest growth would occur on face {001} and face 
{011}. The largest observed faces were found to be face {100} and face {010}. 
The calculated Eatt values are in good agreement with those reported by Buller et al., where a 
universal force field was used.
54
 The authors reported almost identical Eatt values for face 
{100} and face {010}, which suggests that these faces should be expressed equally. 
However, this is contrary to the experimental crystal growth observed by Solomonov et al. 
and Olafson et al. (Section 1.4.1).
73
 
Upon investigating the crystal morphology computationally, it is found that face {100} had 
the highest Eatt value, which supports it being expressed the most. Therefore it is suggested 
that it would be expressed the most, followed by that of face {010}. Face {001} was found to 
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be the fastest growing face with the lowest Eatt, with face {011} being the second-fastest 
growth face.  
 
Growth in the c direction 
                                   
Figure 27: The calculated β-haematin crystal morphology. 
The crystal morphology that was calculated using the Morphology tool in Materials Studio is shown. 
 The crystal faces expressed in the morphology were identified from most to least dominant as {100}, {010}, 
{011} and {001}, respectively. The orientation of the unit cell is indicated, with growth predicted primarily in 
the c direction. 
 
Table 5: Comparison of crystal face attachment energies calculated, and reported by Buller et al.
54
 





) Fraction of {001} Eatt (kcal.mol
-1
) Fraction of {001} 
     
{100} -30.6 0.3 -14.26 0.2 
{010} -27.7 0.3 -32.7 0.5 
{011} -82.4 0.8 -58.3 0.8 
{001} -101.5 1 -71.9 1 
 
By obtaining a greater understanding of the crystal morphology, the individual crystal 
surfaces were subsequently investigated, where the surface morphology of each of the faces 
was carefully examined. 
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2.2.2 Surface morphology of the individual crystal faces 
Upon analysing the crystal morphology of the largest crystal face, face {100}, no distinct 
crevices are observed (Figure 28). Free carboxylic acid side chains are present, which would 
normally form a hydrogen bonding interaction to an adjacent β-haematin dimer in the crystal 
phase. These might be possible sites for nucleation of a new layer onto the face, whereby 
haem or a β-haematin dimer could interact to form hydrogen bonding interactions, in order to 
promote further crystal growth onto this face. 
Face {010} has a hydrophobic tile-like surface upon viewing the crystal surface from the top, 
where each of the porphyrins is slightly overlaid by an adjacent one (Figure 29). When 
viewed from the side, no hydrogen bonding sites are observed. It is possible that the flat 
porphyrin moiety of haem or β-haematin could be attracted to this surface to form  
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Figure 28:  Face {100} 
The crystal face viewed from the top (left), and viewed from the side (right). 




Figure 29: Face {010} 
The crystal face viewed from the top (left), and viewed from the side (right). 
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Face {011} could accommodate more intermolecular actions than the previously mentioned 
faces, where it has an overall step-like surface. By evaluating the overall surface in more 
detail, flat hydrophobic porphyrin surfaces are present for free haem or β-haematin to form 
π-π interactions to, as well as hydrophilic carbonyl groups and free carboxylic side chains 
that could participate in hydrogen bonding interactions (Figure 30).  
The surface of face {001} is very similar to that of face {011}. By viewing face {001} from 
the side, areas for hydrophobic π-π interactions, as well as hydrophilic areas to form 
hydrogen bonding interactions are observed (Figure 31). However, when viewing this face 
from the top, a distinctive crevice is seen, wherein molecules could adsorb. The inside of this 
groove is hydrophobic in nature, where it is reasonable to expect that π-π interactions would 
be favoured to the porphyrin structure at the top, as well as to the one at bottom of this 
crevice. Just on the outside of this crevice, carbonyl groups and free carboxylic acid side 
chains are present at the surface, which could participate in the formation of hydrogen 
bonding interactions. Interestingly, this area on the outside of the crevice is similar in 
topology to the surface of face {011}. 
It could be reasoned that, for instance, a β-haematin dimer would be able to adsorb onto both 
faces {001} and {011} in a similar geometry. However, with face {001} having a distinctive 
crevice where this molecule could adsorb into to form addition π-π interactions to, adsorption 
would most likely be favoured onto this face. Therefore, when the crystal expands in the 
c direction, growth would occur faster on face {001} than on face {011}.  
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Figure 30: Face {011} 
The crystal face viewed from the top (left), and viewed from the side (right). 
Possible hydrogen bonding sites are indicated by , and hydrophobic π-π interaction sites by .  





Figure 31: Face {001} 
The crystal face viewed from the top (left), and viewed from the side (right). 
Possible hydrogen bonding sites are indicated by  , and hydrophobic π-π interaction sites by .  
Only π-π interactions are shown in the image on the left. 
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By comparing the interaction possibilities of the crystal faces, it is found that the larger faces 
might each only form one type of interaction. Face {100} could form hydrogen bonding 
interactions, and face {010} could form π-π interactions to promote the adsorption of other 
molecules, such as haem, β-haematin, or antimalarial drugs. 
Faces {011} and {001} both allow for a greater amount of intermolecular interaction 
possibilities, which might explain why these two faces exhibit the fastest growth rates. 
Furthermore, with face {001} having a distinctive groove in which molecules could adsorb, it 
might give insight as to why this is considered to be the fastest growing face. This is also 
consistent with crystal growth theory, which predicts that inhibition is most likely at the 
fastest growing face. 
If adsorption is favoured for haem or β-haematin onto these faces, the adsorption of 
antimalarial drugs would most likely also be favoured. This might give insight as to why 
β-haematin crystals grown in the presence of QN and CQ were cylindrically tapered at the 
edges, as observed by Solomonov et al.
73
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2.3 A BRIEF ADSORPTION INVESTIGATION. 
Having explored the surface structure and the possible interaction sites on the four dominant 
crystal faces, the next consideration was to investigate the adsorption of clinically-relevant 
antimalarial drugs onto these surfaces, with the aim of identifying a possible target site on 
these surfaces.  Based on the research performed by Solomonov et al., as faces {001} and 
{011} are the fastest growing faces, these were considered of greater importance in the 




Initially, a subset of short-chain quinoline compounds, that are analogues of the antimalarial 
drug chloroquine, was investigated. In this way structure-activity relationships could be 
examined in greater depth, before proceeding to investigate the adsorption of 
clinically-relevant antimalarial drugs. Furthermore, as these compounds have similar 
structures, trends were anticipated in the adsorption study, which would ease the optimisation 
of the overall adsorption simulation. 
 
2.3.1 The initial adsorption study 
For the adsorption protocol, the Forcite module within Materials studio was used.
123
 Here, the 
parameterised cvff force field, defined atom typing for the β-haematin crystal, and 
QEq charges were applied.  
The quinoline inhibitors used in this study were synthesised and tested for β-haematin 
activity by Kaschula et al. and Nsumiwa et al. (Figure 32).
120,142
 These inhibitors were ideal, 
since they are similar in shape and size, and the activity data is available.  
Stellenbosch University  https://scholar.sun.ac.za











R1 = CH3 (KN3), F (KN4), Br (KN5), Cl (KN6), CF3 (KN7), NO2 (KN8). 
R2 = H (KN9), CH3 (KN10), CF3 (KN11), Cl (KN12), CN (KN13), NO2 (KN14). 
 
Figure 32: Quinoline-base inhibitors used for the initial adsorption study. 




Since the adsorption of these compounds onto the β-haematin crystal surface in the food 
vacuole at pH 4.8 was modelled, the speciation at this pH had to be accounted for. Therefore, 
the pKa values and the percentage of each species at pH 4.8 were calculated using the Chem 
Axon Marvin Sketch software package (Table 6).
143
 Experimental pKa values were reported 
for compounds  KN3-8 by Kaschula et al., however the calculated values was used for 
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Table 6: Calculated and experimental pKa values, and speciation at pH 4.8. 
 Quinoline nitrogen pKa Terminal amine pKa
a












KN1  0.00  8.64 100 
KN2  0.32  8.19 100 
KN3 8.12 ± 0.01 8.54 9.51 ± 0.01 9.43 100 
KN4 7.62 ± 0.01 7.61 9.24 ± 0.01 9.42 100 
KN5 7.93 ± 0.02 7.37 7.97 ± 0.05 9.42 100 
KN6 7.56 ± 0.02 7.30 8.83 ± 0.01 9.42 100 
KN7 7.50 ± 0.02 7.52 7.65 ± 0.03 9.42 100 
KN8 6.28 ± 0.03 4.96 8.80 ± 0.02 9.40 55 
KN9  8.54  9.62 100 
KN10  7.52  9.62 100 
KN11  7.30  9.62 100 
KN12  5.86  9.62 92 
KN13  8.15  9.62 100 
KN14  4.96  9.62 59 
 
a
 The second pKa is that of the terminal amine, which is tertiary in KN3-8 and primary in KN9-14. 
b








For this subset of compounds, it is found that the calculated values correlate reasonably well 
with the experimental values. The calculated pKa value for the quinoline nitrogen atom in 
compound KN8, with a nitro functional group in the 7-position of the quinoline, is 
considerably lower than the experimental value. However, as the experimental value is lower 
than those of the other related compounds, it is more likely that compound KN8 is not 100% 
diprotic. 
Most of the compounds were doubly protonated at pH 4.8, thus diprotic, where the quinoline 
nitrogen atom and the terminal amine functional groups on the side-chain are protonated. A 
small number of compounds, namely KN8, KN12 and KN14, were also predicted to be 
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singly protonated, where the quinoline nitrogen atom is neutral. The electron density of the 
aromatic ring is decreased due to the electron-withdrawing effects of the more electron-
negative substituents (cyano and nitro groups) on the ring, making the quinoline nitrogen 
atom less basic. Therefore, the adsorption of these monoprotic forms onto the β-haematin 
crystal surfaces was also investigated. 
Different conformations of each quinoline compound were generated using the Generate 
conformers protocol in the Accelrys Discovery studio software package, where the lowest 
energy conformation was selected before proceeding with the adsorption simulation.
144
 These 
were minimised by means of a geometry optimisation simulation in Materials studio, where 
the atoms were automatically typed as for the original cvff force field. 
As per the adsorption protocol in Materials Studio, the crystal faces of interest were initially 
prepared by cleaving a slice of the crystal surface and growing it into a vacuum slab 
(Figure 33). The slice was selected in such a way that it contains all the possible interaction 
sites on the surface, as discussed in Section 2.2.2. Therefore, a square of 9 unit cells was 
chosen. Furthermore, it was important that the slice was thick enough so that all the crevices 
are seen, therefore it was chosen to be 3 unit cells thick. The vacuum slab was chosen with a 
thickness of 10 Å to allow the inhibitor to move and rotate freely. Finally, the atoms on the 
crystal surface were selected and identified as the adsorption target atoms, which would guide 
the inhibitor to adsorb onto the crystal surface. 
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Figure 33: The vacuum slabs. 
The vacuum slabs of face {001} (left) and face {011} (right), showing the crystal surface within a vacuum slab.  
 
The adsorption simulation was performed using the Adsorption locater tool in Materials 
studio, where the adsorption of inhibitors onto the β-haematin crystal surface was 
investigated.
123
 A simulated annealing temperature step was utilised, where the system was 
heated and allowed to cool again in order to overcome energy barriers and to obtain the 
lowest energy conformation. Monte Carlo rotations and translations were applied in this 
simulation in order to find the best fit of the adsorbed inhibitor onto the crystal surface.  
An initial simulation was commenced with 5 heating steps, each undergoing 100 000 Monte 
Carlo cycles, followed by a final geometry optimisation. The best 50 adsorption results were 
extracted, where the calculated adsorption energies (Eads) were reported. Finally, this 
simulation was repeated three times for each inhibitor, where after the consistency of the 
output results was examined. The calculated Eads values, as well as the visual results, were 
inspected in order to assess whether the output results were of a sufficient standard. 
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2.3.2 The initial adsorption results 
2.3.2.1 Adsorption onto face {011} 
The adsorption of the monoprotic and diprotic forms of the quinoline inhibitors onto 
face {011} was examined first. The quinoline moiety is frequently observed to adsorb flat 
onto the porphyrin surface, which is most likely promoted by π-π interactions between the 
quinoline moiety and the porphyrin on the crystal surface. A typical result, exemplified by 
compound KN12, is shown below (Figure 34).  
 
Figure 34: Adsorption of compound KN12 onto face {011}. 
The adsorption of compound KN12 in the diprotic form onto face {011}, as viewed from the side of the crystal 
face, is shown as an example. No hydrogen bonding interactions were observed. The inhibitor could form 
possible π-π i t racti  s t  t   p rp yri     t   β-haematin crystal surface, with measured interaction 
distances of 3.7 Å. The π-π interactions are indicated by   . 
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This π-π stacking phenomenon is regularly seen with porphyrin structures where the aromatic 
nitrogen-containing heterocycles have a low π-electron density, thereby favouring  
π-π interactions above σ-π interactions.
145,146
 Strong π-π interactions are favoured with an 
interplanar separation of 3.3 Å, and weaker interactions occur over distances above 3.6 Å and 
to a maximum of 3.8 Å.  
The results obtained were not consistent, and no preferred target area has been identified. 
This is not surprising given that there are no distinctive crevices on this surface, as previously 
shown in Figure 30. Rather, the inhibitors adsorb to multiple areas on the crystal surface and 
no one adsorption site is preferred over the other. Furthermore, no hydrogen bonding 
interactions were observed between the KN inhibitors and the crystal surface. These 
inconsistencies were, however, also an indication that the parameters used in this adsorption 
simulation, may not be adequate and would need to be optimised further. 
 
2.3.2.2 Adsorption onto face {001} 
By comparison, for the adsorption onto face {001}, it is found that the inhibitors mostly 
adsorb into the crevice; as an example, the adsorption of KN6 is shown below (Figure 35). 
The area occupied spreads over the width of one β-haematin dimer, with measured 
dimensions of 7.8 Å by 15.5 Å. For the purposes of this study, this location is referred to as 
the primary adsorption site. The side-chain moieties of the molecules extend towards the 
outside of the crevice, where in some cases, a hydrogen boding interaction is formed between 
an amine functional group on the inhibitor and an exposed carbonyl group on the crystal 
surface.  
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Figure 35: Adsorption of compound KN6 in the primary adsorption site on face {001}. 
The adsorption of compound KN6 in the diprotic form, as viewed from the side of the crystal face (left) and onto 
the crystal face (right), is shown as example. The quinoline moiety makes favourable π-π interactions to the 
porphyrin above and below it, with average interaction distances of 3.6Å and 3.9Å respectively. A further 
hydrogen bonding interaction, with a measured interaction distance of 2.7Å, is observed between the protonated 
tertiary amine of compound KN6 a d t   carb  yl gr up    t   β-haematin crystal surface. The hydrogen 
bonding interaction is indicated by   , and the π-π interactions are indicated by   . 
 
Interestingly, compounds KN7 and KN11 were observed to adsorb onto the flat porphyrin 
surface on the outside of the crevice (Figure 36). This is referred to as the secondary 
adsorption site. Given that both of these compounds contain a -CF3 substituent at the 
7-position on the quinoline ring, it is possible that these inhibitors are too bulky to fit into the 
crevice. Unfortunately, for these compounds, no π-π interactions were observed, and the 
geometrical results were not consistent. It might be that a more refined geometry optimisation 
is required to improve these interactions. 
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Figure 36: Adsorption of compound KN7 in the secondary adsorption site on face {001}. 
The adsorption of compound KN7 in the diprotic form is shown, as viewed from the side of the crystal face. 
 
Upon investigating the results more closely, it was apparent that in some cases the optimal 
adsorption conformation of the inhibitor was not attained, where by visual inspection, a slight 
variation in the adsorption geometry would enhance π-π interactions, or the rotation around a 
bond would allow for a hydrogen bonding interaction to form. Moreover, by analysing the 
reported Eads values, it was found that the results were not consistent and large standard 
deviations above 5 kcal.mol
-1
 were calculated. Therefore it was concluded that the adsorption 
simulation had to be further optimised in order to obtain more refined results. 
By evaluating the results obtained from the initial adsorption study, a greater understanding 
as to how these inhibitors adsorb onto the β-haematin crystal surface, was gained. Moreover, 
with faces {001} and {011} possessing both π-π and hydrogen bonding interaction sites, and 
with face {001} having a distinctive crevice on the surface, this might explain why these 
faces are the preferred growing faces of the β-haematin crystal. Therefore, it was deemed that 
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by focussing the study on the adsorption of inhibitors onto the fastest growing faces, and by 
rather spending a greater amount of computational time on these, β-haematin inhibition by 
means of the adsorption of inhibitors could be investigated more thoroughly, where more 
refined Eads values could be used to evaluate structure-activity relationships. 
 
2.3.3 Optimising the overall adsorption protocol. 
2.3.3.1 Improving the adsorption simulation. 
Three main areas for improving the adsorption protocol were identified. Firstly, the final 
geometry optimisation could be optimised or replaced by another minimisation protocol. 
Also, the number of adsorption heating steps and cycles could be optimised. However, by 
adding more heating steps or cycles, this would exponentially increase the computational 
cost. Additionally, the size of the crystal face could also be decreased, thereby defining the 
adsorption target area more clearly. 
In the first attempt to optimise the adsorption simulation, a more refined final geometry 
optimisation protocol that contains an ultra-fine conjugate gradient algorithm, was 
investigated. Unfortunately, this had little effect on the final Eads values and the final 
geometrical adsorption results, as large deviations were still observed. It was therefore 
concluded that the final geometry optimisation step is not able to overcome high energy 
barriers to bring about an improved adsorbed geometry. It was therefore preferable to 
optimise the adsorption simulation itself, since it already includes heating steps with Monte 
Carlo rotations and translations.  
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Upon investigating the adsorption target area, it was realised that a larger vacuum slab was 
necessary in order for the inhibitor to freely move and rotate before adsorbing onto the crystal 
surface. Therefore a vacuum slab of 50 Å in length was chosen. This provided more than 
enough space for even larger molecules to move in, where this increase in the size of the 
vacuum slab had no effect on the computational cost of the simulation. 
Furthermore, the number of heating steps or Monte Carlo cycles could be altered. In order to 
obtain the best adsorption results within adequate computational time, the optimal 
combination of these had to be determined. For this purpose, the standard deviation of three 
identical simulations was evaluated for each combination. It is found that by increasing the 
number of heating steps, the computational time increased exponentially, without necessarily 
improving the final adsorption results. For instance, a simulation with 3 steps and 
1500 000 cycles within 52 h did not present the same consistency as a simulation of 5 steps 
and 500 000 cycles within 45 h. Furthermore, the same consistency was found for a 
simulation of 10 steps and 100 000 cycles within 49 h as for the 5 step simulation. Finally, 
after numerous combinations were investigated, it was determined that the simulation 
involving 5 steps and 500 000 cycles is an optimum combination for this study, where the 
final Eads values did not deviate with more than 1.0 kcal.mol
-1
 after 3 repeats of the same 
simulation. Moreover, a simulation of 5 steps and 700 000 cycles is found to be ideal for the 
adsorption of larger inhibitors. 
In an attempt to reduce the computational time per adsorption simulation, a smaller crystal 
surface (2 x 1 unit cells) was probed for adsorption. In the end it was concluded that the 
initial larger crystal surface (3 x 3 unit cells) is still the best to use for more accurate 
adsorption results. 
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2.3.3.2 Introducing a dynamics simulation. 
After optimising the adsorption simulation, two main concerns were raised with regards to 
the overall adsorption protocol. Firstly, even though the core adsorption simulation was 
optimised, the final geometry minimisation was found to be insufficient for all the adsorption 
simulations, as visual inspection of the results revealed that a slight rotation around a certain 
bond of the inhibitor could lead to enhanced adsorption of the molecule onto the β-haematin 
crystal surface.  Secondly, for the simulations discussed so far, the absolute minimum energy 
conformation of each inhibitor was used. Even though the absolute minimum energy 
conformation is expected to have the lowest internal energy, it was important to consider that 
another conformation could have a much more favourable interaction energy to such an 
extent that it would overcome the penalty of a higher internal energy, therefore resulting in a 
more favoured overall adsorption energy. 
To overcome these limitations, a simulated annealing aided dynamics simulation was 
introduced, where it could serve as a more improved final geometry optimisation protocol, as 
well as probe the geometric shape for improved conformations. For the quinoline molecules, 
the quinoline moiety adsorbs into the primary pocket of face {001}, and onto the flat 
porphyrin surface of face {011}, thereby only allowing the free side-chain to rotate and find 
the optimal adsorbed geometry. 
For this study, the Anneal Dynamics protocol in the Forcite module in Materials studio was 
used.
123
 This protocol is found to be ideal for refining the final adsorption results by 
overcoming high energy barriers. Unfortunately, a less computationally expensive adsorption 
protocol could not be considered to obtain the same quality results, as the adsorption protocol 
allows for the adsorption of the inhibitor at a specific target site. Therefore, it is still ideal to 
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have a more refined adsorption protocol, followed by the dynamics protocol as a final 
geometry optimisation. 
A video was recorded of this final optimisation, where the ability of this simulation to 
overcome high energy barriers was investigated. The geometry optimisation of 
compound KN12 is shown (Figure 37), where the rotation around one bond allows the 
side-chain to move closer to a carbonyl moiety on the crystal surface. This favoured the 
formation of a hydrogen boding interaction between the primary amine and the carbonyl 
moiety, with a measured interaction distance of 2.2 Å. Possible π-π interactions could form 
between both the top and bottom porphyrin and the quinoline, with the measured interaction 
distances being 3.6 Å and 3.8 Å respectively. 
   
Initial  Final 
Figure 37: The Forcite Anneal Dynamics simulation. 
Three frames of the Forcite Anneal Dynamics simulation of compound KN12 in the diprotic form are shown.  
The final frame shows the hydrogen bonding interaction that was formed. 
 
Finally, with the adsorption simulation optimised, the initial adsorption results could be 
reanalysed, where this could allow for more consistent geometry results, as well as more 
repeatable calculated Eads values for the determination of structure-activity relationships. 
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2.3.3.3 Improved initial adsorption results 
The adsorption of the small set of quinoline compounds onto faces {001} and {011} was 
analysed for a second time, by exploiting the optimised adsorption protocol. For this, an 
adsorption simulation with 5 heating steps, 500 000 Monte Carlo cycles, and an ultra-fine 
geometry optimisation, was applied. This was finally subjected to the Forcite Anneal 
dynamics simulation, where after the final Eads values were calculated. 
When inspecting the visual geometry results, the same trends were observed as before, where 
the molecules adsorbed in such geometries that π-π interactions are favoured between the 
inhibitors and the porphyrin surface. For adsorption onto face {001}, the majority of the 
inhibitors adsorbed into the primary adsorption site, with the exception of compounds KN3, 
KN7 and KN11 which adsorbed onto the secondary adsorption site, as previously shown for 
the adsorption of compound KN7 in Figure 36. 
Furthermore, the calculated Eads values were more consistent, with a standard deviation of 
less than 1 kcal.mol
-1
. This allowed for the evaluation of structure-activity relationships, 
where the calculated Eads values were compared with the β-haematin inhibition activity 
results reported by Kaschula et al. and Nsumiwa et al.
120,142
 These activity results were 
determined against acetate-mediated β-haematin formation. 
For the purposes of evaluating possible structure-activity relationships, the speciation forms 
at pH 4.8 for each of the inhibitors were considered. The total adsorption energies (Eads) were 
calculated from the individual adsorption energies of the individual protic forms, where the 
observed adsorption energies were weighted according to the fractional abundance of each 
speciation form (Equation 2.2). 
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These Eads values were then compared to the acetate β-haematin inhibition activity 
(Acetate BHIC50) results. For the adsorption of the short-chain quinoline compounds onto 
face {001}, a non-significant trend is observed, with an R
2
 value of 0.20 and a P value  
of >0.05 (Table 7, Figure 38).  
However, it was observed that while most of the compounds adsorbed into the primary 
adsorption site, some preferred adsorption onto the secondary adsorption site. Thus, by 
considering only the adsorption into the primary adsorption site (thereby excluding KN3 and 
KN7, which have high error values), an R
2
 value of 0.59 and a P value of 0.006 are found 
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Table 7: The determined acetate BHIC50 activity of the small quinoline compounds, as well as the 























































































































KN1 -52.6 ± 0.01    100 0 -52.6 15.6 ± 0.5 
KN2 -50.2 ± 0.4    100 0 -50.2 14.9 ± 0.3 
KN3 -57.3 ± 0.6    100 0 -57.3 17.0 ± 4.0 
KN4 -61.5 ± 0.01    100 0 -61.5 9.7 ± 0.8 
KN5 -62.3 ± 0.5    100 0 -62.3 4.4 ± 0.7 
KN6 -66.5 ± 0.01    100 0 -66.5 2.2 ± 0.2 
KN7 -51.5 ± 0.6    100 0 -51.5 8.0 ± 2.0 
KN8 -79.5 ± 0.1 -88.1 ± 0.0 55 45 -83.4 3.1 ± 0.6 
KN9 -53.4 ± 0.8    100 0 -53.4 10.6 ± 0.4 
KN10 -57.6 ± 0.9    100 0 -57.6 10.3 ± 0.3 
KN11 -38.9 ± 0.01    100 0 -38.9 5.4 ± 0.2 
KN12 -59.4 ± 0.01    100 0 -59.4 5.4 ± 0.5 
KN13 -58.5 ± 0.01 -59.8 ± 0.6 92 8 -58.6 6.3 ± 0.8 
KN14 -63.5 ± 0.2 -71.7 ± 0.0 59 41 -66.9 5.3 ± 0.4 
* 
The acetate BHIC50 vales were reported by Kaschula et al.
120
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Figure 38: Adsorption of quinoline inhibitors to face {001). A comparison of the calculated Eads and 
acetate BHIC50 values. 
An R
2




















Figure 39: Adsorption of quinoline inhibitors to face {001). A comparison of the calculated Eads and 
acetate BHIC50 values for compounds that adsorb only to the primary adsorption site. 
Compounds KN3,  KN7, and KN11 are removed. An R
2
 value of 0.59 and an P value of 0.006 are obtained. 
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On the other hand, by comparing the adsorption of all inhibitors discussed in this chapter onto 
face {011}, an R
2
 value of 0.48 and a P value of 0.006 are found (Table 8, Figure 40). This 
improved correlation (relative to an R
2
 value of 0.20 achieved for face {001}) might be due 
to the surface having no distinctive crevices, where only one adsorption site is recurring over 
the surface. Therefore, adsorption could only occur onto one adsorption site, which results in 
more consistent Eads data. 
Table 8: The determined acetate BHIC50 activity of the small quinoline compounds, as well as the 






















































































































KN1 -34.2 ± 0.2    100 0 -34.2 15.6 ± 0.5 
KN2 -32.6 ± 0.01    100 0 -32.6 14.9 ± 0.3 
KN3 -35.7 ± 0.3    100 0 -35.7 17.0 ± 4.0 
KN4 -39.4 ± 0.0    100 0 -39.4 9.7 ± 0.8 
KN5 -46.5 ± 0.0    100 0 -46.5 4.4 ± 0.7 
KN6 -46.4 ± 0.2    100 0 -46.4 2.2 ± 0.2 
KN7 -53.1 ± 0.01    100 0 -53.1 8.0 ± 2.0 
KN8 -53.9 ± 0.5 -52.5 ± 0.3 55 45 -53.3 3.1 ± 0.6 
KN9 -37.1 ± 0.01    100 0 -37.1 10.6 ± 0.4 
KN10 -33.7 ± 0.1    100 0 -33.7 10.3 ± 0.3 
KN11 -42.7 ± 0.01    100 0 -42.7 5.4 ± 0.2 
KN12 -39.9 ± 0.01    100 0 -39.9 5.4 ± 0.5 
KN13 -34.0 ± 0.01 -39.1 ± 0.0 92 8 -34.4 6.3 ± 0.8 
KN14 -44.0 ± 0.01 -47.1 ± 0.7 59 41 -45.2 5.3 ± 0.4 
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Figure 40: Comparing the calculated Eads vs the acetate BHIC50 values for face {011}. 
An R
2
 value of 0.48 and a P value of 0.006 are obtained. 
 
With the first structure-activity results in hand, possible reasons for the poor correlations 
observed were considered. Analysis of a larger set of inhibitors might provide greater insight 
into the adsorption of inhibitors onto β-haematin. More importantly, a comparison of the 
Eads values obtained in this study to β-haematin inhibition data obtained under more 
biologically-relevant conditions might give rise to better correlations. Unfortunately, the 
activities of most of the compounds discussed thus far were only ever investigated in acetate 
medium.  By comparing the calculated Eads values to β-haematin inhibition activity 
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2.4 ADSORPTION OF THE CLINICALLY-RELEVANT INHIBITORS ONTO THE 
β-HAEMATIN CRYSTAL SURFACES 
With a comprehensive adsorption protocol in hand, which was developed by investigating the 
adsorption of a small set of quinoline compounds onto β-haematin, the study was extended to 
evaluate the adsorption of quinoline clinically-relevant antimalarial drugs onto β-haematin. 
From the current drugs used for malaria treatment, AQ, CQ, MQ (±), and QN were chosen 
(Figure 12), as well as quinidine (QD) (Figure 41), an active antimalarial drug which is no 




Figure 41: The chemical structure of quinidine (QD). 
 
Similarly as for the previous set of quinoline compounds, the speciation at pH 4.8 for each of 
these compounds was calculated (Table 9). AQ and CQ are found to be diprotic at pH 4.8, 
where MQ(±), QN, and QD are predominantly monoprotic at this pH. Both enantiomers of 
CQ were initially considered and investigated, however owing to the fact that both showed 
the same (mirrored) interactions to the crystal surface, and that the same adsorption energies 
for interaction with face {001} were obtained, we proceeded with only one enantiomer of CQ 
for the remainder of the study (CQ-S). 
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Table 9: The calculated and experimental pKa values, as well as the speciation at pH 4.8. 
 Quinoline nitrogen, pKa 1 pKa 2 % Diprotic % Monoprotic 











 10.3 100 0 
MQ(±)   8.6
b
 9.5 0 100 
QN  4.5 8.4
b
 9.1 14 86 
QD  4.5  9.1 14 86 




2.4.1 Adsorption onto face {011} 
For the adsorption onto face {011}, π-π interactions were not commonly observed. The 
inhibitors adsorbed in such a way that a hydrogen bonding interaction is observed between a 
hydrogen donor atom of the inhibitor and a carbonyl group exposed at the crystal surface. 
This is seen for AQ, MQ(±), QN, and QD. The adsorption geometries were consistent, 
irrespective of the various protic forms investigated. 
MQ(±), QD, and QN adsorbed in a similar way, where only the hydrogen atoms on the 
protonated  quinuclidine and piperidine nitrogens formed hydrogen bonding interactions to a 
carbonyl group on the crystal surface (Figure 42). The interaction distances were 2.0, 1.8, and 
2.2 Å respectively. Strangely, the formation of π-π interactions was not observed.  
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Figure 42: Adsorption of QD and MQ-S onto face {011}. 
The adsorption of QD (left) and MQ-S (right) in the monoprotic form onto face {011}, as viewed from the side 
of the crystal face. Hydrogen bonding interactions are indicated by   .  
 
AQ adsorbed slightly differently, where the molecule stretches over the crystal surface 
(Figure 43). However, no π-π interaction was observed, although both the protonated tertiary 
amine and the hydroxyl moiety on the side-chain could form hydrogen bonding interactions 
to a carbonyl group on the crystal surface, with measured interaction distances of 2.7 and 
2.0 Å respectively.  
CQ was the only compound in this set that adsorbed in such a way that a π-π interaction 
could be favoured, in a similar manner to that observed for the adsorption of compound 
KN12 in Figure 34. Furthermore, with the π-π interaction being favoured in this case, the 
side-chain is extended over the crystal surface to an extent that the protonated tertiary amine 
could not form a hydrogen bonding interaction to one of the carbonyl groups on the surface 
(Figure 44).   
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Figure 43: Adsorption of AQ onto face {011}. 
The adsorption of AQ in the diprotic form onto face {011}, as viewed from the side of the crystal face (left), as 
well as viewed from the back (right). Hydrogen bonding interactions are indicated by   . 
 
Figure 44: Adsorption of CQ onto face {011}. 
The adsorption of CQ in the diprotic form onto face {011}, as viewed from the side of the crystal face, is shown. 
No hydrogen bonding interactions were observed. A possible π-π interaction that forms between CQ and the 
p rp yri     t   β-haematin crystal surface, with a measured interaction distance of 3.6 Å, is indicated by   . 
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For the adsorption onto face {011}, most of the inhibitors adsorb in such a way that hydrogen 
bonding interactions are formed between the inhibitor and the crystal surface, where CQ is 
the only inhibitor that adsorbs in such a way that a π-π interaction is formed between the 
inhibitor and the crystal surface. From this study it is clear that the formation of both 
hydrogen bonding interactions and π-π interactions is feasible, but it is not clear which of 
these interactions is necessarily preferred. 
 
2.4.2 Adsorption onto face {001} 
In evaluating the adsorption onto face {001}, all the inhibitors adsorbed into the primary 
adsorption site, with the exception of MQ(±), which, owing to the bulky -CF3 substituent, is 
too large to fit in the small primary adsorption site. Consequently, both stereoisomers of the 
latter compound (MQ-S and MQ-R) show a preference for adsorbing in the secondary 
adsorption site. As for the adsorption onto face {001}, the adsorption geometries were 
consistent, irrespective of the various protic forms investigated. 
The two stereoisomers of MQ adsorbed onto the crystal surface in an unexpected manner 
(Figure 45). Even though the -CF3 substituent makes the quinoline too bulky to fit into the 
primary adsorption site, it was expected that π-π interactions could form between the drug 
and the porphyrin in the secondary adsorption site, or that a hydrogen bonding interaction 
could form between the hydroxyl group and the carbonyl on the crystal surface. These 
interactions were not observed. 
However, for the obtained adsorption geometry of MQ, it might be that the -CF3 substituent 
is too bulky and thus causes repulsion of the quinoline away from the porphyrin surface. It is 
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possible that the fluorine atoms could form C-H···F interactions to nearby non-polar 
hydrogen atoms, with measured interaction distances of 2.7, 2.7, and 3.0 Å, respectively. 
These interactions have been shown to play a role in ligand-protein binding.
148
 Furthermore, 
it is also known for halogens to form an orthogonal C-O···F interaction,
148,149
 where this 
interaction might form between fluorine atoms on both ends of the quinoline to the two 
carbonyl groups on the crystal surface, with measured interaction distances of 2.9 and 3.0 Å. 
 
Figure 45: Adsorption of MQ-R onto face {001}. 
The adsorption of MQ-R in the monoprotic form onto face {001} is shown, as viewed from the side of the crystal 
face. The C-O···F interactions, with measured interaction distances of 2.7, 2.7 and 3.0 Å, are indicated by  , 
and the C-H···F interactions, with measured interaction distances of  2.9 and 3.0 Å, are indicated by  . The 
non-polar hydrogen atoms that form C-H···F interactions are indicated as grey balls, as part of the porphyrin 
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In general, the quinoline moieties of each inhibitor occupy the primary adsorption site, where 
the formation of π-π interactions to the top and the bottom porphyrin on the crystal surface is 
seen. For AQ and CQ, the side-chains are not observed to participate in hydrogen bonding 
interactions, as the proton donor atoms extend too far from the carbonyl groups on the crystal 
surface (Figure 46).  
 
Figure 46: Adsorption of CQ onto face {001}. 
The adsorption of CQ onto face {001} in the diprotic form is shown, as viewed from the side of the crystal face. 
The inhibitor could form possible π-π i t racti  s t  t   p rp yri     t   β-haematin crystal surface, with 
measured interaction distances of 3.5 and 3.7 Å. These interactions are indicated by   . 
 
QN and QD are able to form both π-π interactions to the porphyrin, as well as hydrogen 
bonding interactions just outside the primary pocket (Figure 47). In both cases, the side-chain 
extends to allow the hydrogen atom on the protonated quinuclidine moiety to form a 
hydrogen bonding interaction to a carbonyl group on the crystal surface, with a measured 
interaction distance of 2.0 Å.  
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Figure 47: Adsorption of QN onto face {001}. 
The adsorption of QN in the diprotic form onto face {001}, as viewed from the side of the crystal face (left), as 
well as from the back (right), is shown. The hydrogen bonding interaction that forms over a distance of 2.0 Å 
are indicated by   , and the  π-π interactions, with measured interaction distances of 3.6 and 3.7 Å are 
indicated by   . 
 
The adsorption geometry of QN and QD is considered as the ideal adsorption geometry for 
the adsorption into the primary and secondary adsorption sites, where both π-π intearctions 
and hydrogen bonding interactions form between the inhibitor and the crystal surface. It is 
commonly known in drug development that enhaced drug activity is brought about with the 
formation of an increased number of intermolecular interactions between the drug and the 
active site.
150
 Therefore, for this study, enhanced adsorption could be promoted by increasing 
the number of intermolecular interactions formed between the inhibitor and the crystal 
surface. Furthermore, if a correlation is found between an enhanced adsorption energy 
value (Eads) and a more active β-haematin growth inhibition activity value, a greater number 
of molecular interactions between the inhibitor and the crystal surface would result in an 
improved adsorption, an thus an increased β-haematin growth inhibition activity. 
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Also, considering that face {001} has a distinctive crevice for inhibitors to adsorb into, the 
formation of π-π interactions in the primary adsorption site, as well as the formation of 
hydrogen bonding interactions in the secondary adsorption site, could be optimised for 
enhanced adsorption. Therefore, the computational investigation of the adsorption onto 
face {001} would be beneficial for future drug design purposes. Also, with the surface of 
face {001} (secondary adsorption site) being very similar to that of face {011}, by designing 
a compound for the optimal adsorption onto face {001}, it would be reasonable to expect that 
it would also favour adsorption onto face {011}. 
 
2.4.3 Investigating structure-activity relationships 
2.4.3.1 Comparing the calculated Eads against the lipid BHIC50 for the clinically-relevant 
inhibitors. 
One advantage of investigating the adsorption of clinically-relevant antimalarial drugs onto 
β-haematin, is that these compounds are commercially available and therefore, their 
β-haematin inhibition activity has been assessed using various assays. Furthermore, by 
evaluating the adsorption onto the fastest growing faces computationally, the calculated 
Eads values, as well as the preferred adsorbed geometries of these compounds, could provide a 
greater understanding in the mechanism of β-haematin inhibition by the adsorption of 
inhibitors onto the crystal surface. 
The three assays that were used are discussed in Section 1.4.4, where Ncokazi et al. reported 
the acetate BHIC50 values of these compounds.
107
 The set of clinically-relevant compounds 
was extended by including compounds KN6 and KN7 from the previous study, which were 
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kindly resynthesised by a fellow student within our research group, Jonathan Hay.
151
 A larger 
data set would be more representative and also permit outliers to be excluded if necessary 
without reducing the data set below the minimum required for a significant correlation. 
Furthermore, lipid BHIC50 values determined by Sharné Fitzroy,
119
 and NP40 BHIC50 values 
determined by Dr Kathryn Wicht, using an improved method,
152
 were available. Using the 
same procedure, NP40 BHIC50 values for compounds KN6 and KN7 were determined in the 
current study. However, prior to analysis, it was reasoned that with the conditions of the lipid 
BHIC50 assay best representing the physiological environment within the parasite, it would be 
more suitable to first compare the Eads values against these activity results.  
By first evaluating the adsorption onto face {001} against the lipid BHIC50 activity, and 
thereby taking into account the percentages of speciation, an R
2
 value of 0.49 and a 
significant P value of 0.05 is found (Table 10, Figure 48). Furthermore, by evaluating the 
adsorption onto face {011} against the lipid BHIC50 activity, a non-significant trend is 
observed, with an R
2
 value of 0.1 and a P value of >0.05 (Table 11, Figure 49).  
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Table 10: The determined lipid BHIC50 activity of the clinically relevant-inhibitors, as well as the 





















































































































KN6 -66.5 ± 0.3    100 0 -66.3 29.8 ± 0.7 
KN7 -51.5 ± 0.01    100 0 -51.4 55.5 ± 9.9 
AQ -69.8 ± 0.2 -70.5 ± 0.01 98 2 -69.9 5.9 ± 0.3 
CQ -67.0 ± 0.01    100 0 -66.7 18.8 ± 0.6 
MQ-S    -55.7 ± 0.01 0 100 -55.7 22.9 ± 0.6 
MQ-R    -61.6 ± 0.01 0 100 -61.6 22.9 ± 0.6 
QD -80.8 ± 0.01 -73.6 ± 0.01 14 86 -74.6 20.1 ± 2.7 
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Table 11: The determined lipid BHIC50 activity of the clinically-relevant inhibitors, as well as the 





















































































































KN6 -46.4 ± 0.1    100 0 -46.2 29.8 ± 0.7 
KN7 -53.1 ± 0.01    100 0 -53.0 55.5 ± 9.9 
AQ -59.1 ± 0.01 -58.9 ± 0.01 98 2 -59.1 5.9 ± 0.3 
CQ -48.3 ± 0.01    100 0 -48.2 18.8 ± 0.6 
MQ-S -48.8 ± 0.01 -48.8 ± 0.01 0 100 -48.8 22.9 ± 0.6 
MQ-R -55.3 ± 0.5 -55.3 ± 0.5 0 100 -55.3 22.9 ± 0.6 
QD -57.3 ± 0.1 -56.3 ± 0.01 14 86 -56.4 20.1 ± 2.7 
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Figure 48: Comparison of the calculated Eads values against the lipid BHIC50 activity for adsorption of the 
clinically-relevant inhibitors and compounds KN6 and KN7 onto face {001}. 
An R
2






















Figure 49: Comparison of the calculated Eads values against the lipid BHIC50 activity for adsorption of the 
clinically-relevant inhibitors and compounds KN6 and KN7 onto face {011}. 
An R
2
 value of 0.01 and a P value >0.05 are obtained. 
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These trends were somewhat of a surprise, since the trends for the small quinoline 
compounds were the opposite, where the better correlation was found for the adsorption onto 
face {011}. This result led to the conclusion that there may be more aspects to consider than 
only the adsorption of the preferred speciation form onto the two fastest growing faces. 
Furthermore, it is also found that the Eads values for the adsorption of the clinically-relevant 
drugs onto face {001}, are generally more favourable than that for the adsorption onto 
face {011}. 
It could be that for a single molecule, the adsorption onto one crystal face could be more 
favoured than onto the other. Furthermore, it could also be that the adsorption of one 
speciation form is favoured onto one crystal face, where the adsorption of the other speciation 
form is favoured onto the other crystal face. Therefore, the various speciation forms, as well 
as the adsorption onto the two fastest growing crystal faces, had to be evaluated. 
2.4.3.2 Introducing multiple correlation studies. 
In order to evaluate the contribution of different protic forms, as well as a particular 
compound's preference for either the {001} or {011} face, a type of multiple correlation 
calculation was considered. For this evaluation, the Solver module within Microsoft Office 
Excel was used. 
The speciation is accounted for by taking into account a percentage fraction of each 
speciation form, similar to that discussed in Section 2.3.3. Therefore, y would represent the 
fraction in the monoprotic form (Equation 2.3), and z would represent the fraction in the 
diprotic form (Equation 2.4). 
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)    (2.3) 
         (
         
   
)         (2.4) 
Furthermore, the preferred crystal face for each of these speciation forms is taken into 
account by calculating a fraction of the two Eads values obtained for the adsorption of this 
speciation form onto each of the two crystal faces. For example, for the diprotic form of a 
compound, a
D
 is a function of the adsorption onto face {001} (Equation 2.5), and b
D
 is a 
function of the adsorption onto face {011} (Equation 2.6). 
            {
      
              
}                    (2.5) 
             {
      
             
}            (2.6) 
Similarly, for the monoprotic form, a
M
 is a function of the adsorption onto face {001} 
(Equation 2.7), and b
M
 is a function of the adsorption onto face {011} (Equation 2.8). 
            {
      
              
}                    (2.7) 
             {
      
             
}            (2.8) 
Finally, by combining all of these parameters, a multiple correlation equation is obtained for 




are allowed to 
freely refine in order to obtain the best fit of the calculated Eads values to the activity results. 
 
                                                                   (2.9) 
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Upon applying this multiple correlation equation to the data comparing the calculated 
Eads values to the lipid BHIC50 data for the clinically-relevant antimalarial drugs, the best fit 




 were found to be 0.04, 0.53, 0.30, and 0.13 respectively  
(Table 12), and an R
2
 value of 0.78 and corresponding P value of 0.004 are observed  
(Table 13, Figure 50).  
Table 12: Final variables calculated for the clinically-relevant inhibitors 
Variable Value Crystal face Speciation form 
    
v
1
 0.04 {001} Monoprotic 
v
2
 0.53 {011} Monoprotic 
v
3
 0.30 {001} Diprotic 
v
4
 0.13 {011} Diprotic 
 
Table 13: The determined lipid BHIC50 activity of the clinically relevant inhibitors, as well as the 








Lipid BHIC50  
(μM) 
 
KN6 -73.4 29.8 ± 0.7 
KN7 -57.0 55.5 ± 9.9 
AQ -78.6 5.9 ± 0.3 
CQ -73.8 18.8 ± 0.6 
MQ-S -68.0 22.9 ± 0.6 
MQ-R -77.8 22.9 ± 0.6 
QD -77.0 20.1 ± 2.7 
QN -66.4 31.0 ± 2.5 
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Figure 50: Multiple correlation fit for the clinically-relevant inhibitors. 
The multiple correlation fit for comparing the calculated Eads to the lipid BHIC50 activity for the 
clinically-relevant inhibitors. An R
2




 calculated as having the largest contribution to this correlation and 
variable v
3
 calculated as having the second-largest contribution to this correlation, it could be 
concluded that the clinically-relevant inhibitors have an overall preference to adsorb onto 
face {011} in the monoprotic form, followed by a preference to adsorb in the diprotic form 
onto face {001}. This result is reasonable, since half of the inhibitors investigated, are 
primarily in the monoprotic form at pH 4.8. Furthermore, with compound KN7, as well as the 
two isomers of MQ being unable to adsorb into the primary adsorption site on face {001}, 
adsorption is primarily preferred onto face {011}.  
Similarly, by applying this multiple correlation equation to the data comparing the calculated 
Eads values to the acetate BHIC50 for the small quinoline compounds, the variables v1 - v4  
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were found to be 0.00, 0.57, 0.15, and 0.29 respectively (Table 14), where an R
2
 value of 0.56 
and a P value of 0.004 are found (Table 15, Figure 51). 
Table 14: Final variables calculated for the small quinoline compounds 
Variable Value Crystal face Speciation form 
    
v
1
 0.00 {001} Monoprotic 
v
2
 0.57 {011} Monoprotic 
v
3
 0.15 {001} Diprotic 
v
4
 0.29 {011} Diprotic 
 
Table 15: The determined acetate BHIC50 activity of the small quinoline compounds, as well as the 








Acetate BHIC50  
(eq) 
 
KN1 -45.1 15.6 ± 0.5 
KN2 -42.9 14.9 ± 0.3 
KN3 -48.0 17.0 ± 4.0 
KN4 -52.2 9.7 ± 0.8 
KN5 -57.6 4.4 ± 0.7 
KN6 -59.2 2.2 ± 0.2 
KN7 -60.4 8.0 ± 2.0 
KN8 -64.8 3.1 ± 0.6 
KN9 -47.4 10.6 ± 0.4 
KN10 -46.9 10.3 ± 0.3 
KN11 -48.1 5.4 ± 0.2 
KN12 -51.7 5.4 ± 0.5 
KN13 -47.4 6.3 ± 0.8 
KN14 -56.1 5.3 ± 0.4 
Stellenbosch University  https://scholar.sun.ac.za
























Figure 51: Multiple correlation fit for the small quinoline inhibitors. 
The multiple correlation fit for comparing the calculated Eads values to the acetate BHIC50 activity for the small 
quinoline inhibitors. An R
2
 value of 0.56 and a P value of 0.004 are found. 
 
Notably, a less significant correlation is found for this larger data set. A slightly greater 
preference for adsorption onto face {011} in the monoprotic form is found as for the 
clinically-relevant inhibitors, where variable v
4
, for adsorption of the diprotic form onto 
face {011}, is calculated to have the second-largest contribution to this correlation.  
However, only 2 of the 14 compounds were calculated to adsorb partially in the monoprotic 
form (compounds KN8 and KN14), and only 2 compounds were unable to adsorb into the 
primary adsorption site on face {001} (compounds KN7 and KN11). Therefore, with most of 
the compounds showing preference for adsorbing onto face {001} in the diprotic form, a 
greater contribution of the variable v
3
 is expected.   
Considering that a linear correlation is found between the lipid BHIC50 activity and biological 
activity, and that a non-significant correlation is found between lipid BHIC50 activity and 
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acetate BHIC50 activity, this result does not come as a surprise (Section 1.4.4).
119
 In fact, it 
indicates that the correlations observed here for comparing the Eads values to the two BHIC50 
activities, agrees with what have been previously reported. Therefore, this highlights the 
significance of seeing a linear correlation between the calculated Eads values and the 
lipid BHIC50 activities for the clinically-relevant inhibitors. 
Finally, from these results, it is concluded that the adsorption of inhibitors onto β-haematin is 
a more complex process than originally anticipated. However, by taking into account the 
speciation and the differential adsorption onto both the fastest and the second-fastest growing 
faces, it is demonstrated that there is a significant correlation between the computed 
Eads results and the determined lipid BHIC50 values.  
This finding strongly supports the hypothesis that quinoline antimalarial drugs exert their 
mechanism of action by adsorbing to the fastest growing faces of β-haematin and thereby 
inhibit β-haematin growth. 
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2.5 EXAMINING THE STEP PROPAGATION 
Olafson et al. reported the formation of new layers onto β-haematin in a step-like manner 
(Section 1.4.1).
49
 Nucleation was mainly observed on the largest crystal face, face {100}, 
where newly formed islands were observed by AFM to grow in the b and c directions to form 
new layers. The results are reportedly consistent with a classical mechanism of 
crystallisation. 
At the start of this study, the insights of Olafson et al. regarding the nucleation and growth of 
β-haematin were not published. However, when their report became available, the current 
study was extended to investigate the step propagation in Materials Studio as a means of 
determining the important interaction sites on these crystal faces. Furthermore, with an 
optimised adsorption protocol in hand, it could be used to compare the adsorption of the 
clinically-relevant inhibitors onto the newly formed steps to the results presented above.  
 
2.5.1 Investigating the crystal faces formed upon step propagation. 
Considering the proposed mechanism of crystal growth on the largest face, face {100}, step 
formation on the crystal face and subsequent growth in the b and c directions would result in 
a newly formed island, having similar sides as to that of the overall β-haematin crystal 
(Figure 52). These sides are identical to face {010}, face {011}, and face {001}. Therefore, 
when the crystal grows faster at the fastest growing faces, the island would be extended to 
grow in length in the c direction.  
The crystal grows with the addition of one haem molecule, or one β-haematin dimer at a time. 
The exact mechanism of β-haematin crystal growth is still unknown.
153
 Therefore, for the 
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purposes of this project, crystal growth would be considered as the addition of one 
β-haematin dimer onto the crystal surface. 
 
Figure 52: Step propagation onto face {100}. 
Face {100} is viewed from the top. Here, step propagation onto face {100} is shown in the grey box, where 
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Similarly, for step propagation to occur onto face {010} in the b direction, both the sides of 
the newly formed step would predominantly represent the surface of face {011} (Figure 53). 
However, the corner that forms on the one side of the step between faces {011} and {010}, 
(indicated in red on the left of the blue box in Figure 53), represents the surface of 
face {001}. With further growth in the b direction, this side would further represent the 
surface of face {011}. 
 
Figure 53: Step propagation onto face {010}. 
Step propagation onto face {010} is shown, where growth in the b direction is indicated with a blue arrow. The 
surface that forms on the sides of the box represents face {011}. However, the intersection that forms on the left 
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When the crystal expands in the c direction, steps would form onto face {001} and 
face {011} (Figure 54). Therefore, step propagation onto both these crystal faces was 
examined more closely (Figure 55).  
 
Figure 54: Step propagation onto faces {001} and {011}. 
Step propagation onto faces {001} and {011} is shown, where growth in the c direction is indicated by a blue 
arrow. Face {100} is viewed from the top. 
 
For the step propagation onto face {011} (Figure 55), it is found that the newly formed step 
has sides that are identical to face {010} and face {001}. However, the same observation is 
only made for the one side of the step that forms onto face {001}, where the one side 
represents face {011}. The other side of the step forms a terrace that represents face {010}, 
where this extends over a primary pocket. Here this terrace forms another hydrophobic 
porphyrin surface above the primary pocket, to which the clinically-relevant antimalarial 
drugs could form π-π interactions. 
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Figure 55: Step propagation onto face {001} (left) and face {011} (right). 
Step propagation onto face {001} (left) and face {011} (right), are shown. For the step onto face {011}, the 
surface above the blue box represents face {010}, where the surface below the blue box represents face {001}. 
For the step onto face {001}, the surface above the blue box represents face {011}, where the terrace below the 
blue box represents face {010}. Face {100} is viewed from the top. 
 
With a greater understanding of the crystal morphology attained, this insight was further used 
to explore step propagation onto the four most dominant crystal faces of β-haematin. 
Moreover, by having an in-depth understanding of the step propagation onto the two fastest 
growing faces, faces {001} and {011}, the adsorption of inhibitors onto these more complex 
surfaces could be investigated. 
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2.5.2 Adsorption of clinically-relevant inhibitors onto the steps 
2.5.2.1 Preparing the vacuum slabs 
Once a new step forms on top of face {100}, it will expand in the b and c directions, showing 
faster growth in the c direction. By doing so, steps would form onto face {011} and 
face {001} more rapidly than onto face {010}. Therefore, for the expansion in the b direction, 
face {010} forms a step where the sides represent face {001} and face {011}. Also, the one 
side of the step onto face {001} represents face {011}, where the one side of the step onto 
face {011} represents face {001}. The adsorption of the clinically-relevant inhibitors onto the 
faces {001} and {011} was already investigated and is previously discussed in this chapter 
(Section 2.4). 
However, for step propagation onto face {011}, one of the sides of the step represents 
face {010}, where the newly formed flat surface adjacent to face {011} might allow for 
additional π-π interactions to form to it. Furthermore, for step propagation onto face {001}, 
the one side of the step forms a terrace that represents face {010}. This terrace extends over a 
primary pocket, where it could allow side-chains of molecules to form π-π interactions or 
hydrophobic interactions to. Therefore, considering that a new step forms onto the largest 
crystal face, face {100}, and that fastest growth occurs in the c direction, the adsorption of 
clinically-relevant inhibitors onto these two areas was examined (Figure 56). 
For this, vacuum slabs were created that mimicked these corners between the crystal faces. 
A larger crystal thickness was used compared to the previous studies, where selected unit 
cells were deleted to create a three dimensional surface that would mimic the corners formed 
between the crystal faces.  
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Upon further investigating the new corner that forms between face {001} and face {100}, an 
additional free carbonyl group is observed on the surface of face {100} in the primary pocket. 
This could form a hydrogen bonding interaction to either another β-haematin dimer, haem, or 
an inhibitor. The same is observed for the corner that forms between face {011} and face 
{100}, but this is not a new interaction on face {011}. 
By preparing the vacuum slabs that represent the step propagation at the two corners that 
form between faces {001} and {100}, and faces {011} and {100}, adsorption of the 
clinically-relevant inhibitors onto these faces was investigated. 
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Figure 56: The two crystal surfaces investigated. 
The newly formed steps onto face {001} (a and b) and face {011} (c and d) are shown, where the steps are 
indicated in orange and face {100} is shown in green. The newly formed corner interaction sites are indicated 
by a red button for face {001} (b) and face {011} (d). The new hydrogen bonding interaction site  
on face {001} is indicated by  in (a). 
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2.5.2.2 The results pertaining to the adsorption of clinically-relevant inhibitors onto the 
steps  
2.5.2.2.1 Adsorption with step propagation onto face {001}  
For the adsorption of the inhibitors onto face {001}, it is found that these compounds 
preferentially adsorb into the slightly more embedded primary adsorption site (previously 
shown in Figure 55), in a manner similar to that observed for the original primary adsorption 
site investigated, with similar calculated Eads values (Table 16). MQ (both R and S isomers) 
and compound KN7 were excluded from this study, as these compounds showed preference 
to adsorb onto the secondary adsorption site in the previous study (Section 2.4). 
Some of the inhibitors (AQ, CQ, QD) showed a preference for adsorbing into the new corner 
that formed between face {100} and face {001}, where  improved Eads values of up to 
5 kcal.mol
-1
 were determined. However, the same geometries as previously observed, is 
found. It is possible that the increase in the Eads values is simply due to the formation of 
hydrophobic interactions to the surface on face {100}, therefore allowing for higher 
interaction energies. For the adsorption of AQ into this corner (as an example), the formation 
of C-H···Cl halogen bonding interactions between the inhibitor and the porphyrin structure 
on face {100} are observed, with measured interaction distances of 2.7 and 3.0 Å (Figure 57). 
This interaction is not possible in the absence of face {100}. Therefore, this interaction was 
not observed in the previous study (Section 2.4). 
Unfortunately, with not all of the inhibitors adsorbing into the corner formed between 
face {100} and face {001}, structure-activity relationships could not be meaningfully 
investigated.  
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Figure 57: Adsorption of AQ in the corner between faces {001} and {100}. 
The adsorption of AQ in the diprotic form, into the corner that forms between faces {001} and {100}, is shown, 
as viewed from the front of face {001}. The original face {001} is shown in grey, face {100} is shown in green, 
and the new terrace that forms above the crevice is shown in orange. The formation of π-π interactions, with 
measured interaction distances between 3.6 and 3.8 Å, are indicated by   . The C-H···Cl interactions that 
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Table 16: Calculated Eads values for the step propagation onto face {001}. 





















    
Diprotic    
KN6 -66.5 ± 0.3 -66.5  
AQ -69.8 ± 0.2 -69.7 -74.5 
CQ -67.0 ± 0.01 -67.0 -72.3 
QD -80.8 ± 0.01 -80.8 -85.9 
QN -66.2 ± 0.01  -70.6 
    
Monoprotic    
QD -73.6 ± 0.01 -74.9 -83.7 
QN -65.4 ± 0.01 -65.4  
    
a
The primary site originally investigated in Section 2.4. 
b
The new embedded primary site that forms. 
c
The primary site that forms between faces {001} and {100}. 
*
No standard deviations are reported for the adsorption onto the steps. These results were less consistent,  
 where some of these adsorbed geometries were only observed once. Therefore, the best Eads value for each  
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2.5.2.2.2 Adsorption with step propagation onto face {011} 
Upon evaluating the adsorption of the inhibitors onto face {011}, significantly more favoured 
Eads values were calculated as compared to the initial adsorption study without the step, 
where an additional interaction towards the flat surface resembling face {010}, is observed 
(Table 17).  
However, similar Eads values are calculated for inhibitors that adsorbed into the corner formed 
between face {100} and face {011}, compared to the ones that did not. This might be an 
indication that the newly formed π-π interactions that form between the inhibitors and the 
porphyrin structures on face {010}, have a greater contribution to the overall Eads energy, as 
opposed to the hydrophobic interactions to face {100}. Furthermore, the adsorption onto the 
flat surface resembling face {010} alone, results in lower Eads values compared to the 
adsorption onto both faces {011} and {010}. This indicates that adsorption onto both the two 
crystal faces is required for a significantly improved adsorption. 
This result could be explained by evaluating the adsorption of AQ (as an example) onto the 
crystal surface that forms upon step propagation onto face {011} (Figure 58). The formation 
of two π-π interactions (measured distances of 3.6 and 3.8 Å, respectively) between the 
quinoline moiety of the inhibitor and face {011} is observed. A third π-π interaction forms 
between the benzene ring in the side-chain of the inhibitor and face {010}.  
For the adsorption onto face {011} alone (Section 2.4), the formation of this third 
π-π interaction was not possible. Therefore, with the formation of an increased number of 
intermolecular interactions, a more favoured Eads value is obtained. 
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Figure 58: Adsorption of AQ onto the newly formed flat surface  
The adsorption of AQ in the diprotic form onto the newly formed flat surface that involves face {011} (grey) and 
face {010} (orange), is shown, as viewed from the side of face {011}. Face {100} is omitted from this image.  
The newly formed π-π interaction between the inhibitor and the porphyrin structure on face {010}, is indicated 
by   ,  and is measured to be 3.7 Å. The two π-π interactions that form between the inhibitor and the 
porphyrin structure on face {011}, is indicated by  , and is measured to be 3.6 and 3.8 Å. 
 


























Corner between faces {011} 






     
Diprotic     
KN6 -64.4 ± 0.1  -60.5  
AQ -59.1 ± 0.01  -77.3 -77.3 
CQ -48.3 ± 0.01 -73.4 -62.3 -69.7 
QD -57.3 ± 0.1 -85.5  -81.7 
QN -48.5 ± 0.01 -68.8 -60.4 -69.2 
     
Monoprotic     
QD -56.3 ± 0.01 -74.7 -59.5  
QN -49.3 ± 0.01 -65.8 -61.6  
     
a
The original surface investigated in Section 2.4. 
b
The new surface that forms with face {011} and {010}. 
c
The new flat surface (face {010}). 
d
The new corner that forms between the surface of face {011} and {010}, and that of face {100}. 
*
No standard deviations are reported for the adsorption onto the steps. These results were less consistent, where some of these adsorbed  
 geometries were only found once. Therefore, the best Eads value for each adsorbed geometry found, is rather reported. 
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As not all of the inhibitors adsorb onto the same adsorption site, structure-activity 
relationships could not be determined for this part of the study. However, a more in-depth 
understanding as to how the clinically-relevant inhibitors might adsorb onto these steps, has 
been obtained, and the interaction sites that might be involved in this process, were identified. 
The formation of additional intermolecular interactions between the inhibitors and the new 
crystal face that is introduced, has been observed, which also resulted in more favoured Eads 
values. This has demonstrated that an increased number of intermolecular interactions results 
in more favoured Eads values. 
Olafsen et al. demonstrated that the β-haematin crystal grows in a step-like manner, where 
the inhibitors could also adsorb onto these steps to inhibit further crystal growth. What is not 
yet clear, is to what extent the inhibitors would prefer to adsorb onto the corners of these 
steps, as opposed to the larger crystal faces (faces {001} and {011}). It might be that a larger 
percentage of adsorption could occur onto the larger crystal faces, as opposed to the steps, 
since the available adsorption sites might be more abundant. 
To one end, it is pleasing to find that the clinically-relevant inhibitors adsorb onto these 
step-like surfaces (especially onto face {001}) in a similar manner as for the adsorption study 
performed without considering the step. This suggests that the less complex simulation is 
sufficiently valid as a model system for investigating the adsorption of small inhibitors onto 
β-haematin. This protocol could be used to design more potent β-haematin inhibitors. 
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2.6 CONCLUDING REMARKS PERTAINING TO CHAPTER 2 
2.6.1 The significance of this chapter 
Solomonov et al. reported physical evidence that β-haematin growth is inhibited in the 
presence of quinoline antimalarial drugs,
73
 where Buller et al. proposed possible geometries 
for the adsorption of clinically-relevant inhibitors onto the fastest growth face of 
β-haematin.
54
 However, in order to gain a more comprehensive understanding of the 
adsorption of inhibitors onto the β-haematin crystal, a more in-depth study was needed. 
The main aim of this chapter was to investigate the adsorption of clinically-relevant inhibitors 
onto the fastest growing crystal faces. In order to achieve this goal, a force field was 
parameterised that is able to accommodate the high-spin Fe (III) atom. An additional 
investigation was performed where the crystal morphology of the β-haematin crystal was 
computed, and possible interaction sites on the four largest expressed crystal faces were 
identified. To this end, the adsorption of a set of quinoline compounds onto the fastest and the 
second fastest growth faces were evaluated by means of a simulated annealing adsorption 
protocol, where this data set was used to determine the optimum parameters needed for this 
protocol. 
Finally, with this adsorption protocol optimised, it was applied to evaluate the adsorption of 
clinically-relevant inhibitors onto face {001}, as well as onto face {011}. The adsorbed 
geometries that were obtained for the adsorption of the inhibitors onto face {001}, were 
similar to that reported by Buller et al., where the inhibitors were fitted manually onto the 
crystal surface.
54
 The ideal adsorbed geometry is obtained for the adsorption of QN and QD 
into the primary adsorption site, where both the formation of hydrogen and π-π interactions 
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between the inhibitor and the crystal surface is observed. It is found that larger molecules, 
such as MQ, preferred adsorption onto the secondary adsorption site. For the adsorption onto 
face {011}, the adsorption geometries obtained were less favoured, where this crystal surface 
resembles the secondary adsorption site on face {001}.  
To this end, structure-activity relationships were evaluated, where the calculated Eads values 
were compared to the determined lipid BHIC50 activities. A linear correlation is obtained for 
the adsorption onto face {001}, when taking into account the percentage speciation at pH 4.8. 
This correlation is considered to be significant, with an R
2
 value of 0.49 and a P value 
of 0.05. By considering that adsorption occurs onto both of the fastest growing crystal faces, 
a multiple correlation equation was applied to the data, where an improved correlation is 
found, with an R
2
 value of 0.78 and a P value of 0.004. It is thus demonstrated that a linear 
correlation exists between the calculated Eads values, and the determined lipid BHIC50 
activities, for clinically-relevant quinoline β-haematin inhibitors, when taking into account 
adsorption onto both faces {001} and {011}, and the percentage speciation at pH 4.8. This is 
a significant contribution, and adds weight to the argument that quinoline antimalarial drugs 
execute their mechanism of action by adsorbing onto the β-haematin crystal surface, and 
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By parameterising a force field that is able to accommodate the high-spin Fe(III)-complex, 
and by optimising the adsorption protocol, a comprehensive study on the adsorption of 
clinically-relevant inhibitors onto both the fastest and the second fastest β-haematin crystal 
faces, was performed. 
To this end, it is established that the adsorption of inhibitors onto β-haematin is a more 
complex process than originally anticipated, since multiple factors need to be considered. 
As a result, it has been demonstrated that a linear correlation exists between the calculated 
Eads values and the determined lipid BHIC50 activities, when the adsorption onto both the 
fastest and the second fastest growth faces is considered, as well as the percentage speciation 
at pH 4.8. 
This finding contributes significantly to the understanding that clinically-relevant inhibitors 
brings about β-haematin growth inhibition by adsorbing onto the fastest growing crystal 
surfaces. 
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The current antimalarial drugs used in ART treatment are quinoline-based or 
artemisinin-based, where the artemisinin compounds are believed to have a different mode of 
action. However, due to growing resistance to quinoline compounds, a greater emphasis is set 
on finding more potent antimalarial drugs, especially with non-quinoline scaffolds. 
With this research project forming part of a larger collaborative project, three small libraries 
of larger non-quinoline compounds were accessible, where the adsorption of these 
compounds onto the two fastest growing faces of β-haematin could be investigated. Rather 
than opting for a larger library, a more thorough investigation could be performed by 
studying a smaller library more closely. It is anticipated that these compounds would follow 
the same structure-activity trend as seen for the clinically-relevant antimalarial drugs, where 
these findings could be combined with the results obtained in the initial adsorption study, in 
order to strengthen the argument on β-haematin inhibition by adsorption of antimalarial drugs 
onto the crystal surface. 
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3.1 INVESTIGATING THE ADSORPTION GEOMETRY OF NON-QUINOLINE INHIBITORS 
ONTO β-HAEMATIN  
3.1.1 Introducing the three libraries of inhibitors  
The three libraries of compounds used in this study were chosen based on their ability to 
inhibit β-haematin formation, as well as for the variance in molecular structure that they 
offer. These molecules were shown to be active β-haematin inhibitors in previous studies 
within our research group; therefore it was reasoned that by analysing the adsorption of these 
inhibitors onto β-haematin, a greater understanding of how these non-quinoline inhibitors 
might affect β-haematin growth by adsorption could be gained. 
Given the findings in the preceding chapter, it seemed reasonable that the smaller compounds 
would be able to fit into the primary adsorption site on face {001}, where the larger 
compounds would be left to adsorb onto the secondary adsorption site. Furthermore, given 
the more even topology of face {011}, the possibility that the larger compounds may prefer 
adsorption on this face is not excluded. 
3.1.1.1 2,4,5-Triaryl substituted imidazole inhibitors 
The first set of inhibitors to be investigated was a library of three 2,4,5-triaryl substituted 
imidazole compounds (Table 18). These were synthesised, and the NP40 BHIC50 activities 
were determined by Kathryn Wicht.
121,122
 The speciation of these inhibitors was determined 
to be neutral and monoprotic of nature at pH 4.8, where the second nitrogen in the imidazole 
ring could be protonated.  
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Table 18: The speciation of the 2,4,5-triaryl substituted imidazole inhibitors at pH 4.8. 


















































    
*
 These inhibitors were synthesised and the NP40 BHIC50 activities were determined by     
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3.1.1.2 Benzamide inhibitors 
The benzamide inhibitors used in this study were also synthesised by Kathryn Wicht, and the 
NP40 BHIC50 activities were subsequently determined, using the standard protocol  
(Table 19).
121,122
 The speciation of these inhibitors was predicted to be diprotic, monoprotic, 
as well as neutral of nature at pH 4.8, where either one or both of the pyridine nitrogen atoms 




Table 19: The speciation of the benzamide inhibitors at pH 4.8. 
Compound  % Diprotic % Monoprotic % Neutral 
     
KW4 
 
75 25 0 
KW5 
 
7 39 54 
KW6 
 
0 27 73 
KW7 
 
75 25 0 
*
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3.1.1.3 Benzimidazole inhibitors 
The benzimidazole inhibitors investigated in this study were synthesised, and the 
NP40 BHIC50 activities were determined by Fabrizio L’abbate, where this research forms 
part of his current PhD project (Table 20).  
The speciation of these inhibitors at pH 4.8 was determined.
143
 For all three inhibitors it is 
found to be 70% monoprotic and 30% neutral, where the second nitrogen in the 
benzimidazole ring could also be protonated. 
 
Table 20: The speciation of the benzimidazole inhibitors at pH 4.8. 
Compound  % Monoprotic % Neutral 























These inhibitors were synthesised and the NP40 BHIC50 activities were determined by  
 Fabri i  L’abbat . 
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3.1.2 Adsorption of non-quinoline inhibitors onto the β-haematin crystal surfaces 
3.1.2.1 Adsorption onto face {011} 
3.1.2.1.1 Adsorption of 2,4,5-triaryl substituted imidazole inhibitors  
For the adsorption onto face {011}, compounds KW1 and KW3 adsorbed in such a manner 
that maximised the formation of π-π interactions. However, these interactions were long-
range in nature and measured to be greater than 4 Å (Figure 59). Therefore, it is more likely 
that the adsorption of these inhibitors onto the crystal surface is rather promoted by 
hydrophobic attractions.  
The adsorption geometry of compound KW2 is considered slightly more favourable than that 
of compounds KW1 and KW3. For this compound, the formation of π-π interactions is 
observed between the aromatic rings of the inhibitor and a porphyrin on the crystal surface, 
with measured distances of 3.5 and 3.9 Å (Figure 60). Furthermore, a hydrogen bonding 
interaction is observed between the protonated nitrogen atom in the imidazole ring and a 
carbonyl group on the crystal surface, with a measured distance of 2.6 Å.  
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Figure 59: Adsorption of compounds KW1 and KW3 onto face {011} 
The adsorption of compounds KW1(top left) and KW3(top right) in the monoprotic forms onto face {011}, as 
viewed from above, is shown. The adsorption of compound KW3(bottom left) in the monoprotic form onto 
face {011}, as viewed from the side of the crystal face, is also shown. Weak π-π interactions, with measured 
interaction distances >4.0 Å, are indicated by   . 
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Figure 60: Adsorption of compound KW2 onto face {011}. 
The adsorption of compound KW2 in the monoprotic form onto face {011} as viewed from above, is shown. The 
hydrogen bonding interaction, with a measured interaction distance of 2.6 Å, is indicated by   .  
The π-π interaction to the imidazole ring is indicated by two dots ( ), and the other π-π interaction is indicated 
by   . The measured interaction distances are 3.5 and 3.9 Å, respectively. 
 
3.1.2.1.2 Adsorption of benzamide inhibitors onto face {011} 
Compounds KW4 and KW5 adsorbed onto face {011} in the same manner, where for 
compound KW4, two π-π interactions, with measured distances of 3.5 and 3.6 Å, 
respectively, were observed between the inhibitor and the porphyrin moiety, as well as a 
hydrogen bonding interaction between the amide N-H and a carbonyl group on the crystal 
surface, with a measured interaction distance of 2.7 Å (Figure 61). Only two of the aromatic 
rings are able to form π-π interactions to a porphyrin on the crystal surface, as the molecule 
extends too widely relative to the porphyrin moiety to allow for all three aromatic rings to 
form π-π interactions. 
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Figure 61: Adsorption of compounds KW4 and KW5 onto face {011} 
The adsorption of compounds KW4(left) and KW5(right) in the diprotic form onto face {011}, as viewed from 
above, is shown. Hydrogen bonding interactions, with measured interaction distances of 2.7 and 2.6 Å, 
respectively, are indicated by   , and π-π interactions, with measured interaction distances between 3.5 and 
3.8 Å, are indicated by   . 
 
Compounds KW6 and KW7 adsorbed in a slightly different geometry as seen above for 
compounds KW4 and KW5 (Figure 62), where for compound KW6 two π-π interactions to 
the porphyrin structure are formed, with measured distances of 3.5 Å, and a hydrogen 
bonding interaction with a measured distance of 2.7 Å. Again, for compound KW7, two π-π 
interactions were observed at measured distances of 3.4 and 3.5 Å, as well as a hydrogen 
bonding interaction at a distance of 2.5 Å.  
Interestingly, it is noticed that compound KW7 extends towards an adjacent porphyrin in 
another unit cell. No significant interactions are observed in this second unit cell. 
Furthermore, if compound KW7 had adsorbed slightly to the left on the crystal surface, a 
similar adsorption geometry as for compounds KW4 and KW5 would be obtained, and the 
hydrogen bonding interaction would rather form between the amide N-H on the left hand side 
of the molecule. With the current adsorbed geometry, this interaction distance is measured to 
be 3.4 Å, which is too long to form a strong hydrogen bonding interaction. 
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Figure 62: Adsorption of compounds KW6 and KW7 onto face {011} 
The adsorption of compounds KW6(top) in the monoprotic form  and KW7(bottom) in the diprotic form onto 
face {011}, as viewed from above, is shown. Hydrogen bonding interactions, with measured interaction 
distances of 2.7 and 2.5 Å, respectively, are indicated by   , and π-π interactions, with measured interaction 
distances between 3.5 and 3.8 Å, are indicated by   . 
 
3.1.2.1.3 Adsorption of benzimidazole inhibitors  
Compounds FL1-3 adsorbed onto the β-haematin crystal surface in the same manner, where 
the formation of two π-π interactions between the aromatic rings and the porphyrin moiety on 
the crystal surface are observed, with measured interaction distances of 3.6 Å each. 
Moreover, a hydrogen bonding interaction between the amide N-H and a carbonyl group on 
the crystal surface is observed, with a measured distance of 2.6 Å (Figure 63). As seen for 
compound KW7, these inhibitors adsorbed such that the molecule in each case extends over 
two unit cells.  
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Figure 63: Adsorption of compound FL3 onto face {011} 
The adsorption of compound FL3 in the monoprotic form onto face {011}, as viewed perpendicular to the 
crystal face, is shown. The hydrogen bonding interaction of 2.6 Å is indicated by   , and π-π interactions, 
with measured interaction distances 3.6 Å, are indicated by   . 
 
When adsorbing onto face {011}, the molecules mostly form two π-π interactions, as well as 
a hydrogen bonding interaction to the crystal surface. With the molecules observed to extend 
over an adjacent unit cell, it gives rise to the possibility that longer and more planar 
molecules could be able to form additional interactions on the crystal surface in the 
neighbouring unit cell. Therefore, by optimising the intermolecular interactions that could 
form, the adsorption onto face {011} could be enhanced for greater β-haematin inhibition. 
 
3.1.2.2 Adsorption onto face {001} 
3.1.2.2.1 Adsorption of 2,4,5-triaryl substituted imidazole inhibitors onto face {001} 
Compounds KW1-3 were found to adsorb into the primary adsorption site on face {001} 
(Figure 64). For these, π-π interactions are formed between the aromatic rings and the 
porphyrins on the crystal surface, with measured interaction distances of 3.5-3.7 Å. For all 
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three of these compounds, one of the aromatic rings is angled towards the outside of the 
crevice. This is seen to the left of the images in the case of compounds KW1 and KW2, and 
to the right of the image for compound KW3.  
   
 
Figure 64: Adsorption of compounds KW1-3 onto face {001}. 
The adsorption of compounds KW1(left), KW2(middle), and KW3(right) in the monoprotic form onto 
face {001}, as viewed onto the crystal face, is shown. The π-π interactions, with measured interaction distances 
between 3.5 and 3.8 Å, are indicated by   . 
 
3.1.2.2.2 Adsorption of benzamide inhibitors onto face {001} 
For the adsorption onto face {001}, compounds KW4-7 adsorbed into the primary adsorption 
site (KW5 and KW6 are shown as examples in Figure 65). Interestingly, compounds  
KW4 (monoprotic only), KW5, and KW7 (monoprotic only) adsorbed in such a manner that 
two adjacent primary adsorption sites are occupied, where π-π interactions are formed 
between the aromatic rings and the porphyrins on the crystal surface. These interaction 
distances were measured to be in the range of 3.4-3.8 Å. The more bulky functional groups 
are orientated towards the outside of the primary adsorption site, as illustrated by the 
tert-butyl moiety of compound KW5.  
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Figure 65: Adsorption of compound KW5 and KW6 onto face {001}. 
The adsorption of compounds KW5 (left) in the diprotic form and KW6 (right) in the monoprotic form onto 
face {001}, as viewed onto the crystal face, is shown. The π-π interactions, with measured interaction distances 
between 3.5 and 3.8 Å, are indicated by   . 
 
Compounds KW4 and KW7 displayed different adsorption geometries depending on whether 
the diprotic or monoprotic species were investigated. This was indeed a surprise, since for all 
of the other compounds investigated thus far, the same adsorption geometry, irrespective of 
the protic form, was observed.  As shown below, compounds KW4 and KW7 in the diprotic 
form are able to occupy both the primary and the secondary adsorption sites (Figure 66). It 
could be that the protonation on the pyridine nitrogen atom prevents the molecule from fitting 
soundly into the two adjacent primary adsorption sites, therefore promoting this alternative 
adsorption geometry. 
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Figure 66: Adsorption of compound KW4 onto face {001}. 
The adsorption of compound KW4 in the diprotic form onto face {001}, as viewed onto the crystal face (left), 
and as viewed from the side (right), is shown. The π-π interactions, with measured interaction distances between 
3.5 and 3.8 Å, are indicated by   . 
 
3.1.2.2.3 Adsorption of benzimidazole inhibitors onto face {001} 
The benzimidazole inhibitors adsorbed onto face {001} in a similar way as seen for the 
benzamide inhibitors. Compound FL1 adsorbed in a similar geometry as compound KW4 in 
its diprotic speciation form, where both the primary and the secondary adsorption sites are 
occupied (Figure 67). Here, it is more obvious that the chlorine atom in the 2-position of the 
aromatic ring may be responsible for preventing the molecule from adsorbing into the 
crevice, where in the absence of this chlorine atom, it would most likely occupy the two 
neighbouring primary adsorption sites simultaneously. The formation of π-π interactions 
between the aromatic rings and the porphyrins on the crystal surface is observed, with 
measured distances of 3.6 and 3.7Å, as well as a hydrogen bonding interaction between the 
benzimidazole N-H and a carbonyl oxygen on the crystal surface. This interaction distance 
was measured to be 2.4 Å. 
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Compound FL2 and FL3 adsorbed in similar geometries as compound KW5 (Figure 67), 
where two adjacent primary adsorption sites are occupied. The formation of π-π interactions 
between the aromatic rings and the porphyrins on the crystal surface is seen, with measured 
interaction distances of 3.4-3.7 Å. Moreover, a hydrogen bonding interaction is formed 
between the amide N-H and a carbonyl group on the crystal surface, with a measured 
interaction distance of 2.4 Å. 
  
 
Figure 67: Adsorption of compounds FL1 and FL2 onto face {001}. 
The adsorption of compounds FL1(left) and FL2(right) in the monoprotic form onto face {001}, as viewed onto 
the crystal face, is shown. Hydrogen bonding interactions of 2.4 Å are indicated by   , and π-π interactions, 
with measured interaction distances between 3.5 and 3.7 Å, are indicated by   . 
 
Upon evaluating the adsorption of the non-quinoline inhibitors onto the crystal surfaces, it 
appears that compounds KW1-3, KW5, KW6, FL2, and FL3, had the optimum adsorbed 
geometries, where the interaction surfaces were probed to such an extent that the maximum 
number of intermolecular interactions were formed. These molecular scaffolds, especially 
those of compounds KW5 and FL2, which occupy two primary adsorption sites, could be 
used as a starting point for designing new non-quinoline β-haematin inhibitors. 
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The results suggest that improved adsorption is obtained when the inhibitor adsorbs over two 
unit cells, thereby occupying two primary adsorption sites simultaneously. For all compounds 
that were able to occupy two neighbouring primary adsorption sites, adsorption onto 
face {001} was more ideal than for the adsorption onto face {011}, as the formation of a 
greater number of intermolecular interactions is observed. However, for compounds KW4, 
KW7, and FL1, that were unable to occupy the two neighbouring primary adsorption sites, 
adsorption onto face {011} was more favoured. 
For the adsorption onto face {011}, and the primary adsorption site on face {001}, the same 
linear and relatively planar configurations are favoured. Therefore, it is suggested that if an 
inhibitor is structurally optimised for the adsorption into the primary adsorption site on 
face {001}, it would also show favoured adsorption onto face {011}. 
Furthermore, as seen for the adsorption of QN in Section 2.4.1.2, adsorption geometries are 
observed in which both the primary and secondary adsorption sites on face {001} are 
occupied. These geometries could be optimised for enhanced adsorption onto face {001}. 
The synthesis of molecules that exploit the maximal interaction opportunities by adsorbing 
into both the primary and secondary adsorption sites on face {001}, is currently being 
investigated by a student in our collaborator's research group, Fabrizio L’abbate, where this 
work forms part of his PhD thesis. Therefore, this rationale was not investigated further in 
this dissertation.  
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3.1.3 Conformational analysis of the non-quinoline inhibitors 
Unlike the clinically-relevant quinoline inhibitors, it was found that the dynamics simulation 
was not sufficient to overcome high energy barriers in order to probe various conformations 
of the non-quinoline inhibitors. In fact, for the inhibitors that completely adsorbed into the 
primary adsorption sites, such as compounds KW5 and FL2, no significant change in the 
adsorption geometry was observed.  
Once an inhibitor adsorbs into the primary adsorption site, rotations about certain single 
bonds would bring about up to 90°, and finally 180° rotations of aromatic rings. This is not 
possible due to the height restriction inside the crevice once the inhibitor is adsorbed into the 
crevice, and therefore these conformations were not investigated during the dynamics 
simulation. In order to overcome this limitation, it was imperative to consider the adsorption 
of more than one starting conformation in order to ensure that the absolute minimum 
adsorbed conformation is found. 
Excluding peripheral methoxy substituents, compounds KW1-3 are somewhat symmetrical. 
Rotation around single bonds did not yield any new conformations (Figure 68). Therefore, a 
conformational search was not performed on these compounds and the final dynamics 
optimisation was considered to be sufficient.  
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Figure 68: The three rotatable bonds of compound KW3  of interest in generating different 
conformations. 
 
The rotatable bonds for compounds KW5 (a representative benzamide) and FL2 
(a representative benzimidazole) were identified, where the conformations of interest were 
generated by rotating these bonds by 180° (Figure 69).  Considering that these inhibitors were 
previously observed to adsorb into the primary adsorption site, and form π-π interactions in 
the secondary adsorption site, only conformations where the aromatic rings are planar to one 
another were investigated. Otherwise, the molecules would not be able to form the optimum 





Figure 69: Rotatable bonds of interest for compounds KW5 (left) and FL2 (right). 
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3.1.3.1 Results pertaining to the conformational analysis 
In order to justify our decision to only rotate the bonds by 180° and not by just 90°, an 
adsorption simulation, followed by a dynamics optimisation was performed on a non-planar 
conformation where a single bond was rotated by only 90° degrees (Figure 70). It is found 
that during the dynamics simulation, the bond rotated to ensure a planar configuration in the 
end, where the molecule was able to fit into the primary adsorption site. However, it did not 
always rotate back in the same direction to form the original conformation. In some cases a 
full 180° rotation was obtained. Therefore, we deemed it suitable to investigate the 






Figure 70: The conformations investigated with 90° rotations around single bonds. 
The conformations investigated for compound KW5(top left and bottom left), and compound FL2(top right and 
bottom right), when only a 90° rotation is permitted around a single bond, as indicated. 
 
The newly-generated starting conformations were subjected to a full adsorption simulation, 
followed by the dynamics optimisation, where after the adsorption energies (Eads) were 
calculated by using the initial energies of the new conformations. 
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For the adsorption onto face {001}, it is found that the lowest energy conformations, which 
were generated by using the standard protocol, still had the most favoured Eads values. 
Furthermore, it is found that the Eads values obtained for the adsorption onto face {011} were 
similar to those of the original lowest energy conformation. This is not surprising, as no 
distinctive crevices are present on this face for the inhibitors to adsorb into, and the formation 
of π-π interactions is mostly observed. Therefore, it is not surprising that the 180° rotation of 
an aromatic ring would not cause a large variance in the calculated Eads value.  
With the Eads value being calculated as the difference in energy of the system before and after 
adsorption, the initial internal energy of the new conformation is used in this calculation. 
Considering that for the less favoured conformations, an internal energy penalty is added in 
the form of a higher energy, the calculated Eads values were less favoured. The Eads values of 
the original lowest energy conformation are found to be lower and thus more favoured. 
Therefore, it was possible to confirm that the adsorption results obtained by using the lowest 
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3.2 DETERMINING STRUCTURE-ACTIVITY RELATIONSHIPS 
3.2.1 Investigating structure activity relationships of the non-quinoline inhibitors 
The structure-activity study discussed in Chapter 2 has shown that more than one parameter 
needs to be taken into account in order to appreciate the linear correlation between the 
calculated Eads values and the experimentally determined β-haematin inhibition activity. For 
the clinically-relevant inhibitors, a linear correlation was found between the calculated Eads 
results and the lipid BHIC50 (LBHIC50). Similarly, for the small quinoline inhibitors, a 
correlation was found between the calculated Eads results and the acetate BHIC50 (ABHIC50).  
Unfortunately, in an attempt to determine the LBHIC50 of the non-quinoline inhibitors, it was 
found that the inhibitors were not soluble in the buffer solution at pH 4.8. Therefore, the 
LBHIC50 were not determined, and the NP40 BHIC50 values that had been determined by the 
students who have synthesised the compounds were used to evaluate structure-activity 
relationships. 
A linear correlation is found between the LBHIC50 activities and the NP40 BHIC50 
activities.
119
 Therefore, the NP40 BHIC50 activity results were deemed suitable for evaluating 
structure-activity relationships for the non-quinoline inhibitors. 
With the non-quinoline inhibitors also being present in the neutral form, this speciation form 
was also considered at pH 4.8 (Equation 3.1). 
        (
        
   
)                                    (3.1) 
Furthermore, the parameters for this speciation form were included into the multiple 
correlation calculation, where for the neutral form, a
N
 is a function of the adsorption onto 
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face {001} (Equation 3.2), and b
N 
is a function of the adsorption onto face {011}  
(Equation 3.3). 
            {
      
              
}               (3.2) 
             {
      
              
}          (3.3) 
Finally, by combining all of these parameters, a multiple correlation equation is obtained 




were allowed to freely refine in order to obtain the 
best fit between the calculated Eads values and the activity results across the whole data set. 
 
                                                        
                                     (3. 4) 
 
3.2.1.1 Results pertaining to the structure activity relationships of the  
non-quinoline inhibitors 
For the adsorption of the non-quinoline inhibitors onto face {001} (Table 21, Figure 71) and 
face {011} (Table 22, Figure 72), no structure-activity correlation was found. The R
2
 values 
of 0.13 and 0.00045 that were found are not significant.  
 
 





Table 21: The determined NP40 BHIC50 activity of the non-quinoline inhibitors, as well as the calculated Eads for the adsorption onto face {001},  

































































































































































-77.4 ± 0.9 -82.9 ± 0.1  0 52 46  -78.3 13.8 ± 0.4 
                   




 75 23 0  -73.9 13.3 ± 0.7 





-72.5 ± 0.01 -73.2 ± 1.0  0 27 73  -73.0 12.7 ± 1.4 




 75 23 0  -78.7 22.2 ± 1.4 















-68.9 ± 0.3 -89.8 ± 0.4  0 70 30  -75.2 32.0 ± 1.4 
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Table 22: The determined NP40 BHIC50 activity of the non-quinoline inhibitors, the calculated Eads for the adsorption onto face {011}, 



































































































































































-65.5 ± 0.7 -66.8 ± 0.7  0 52 46  -64.7 13.8 ± 0.4 
                   




 75 23 0  -62.5 13.3 ± 0.7 





-59.8 ± 0.01 -62.0 ± 0.01  0 27 73  -61.4 12.7 ± 1.4 




 75 23 0  -63.7 22.2 ± 1.4 















-61.9 ± 0.01 -65.1 ± 0.01  0 70 30  -62.9 32.0 ± 1.4 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za



























Figure 71: Comparing the calculated Eads vs the NP40 BHIC50 for adsorption of  
non-quinoline inhibitors onto face {001}. 
The 2,4,5-triaryl substituted imidazole inhibitors are indicated in orange, the benzamide inhibitors are indicated 
in green, and the bezimidazole inhibitors are indicated in blue. 
An R
2
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Figure 72: Comparing the calculated Eads vs the NP40 BHIC50 for adsorption of  
non-quinoline inhibitors onto face {011}. 
The 2,4,5-triaryl substituted imidazole inhibitors are indicated in orange, the benzamide inhibitors are indicated 
in green, and the bezimidazole inhibitors are indicated in blue. 
An R
2
 value of 0.00045 and a P value of >0.05 are found. 
 
However, by evaluating only the three benzimidazole inhibitors (shown in blue), a favourable 
trend is observed for both the adsorption onto face {001} and face {011}. For the adsorption 
onto face {001}, more favoured Eads values were obtained for the adsorption in the neutral 
form compared to those in the monoprotic form. The same is not found for the adsorption 
onto face {011}. Since the monoprotic forms of FL1 and FL3 were not able to adsorb into 
the crevice on face {001}, it might be that improved adsorption is obtained when the two 
neighbouring primary adsorption sites (only the neutral forms) are occupied. 
Upon applying the multiple correlation equation (eqn 3.4) to the data comparing the 
calculated Eads values to the NP40 BHIC50 for the non-quinoline compounds, a linear 
correlation, with and R
2
 value of 0.72 and a P value of 0.002, is found (Table 23, Table 24, 
and Figure 73).  Therefore, a linear correlation exists between the calculated Eads values and 
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the determined NP40 BHIC50 activity of the non-quinoline inhibitors, when the speciation 
and the adsorption onto the two fastest growing faces are taken into account.  
 
Table 23: Final variables calculated for the multiple correlation calculation 
Variable Value Crystal face Speciation form 
    
v
1
 0.20 {001} Monoprotic 
v
2
 0.00 {011} Monoprotic 
v
3
 0.00 {001} Diprotic 
v
4
 0.37 {011} Diprotic 
v
5
 0.06 {001} Neutral 
v
6
 0.37 {011} Neutral 
 
Table 24: The determined NP40 BHIC50 activity and the calculated Eads values obtained from the multiple 










KW1 -59.8 18.7 ± 0.1 
KW2 -55.1 14.6 ± 0.2 
KW3 -62.9 13.8 ± 0.4 
KW4 -62.4 13.3 ± 0.7 
KW5 -70.6 9.1 ± 0.7 
KW6 -68.1 12.7 ± 1.4 
KW7 -60.6 22.2 ± 1.4 
FL1 -59.8 38.2 ± 1.4 
FL2 -55.1 24.5 ± 4.2 
FL3 -59.8 32.0 ± 1.4 
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Figure 73: Multiple correlation fit for the non-quinoline inhibitors. 
The multiple correlation fit for comparing the calculated Eads to the NP40 BHIC50 activity for the non-quinoline 
inhibitors. The 2,4,5-triaryl substituted imidazole inhibitors are indicated in orange, the benzamide inhibitors 
are indicated in green, and the bezimidazole inhibitors are indicated in blue. An R
2
 value of 0.72 and a P value  
of 0.002 are found. 
 
A greater contribution of v
1
 is calculated for the adsorption in the monoprotic form onto 




 is calculated for the adsorption in the 
diprotic and neutral forms onto face {011}. This result is consistent with the adsorbed 
geometries, where three of the compounds are unable to adsorb into the crevice on 
face {001}, which would allow for a greater contribution of the adsorption onto face {011}. 
With a significant linear correlation obtained, this is a very pleasing result, as the same trend 
is observed as seen for the clinically-relevant inhibitors in the previous chapter, where 
compounds with lower Eads values showed greater β-haematin growth inhibition. If these two 
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results agree, then it should give the same multiple correlation when these data sets are 
combined. This would strengthen the argument that a linear correlation exists between the 
adsorption of these inhibitors onto β-haematin, and the determined β-haematin inhibition 
activity. 
 
3.2.2 Combining the non-quinoline inhibitors with the clinically-relevant inhibitors 
In this project, structure activity relationships were determined for both clinically-relevant 
inhibitors (Chapter 2), as well as for a set of non-quinoline inhibitors (current chapter). In 
both cases a linear correlation is found when the calculated Eads values are compared to the 
determined β-haematin inhibition activity, when the speciation as well as the adsorption onto 
the two fastest growing faces is considered. For the clinically-relevant inhibitors, this 
correlation was initially determined with the LBHIC50 activity data, however the relevant 
NP40 BHIC50 activity data is also available. 
Therefore, by combining the two data sets for the multiple correlation, and by including all 
the molecules that adsorb into the primary, as well as onto the secondary adsorption sites 
(including MQ and compound KN7), a correlation with an R
2
 value of 0.67 and a P value  
of <0.0001, is obtained (Table 25, Table 26, and Figure 74). The two data points to the far 
right of the trend are that of MQ(R and S), and the one on the far right on the trend line, is 
that of compound KN7. 






, where adsorption is favoured onto 
face {001} in the monoprotic and diprotic forms, and adsorption is favoured onto face {011} 
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in the neutral form. This result is indeed satisfying, and is consistent with the previous 
structure-activity relationships evaluated for the adsorption onto β-haematin. 
Even though a linear correlation between the calculated Eads values and NP40 BHIC50 activity 
is seen for the clinically-relevant inhibitors when adsorption onto the secondary adsorption 
site is also considered, the graph tends towards an exponential curve. However, with only 
three less active inhibitors in this data set (NP40 BHIC50 activity above 100 μM), this 
observation is not conclusive, and a more definitive conclusion could only be made by also 
evaluating structure-activity relationships of additional less active inhibitors for the 
adsorption onto β-haematin.  
Table 25: Final variables calculated for the combined correlation of the non-quinoline and  
clinically-relevant inhibitors. 
Variable Value Crystal face Speciation form 
    
v
1
 0.24 {001} Monoprotic 
v
2
 0.00 {011} Monoprotic 
v
3
 0.22 {001} Diprotic 
v
4
 0.13 {011} Diprotic 
v
5
 0.11 {001} Neutral 
v
6
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Table 26: The determined NP40 BHIC50 activity and the calculated Eads values obtained from the multiple 






NP40 BHIC50  
(μM) 
 
KN6 -91.5 58.8 ± 3.8 
KN7 -75.0 134.6 ± 10.4 
KW1 -98.0 18.7 ± 0.1 
KW2 -88.6 14.6 ± 0.2 
KW3 -98.6 13.8 ± 0.4 
KW4 -99.0 13.3 ± 0.7 
KW5 -118.4 9.1 ± 0.7 
KW6 -102.3 12.7 ± 1.4 
KW7 -104.6 22.2 ± 1.4 
FL1 -82.2 38.2 ± 1.4 
FL2 -89.8 24.5 ± 4.2 
FL3 -86.4 32.0 ± 1.4 
AQ -97.6 7.2 ± 0.5 
CQ -92.3 31.5 ± 2.0 
MQ-S -58.9 304.8 ± 9.2 
MQ-R -64.4 304.8 ± 9.2 
QD -86.8 25.6 ± 2.0 
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Figure 74: Multiple correlation fit for all the clinically-relevant and the non-quinoline inhibitors. 
The non-quinoline inhibitors are indicated in green, and the clinically-relevant inhibitors are indicated in 
orange. An R
2
 value of 0.67 and a P value of <0.0001 are obtained. 
 
The multiple correlation calculation was carried out a second time on the two data sets, this 
time excluding the inhibitors that adsorbed onto the secondary adsorption site (MQ(±) and 
compound KN7). Interestingly, an improved linear correlation, with an R
2
 value of 0.73 and a 
P value of <0.0001, is found (Table 27, Table 28, Figure 75).  





adsorption is favoured onto face {011} in the diprotic and neutral forms respectively. It is 
rather expected that when only inhibitors which are able to adsorb into the primary adsorption 
site on face {001} are included in the correlation, that the variables for adsorption onto 
face {001} would have the greatest contribution.  Therefore, the improved linear correlation 
that exists between the calculated adsorption results and the determined NP40 BHIC50 
activity results, for both sets of clinically-relevant inhibitors and non-quinoline inhibitors 
when these compounds are able to adsorb into the primary adsorption site, is not convincing. 
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This raises the question as to whether different types of compounds could be combined into 
one correlation. 
Furthermore, this highlights the importance of evaluating a larger and a more representative 
data set, where both active and less active inhibitors are included in the study. Therefore, 
structure-activity relationships for the adsorption of additional less active inhibitors (with 
NP40 BHIC50 activities of >100 μM) onto β-haematin, also need to be evaluated. 
 
Table 27: Final variables calculated for the combined correlation of the non-quinoline and  
clinically-relevant inhibitors that adsorb into the primary adsorption site. 
Variable Value Crystal face Speciation form 
    
v
1
 0.15 {001} Monoprotic 
v
2
 0.07 {011} Monoprotic 
v
3
 0.00 {001} Diprotic 
v
4
 0.39 {011} Diprotic 
v
5
 0.09 {001} Neutral 
v
6
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Table 28: The determined NP40 BHIC50 activity and the calculated Eads values obtained from the multiple 
correlation, of the non-quinoline and the clinically relevant inhibitors which were able to adsorb into the 









NP40 BHIC50  
(μM) 
 
KN6 -57.0 58.8 ± 3.8 
KN7  134.6 ± 10.4 
KW1 -75.8 18.7 ± 0.1 
KW2 -71.7 14.6 ± 0.2 
KW3 -81.0 13.8 ± 0.4 
KW4 -84.4 13.3 ± 0.7 
KW5 -90.3 9.1 ± 0.7 
KW6 -85.6 12.7 ± 1.4 
KW7 -82.3 22.2 ± 1.4 
FL1 -67.8 38.2 ± 1.4 
FL2 -72.9 24.5 ± 4.2 
FL3 -71.2 32.0 ± 1.4 
AQ -80.8 7.2 ± 0.5 
CQ -60.6 31.5 ± 2.0 
MQ-S  304.8 ± 9.2 
MQ-R  304.8 ± 9.2 
QD -63.7 25.6 ± 2.0 
QN -56.4 61.8 ± 1.8 
* Calculated Eads values obtained from the 
      multiple correlation of inhibitors which were 
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Figure 75: Multiple correlation fit for the clinically-relevant and the non-quinoline inhibitors that adsorb 
into the primary adsorption site. 
The non-quinoline inhibitors are indicated in green, and the clinically-relevant inhibitors are indicated in 
orange. An R
2
 value of 0.74 and a P value of <0.0001 are observed. Note that when different variables are 
included in the multiple correlation equation, the final Eads values differ (compare to figure 74). 
 
From this study, it is obvious that more active β-haematin inhibitors have more favoured 
adsorbed geometries, as well as more favoured Eads values for the adsorption onto the two 
fastest growing faces, faces {001} and {011}. Furthermore, a significant linear correlation is 
found when the Eads values are compared to the determined NP40 BHIC50 activities, for the 
adsorption of all the clinically-relevant and non-quinoline compounds, without excluding any 
outliers. 
Therefore, it could be concluded that this computational adsorption study is suitable to 
evaluate the adsorption of inhibitors onto the fastest growing faces of β-haematin, for 
quinoline as well as for non-quinoline compounds.  
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3.3 CONCLUDING REMARKS PERTAINING TO CHAPTER 3 
3.3.1 The significance of this chapter 
In Chapter 2, a thorough investigation was performed on evaluating the adsorption of 
clinically-relevant quinoline inhibitors, where a linear correlation was found when comparing 
the determined NP40 BHIC50 activities to the calculated Eads values for the adsorption onto 
faces {001} and {011} when different speciation forms are taken into account. This was 
indeed a remarkable breakthrough. Therefore, this study was also extended to evaluate the 
adsorption of non-quinoline inhibitors onto β-haematin; such work has not yet been reported 
in literature. 
With this study forming part of a larger research project, a small library of active 2,4,5-triaryl 
substituted imidazole, benzamide, and benzamidazole β-haematin inhibitors was available. It 
is found that these compounds adsorbed onto face {011} in such a manner that the molecules 
extended over two unit cells. Similar adsorption geometries were obtained for the adsorption 
onto face {001}, where most of these molecules were able to adsorb into two neighbouring 
primary adsorption sites. This is the first time that these geometries were observed. 
Furthermore, it is found that the molecules that were not able to adsorb into the two primary 
adsorption sites, preferred an adsorbed geometry where both the primary and the secondary 
adsorption sites were occupied. In this case, the formation of a hydrogen bonding interaction 
was seen between the inhibitor and a free carbonyl group outside of the crevice. 
In evaluating structure-activity relationships for the adsorption of these inhibitors onto 
β-haematin, no correlations were found when the adsorption onto face {001} or face {011} 
were evaluated separately. Finally, by applying the multiple correlation calculation, and 
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thereby combining both the speciation and the adsorption onto both faces, a significant linear 
correlation, with an R
2
 value of 0.72 and a P value of 0.002, was found, where the determined 
variables were representative of the data set. In this study, unlike for the clinically-relevant 
inhibitors, a greater percentage of the molecules preferred adsorption onto the second fastest 
growth face, and therefore a larger contribution of the Eads values for the adsorption onto this 
face was accounted for.   
This result again highlights the importance of considering both the adsorption onto 
face {001} and face {011}. Furthermore, with these crystal faces being similar in geometry, 
where the secondary adsorption site on face {001} closely resembles the surface of 
face {011}, this observation for the adsorption of these larger molecules, could possibly be 
rationalised. 
In the end, these results were combined with those obtained for the adsorption of the 
clinically-relevant inhibitors. By applying the multiple correlation calculation, a significant 
linear correlation, with an R
2
 value of 0.67 and a P value of <0.0001, was obtained. However, 
when visually inspecting this graph, it is seen that the larger, less active inhibitors (MQ(±) 
and KN7) did not fit this trend well. Rather, the data tend toward an exponential function. 
However, with only two of these less active inhibitors forming part of the correlation, this is 
not conclusive. Therefore, in order to determine whether an exponential curve might be valid, 
additional less active inhibitors need to be included in this correlation. 
What is however, still significant to see, is that the non-quinoline and quinoline inhibitors 
could be combined to obtain a linear correlation, when comparing the molecular modelling 
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results for the adsorption onto the two fastest growing faces of β-haematin and the 
determined β-haematin growth inhibition activities. 
This adds merit to the hypothesis that antimalarial drugs that target the β-haematin pathway, 
may indeed exert their mechanism of action by adsorbing onto the two fastest growing faces 
of the β-haematin crystal, and thereby impeding further crystal growth.  
 
3.3.2 Final conclusion 
In extending the work discussed in the previous chapter to evaluating the adsorption of active 
non-quinoline β-haematin inhibitors, a new geometry for the adsorption onto face {001}, as 
well as for the adsorption onto face {011} is observed, where the inhibitors were able to 
adsorb onto two neighbouring porphyrin structures. 
Furthermore, by evaluating structure-activity relationships, the significance of evaluating the 
adsorption onto both the fastest and the second fastest growth faces, was emphasised. 
Therefore, in the end of this chapter, it can be concluded that a linear correlation exists, for 
both quinoline and non-quinoline compounds, between the β-haematin inhibition activity and 
the ability of a compound to adsorb onto both the fastest and the second fastest growth faces, 
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ADSORPTION INTO THE PRIMARY ADSORPTION SITE 
In the previous two chapters, a thorough investigation was performed on the adsorption of 
clinically-relevant inhibitors and non-quinoline inhibitors onto the two fastest growing crystal 
faces of β-haematin. 
The clinically-relevant inhibitors and the small quinoline inhibitors mainly showed 
preference for adsorbing into the primary adsorption site on face {001}, where more bulky 
inhibitors, such as MQ, showed preference for adsorbing onto the secondary adsorption site 
on face {001}. It is concluded that the optimum adsorbed geometry is obtained for the 
adsorption of QN and QD in the primary adsorption site. The quinoline moiety of the 
inhibitors were able to form π-π interactions to the porphyrin structures in the crevice, and 
hydrogen bonding interactions were formed between amine hydrogen atoms on the inhibitor 
and free carbonyl groups on the crystal surface outside of the crevice.  
This observation has previously been discussed by Buller et al.
54
 With a greater 
understanding of the preferred adsorbed geometries onto face {001}, as well as with a linear 
correlation found between the calculated Eads values and the determined NP40 BHIC50 
activities for the adsorption of the clinically-relevant inhibitors onto β-haematin (Section 2.4), 
a comprehensive study is currently being performed on further evaluating this adsorption 
geometry, as part of another PhD project.  
However, upon evaluating the adsorption of the non-quinoline inhibitors onto β-haematin 
(Chapter 3), a new adsorption geometry is found, that has not yet been reported in literature. 
Stellenbosch University  https://scholar.sun.ac.za





Here, the long linear non-quinoline inhibitors adsorbed in such a manner that two 
neighbouring primary pockets on face {001} were occupied, consequently forming molecular 
interactions to two neighbouring porphyrin structures in two adjacent unit cells. Moreover, 
these molecules have shown favourable adsorption onto face {011}, where multiple 
π-π interactions were formed to the porphyrin structures on the crystal surface. 
These molecular scaffolds that are able to adsorb into two neighbouring primary adsorption 
sites, could be used as a guide for developing more active β-haematin inhibitors. The 
formation of a greater number of molecular interactions between the molecule and the crystal 
surface would result in a more favourable adsorption onto the crystal surface. With a linear 
correlation found between the calculated Eads values and the determined NP40 BHIC50 
activity, enhanced adsorption onto the β-haematin crystal surface may also translate into 
improved β-haematin inhibition. 
Therefore, by evaluating the adsorption of both molecules that adsorb favourably, as well as 
less favourably into two neighbouring primary adsorption sites on face {001}, and by 
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4.1 INVESTIGATING SMALL MOLECULAR STRUCTURES TO ADSORB INTO THE 
PRIMARY ADSORPTION SITE 
4.1.1 The small molecular structures investigated 
In order to fully understand the adsorption of the quinoline inhibitors into the primary 
adsorption site, the optimum size molecular scaffold that would best fit into the primary 
adsorption site, had to be determined. Thereafter, the overall molecule could be optimised for 
enhanced adsorption into two neighbouring primary adsorption sites. 
For the clinically-relevant inhibitors, the quinoline moiety was observed to fit into the 
primary adsorption site, with the side-chain protruding towards the outside of the crevice. 
Therefore, without the side-chain, the adsorption into only one primary adsorption site could 
be evaluated.  
Larger aromatic systems are also used as scaffolds in antimalarial drugs. For example, the 
active antimalarial drugs quinacrine (QC) and pyronaridine contains benzo(b)-







Figure 76: The chemical structures of pyronaridine and quinacrine 
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Therefore, by starting from a small quinoline scaffold, such as 7-chloroquinoline 
(compound S1), and by gradually changing the size of the molecule by adding aromatic rings, 
or by varying the size of the aromatic rings (Compounds S1, S5-10, Table 29 and Table 30), 
adsorption studies would provide valuable information as to how these molecules would 
adsorb into the primary adsorption site. In order to achieve this, three different scaffolds were 
chosen, namely quinolines, carbazoles, and benzonapthypyridines. In particular, the carbazole 
scaffold had been identified in a screen of compounds that are available through the 
collaborative NIH project, while the benzonaphypyridine scaffold is present in 
clinically-relevant antimalarial drugs, such as pyronaridine and quinacrine. 
The intermolecular contribution of halogen bonding interactions could be evaluated by 
varying the number of halogen atoms on the aromatic rings, as well as the positions thereof 
(as seen for compounds S2 and S3, Table 29). Moreover, the effect of steric bulk on the 
adsorption geometry of the molecules could be investigated by adding a methyl group 
(compound S4), or by extending the side-chain (compound S10). 
It is considered that when determining the NP40 BHIC50 activity of these small molecular 
scaffolds, solubility in the assay medium might be a problem. However, with most of these 
molecules being commercially available, it is still worth evaluating the adsorption of these 
into the primary adsorption site computationally, as well as attempt to determine the 
NP40 BHIC50 activities, in order to gain a greater understanding on how these small scaffolds 
would occupy a single primary adsorption site. 
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Table 29: Quinoline compounds investigated in this study 




             
 
S2 

















Stellenbosch University  https://scholar.sun.ac.za





Table 30: Non-quinoline scaffolds investigated in this study 
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4.1.2 Adsorption of the small molecular scaffolds into the primary adsorption site 
For these small molecules, the same adsorption protocol was used as applied in the previous 
adsorption studies. Similarly as for compounds KW5 and FL2, it is found that the dynamics 
optimisation had no effect on the final adsorption geometries. Furthermore, all of the small 
scaffolds are calculated to be in the neutral speciation form at pH 4.8. 
Compounds S1 and S2 adsorbed in a similar manner into the primary adsorption site, where 
the chlorine atoms faced into the crevice (Figure 77). Interestingly, compound S5 adsorbed 
with the indole N-H facing towards the outside of the crevice. It might be that this adsorption 
geometry is simply preferred due to the steric bulk of the hydrogen atom on the indole 
nitrogen. 
 
   
   
Figure 77: Adsorption of compounds S1, S2 and S5 in the primary adsorption site 
The adsorption of compounds S1(left), S2(middle) and S5(right) in the neutral form onto face {001}, is shown, 
as viewed from above. The π-π interactions are indicated by   , and are measured to be between  
3.5 and 3.8 Å. 
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Compounds S6-8 adsorbed with the carbazole N-H towards the outside of the crevice  
(Figure 78). Comparing the adsorbed geometries of these molecules, it is found that 
compound S8 had the optimal adsorption geometry for the adsorption into a single primary 
adsorption site, since the internal space of the adsorption site is fully occupied. 
  
   
   
Figure 78: Adsorption of compounds S6-8 in the primary adsorption site 
The adsorption of compounds S6 (left), S7 (middle) and S8 (right) in the neutral form onto face {001}, is shown, 
as viewed from above. The π-π interactions are indicated by   , and are measured to be between  
3.5 and 3.8 Å. 
 
The adsorption of compound S6 into the primary pocket is found to be slightly more random, 
where after successive adsorption simulations, the output geometry results varied. The 
compound did not show preference for adsorbing to the left, to the right, or into the centre of 
the adsorption site. All of the other compounds adsorbed to one side of the adsorption site. 
Furthermore, the calculated Eads values of compounds S7 and S8 of 
  58.0 and   58.2 kcal.mol
-1
 respectively, are considered more favourable than the calculated 
Eads value of compound S6 of   52.0 kcal.mol
-1
 (Table 31).  With the Eads values for 
compound S7 and S8 being almost similar, this suggests that the chlorine atoms might play a 
directing role for the adsorption location in the primary adsorption site.  
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S6 -52.2 ± 0.01 
S7 -58.0 ± 0.01 
S8 -58.2 ± 0.01 
 
Compound S3 showed preference for adsorbing with this chlorine atom (in the 4-position) 
facing into the crevice. The aromatic scaffold was still located in the crevice and weak π-π 
interactions were formed between the quinoline moiety and the porphyrin structure on the 
crystal surface, with measured interaction distances of 3.9 and 4.0 Å. It is possible that this 
chlorine atom in the 4-position of the quinoline forms hydrophobic C-H···Cl halogen 
bonding interactions to non-polar hydrogen atoms in the back of the crevice (Figure 80).
154
 
Furthermore, compound S4 adsorbed into the primary adsorption with the large methyl group 
protruding towards the outside of the crevice (Figure 79). As a result, the 4-chloro group is 
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Figure 79: Adsorption of compounds S3 and S4 in the primary adsorption site 
The adsorption of compounds S3 (left), and S4 (right) in the neutral form onto face {001}, is shown, as viewed 
from above. The π-π interactions are indicated by   , and are measured to be between  
3.5 and 3.8 Å. 
 
 
Figure 80: Adsorption of compound S3 in the primary adsorption site 
The adsorption of compound S3 in the neutral form onto face {001}, is shown, as viewed from the side of the 
crystal face. The π-π interactions are indicated by   , and are measured to be between 3.5 and 3.8 Å, where 
the C-H···Cl interactions are indicated by  , and are measured to be 2.2, 2.5, and 2.7Å . The non-polar 
hydrogen atoms in the back of the crevice are indicated as grey balls.   
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By replacing this chlorine atom in the 4-position of compound S3 with an amine group 
(compound S11), this halogen bonding interaction is not possible. Therefore, it is found that 
the 4-amino-7-chloroquinoline molecule adsorbs in the same geometry as CQ (Figure 81). 
 
       
Figure 81: Adsorption of compound S11 in the primary adsorption site 
The adsorption of compound S11 in the diprotic form onto face {001}, is shown (left), as viewed from above.  
The π-π interactions are indicated by   , and are measured to be between 3.5 and 3.8 Å. 
The chemical structure of compound S11 is shown (right), where this compound is 100% diprotic at pH 4.8. 
 
When investigating the adsorption of the larger benzo(b)(1-5)napthyridine compounds, it is 
found that compound S9 was not able to adsorb completely into the primary adsorption site 
(Figure 82). All three aromatic rings of compound S9 were able to form π-π interactions to 
the porphyrin structure on the crystal surface, where only two of the aromatic rings of 
compound S10 were able to form these π-π interactions. The other aromatic ring was too far 
out of the crevice to form a favourable π-π interaction, with a measured interaction distance 
above 4.0 Å. 
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Figure 82: Adsorption of compounds S9 and S10 in the primary adsorption site 
The adsorption of compounds S9 (left) and S10 (right) in the neutral form onto face {001}, is shown, as viewed 
from above. The π-π interactions are indicated by   , and are measured to be between  
3.5 and 3.8 Å. 
 
This observed adsorption geometry of compound S9 was not as expected, when comparing it 
to the adsorption of QC into the primary adsorption site (Figure 83). QC showed preference 
for adsorbing into the primary adsorption site, where the chlorine atom, as well as the 
methoxy side-chain were able to adsorb into the crevice. The methoxy side-chain probed into 
a second primary adsorption site. For the adsorption of compound S9, it is considered that the 
chlorine atom in the 10-position of the benzo(b)(1-5)napthyridine shows preference for 
adsorbing into the primary adsorption site, as seen for compound S3 (Figure 80). It is 
possible that this chlorine atom forms C-H···Cl halogen bonding interactions (2.2-2.7 Å) to 
non-polar hydrogen atoms in the back of the crevice.
154
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Figure 83: The adsorption of quinacine in the primary adsorption site 
The adsorption of quinacrine in the diprotic form onto face {001}, is shown, as viewed from the side of the 
crystal face (left), and as viewed from above (right). The π-π interactions are indicated by   , and are 
measured to be between 3.5 and 3.8 Å. 
 
As noticed for the adsorbed geometries of QC and CQ, by adding a larger side-chain at this 
position (4-position of the quinoline and the 10-position of the benzo(b)(1-5)napthyridine), 
the larger side-chain would be too big to fit into the crevice, and the molecule would show 
preference for adsorbing with the aromatic rings into the primary adsorption site, in order to 
form π-π interactions to the porphyrin on the crystal surface. As a result, the larger side-chain 
is permitted to probe towards the outside of the crevice. The contribution of this side-chain 
for the adsorption into the primary adsorption site is not clear. It might be that this side-chain 
rather plays a larger role in the crossing of cell membranes, or promotes adsorption onto the 
second fastest growth face, face {011}. Indeed, QC is known to be a more potent antimalarial 
drug than CQ,
155
 and related to this, the NP40 BHIC50 activity will be discussed later in 
Section 4.1.5. 
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Overall, by evaluating the adsorption of these small molecular fragments onto face {001}, a 
greater understanding is obtained on how these would adsorb, as well as how a small change 
in the molecular structure would affect the adsorption geometry.  
 
4.1.3 Synthetic strategies for obtaining the small molecular scaffolds 
Most of the compounds used in this study were commercially available at the time, although 
compound S8 was considered too expensive to purchase. Compound S11 was effortlessly 
synthesised, and the starting reagents were readily available. At the same time the synthesis 
of the compounds S2 and S7 was considered, as they had been previously reported in 
literature in good yields. 
 
4.1.3.4 Towards the synthesis of the desired 2,7-dichloroquinoline 
For the synthesis of compound S2, Zaragoza et al. reported a general procedure for the 
preparation of substituted 1H-2-quinolines (Scheme 1), where they have used a known 
method for chlorinating these to substituted 2-chloroquinolines upon treatment with 
phosphorus oxychloride (Scheme 2).
156
 
Starting from compound 1, the ester was saponified, where after the carboxylic acid 2 was 
converted to the corresponding acid chloride 3. This was again treated with 3-chloroaniline, 
which acted as a nucleophile in order to obtain the anilide 5. This was subsequently cyclised 
in the presence of glacial sulphuric acid to obtain 7-chloroquinolone 6 as the major product, 
and 5-chloroquinolone 7 as the minor product. Upon treating 7-chloroquinolone with 
phosphorus oxychloride, the desired 2,7-dichloroquinoline S2 was obtained. 
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6  S2 
 
 
4.1.3.5 Towards the synthesis of the carbazoles 
As compound S7 is not commercially available and compound S8 is deemed too expensive to 
purchase, it is reasonable to also synthesise compound S6. Gao et al. reported a procedure for 
developing structurally diverse carbazoles by an intermolecular amination of an aromatic 
bond, under mild reaction conditions.
157
 Based on DFT studies, it is proposed that, starting 
from a nitroso intermediate, an O-addition of phenyl magnesium bromide, followed by an 
N-O bond cleavage, an aromatic addition, and finally a hydrogen migration, results in the 
formation of a carbazole (Scheme 3).  
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The reaction mechanism proposed by Gao et al. for the formation of a carbazole from a nitroso intermediate is 
shown.
157
 The O-addition of phenyl magnesium bromide (a), the N-O bond cleavage (b),  
the aromatic addition (c), as well as the hydrogen migration (d), are indicated. 
 
The same synthetic route would be used for the synthesis of compounds S6-8.  Therefore, by 
starting from a 2-bromo-nitrobenzene derivative, a Suzuki coupling reaction would provide a 
2-nitrobiphenyl derivative, upon which the intermolecular amination reaction would be 
performed (Scheme 4).  
Scheme 4 
 
                                                                                              
 
 
Compound S6: R = H, R2 = H;       Compound S7: R = Cl, R2 = H;       Compound S8: R = Cl, R2 = Cl.                                                         
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The Suzuki reaction was first published by Akira Suzuki and his co-workers in 1979,
158
 upon 
which he was awarded a joint Nobel Prize for his contribution to palladium-catalysed cross 
couplings in organic synthesis.
159
 Traditionally, this reaction is performed using 
palladium-tetrakis(triphenylphosphine) as catalyst. However, to date, several new variations 
of this coupling reaction have been reported, where numerous catalysts have been developed 
to achieve more selective couplings.
160–164
 
For the purposes of this project, the Suzuki-Mayaura transmetalation coupling reaction was 
used (Scheme 5).
164
 Starting form palladium(0)-tetrakis(triphenylphosphine), the halide is 
introduced by means of an oxidative addition, where a palladium(II) species is formed. The 
boronic acid is activated in the presence of base (potassium carbonate), where after the 
transmetalation reaction proceeds. Finally, the complex undergoes reductive elimination, 
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The reaction mechanism proposed by Lennox et al. for the Suzuki-Mayaura cross-coupling reaction is shown.
164
  
The reaction proceeds via the oxidative addition of the halide (a), followed by the transmetalation step by 
introducing the boronic acid (b), and then the final reductive elimination (c), which results in the regeneration 
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The synthesis of compound S11 would be commenced by treating 4,7-dichloroquinoline with 
sodium azide to obtain the 4-azido-7-chloro intermediate, where after the azide functional 
group could be reduced in the presence of Raney
®
-Nickel in order to obtain the desired amine 
product S11 (Scheme 6).  
Scheme 6 
 
  S11 
 
 
The reasons for this choice of synthetic route will be discussed later in this chapter for the 
synthesis of 2-aminoquinoline L16 (Section 4.2.4.1), as this compound was synthesised prior 
to compound S11. However, unlike the synthesis of 2-aminoquinoline, the synthesis of the 
azide intermediate via this synthetic route has to be undertaken carefully, as the azide 
functional group might be introduced on both the 4- and the 7-position of the quinoline. 
As a result, milder reaction conditions might be required. 
With the synthetic strategy outlined, the small molecular scaffolds that were not purchased 
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4.1.4 Synthesis of the small molecular scaffolds 
4.1.4.1 Synthesis pertaining to the 7-chlorquinoline 
4.1.4.1.1 Synthesis of 3,3-diethoxypropanoic acid - 2 
As an introduction to our synthetic venture, a simple saponification of commercially 






1                                                      
 
 
       2  
The starting material was exposed to a strong sodium hydroxide solution, whereupon the 
reaction mixture was refluxed at 110 °C for 4 hours. Upon completion, the starting material 
was extracted from the basic reaction mixture with ethyl acetate. The water layer was 
acidified with 2M hydrochloric acid, whereupon the desired product 2 was extracted with 
ethyl acetate. The solvent was dried on magnesium sulphate, where after it was filtered and 
removed in vacuo to obtain the desired product as an yellow oil that needed no further 
purification, in a high 85% yield. 
  
A broad O-H stretch observed in the infrared spectra at 3427 cm
-1
, as 
well as a strong C=O stretch at 1667 cm
-1
, are indicative of the 
present carboxylic acid. Furthermore, in the 
1
H NMR, only two 
chemically equivalent ethyl chains are integrated for, where a 
carbonyl peak is observed in the 
13
C NMR spectrum at 173.52 ppm. 
2 
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4.1.4.1.2 Synthesis of (E)-N-(3-chlorophenyl)-3-ethoxyacrylamide - 5 
For the synthesis of compound 5 from 2, the carboxylic acid was first converted to the acid 
chloride 3 (not isolated), which was subsequently treated with 3-chloroanaline to obtain the 





2  3 4 
 
 3 + 4 
 
                                                              5 
 
The carboxylic acid was dissolved in a small amount of dichloromethane, whereupon it was 
refluxed in the presence of an excess amount of thionyl chloride overnight. Upon completion, 
the thionyl chloride was evaporated off, and the resulting acid chlorides were diluted in a 
small amount of dichloromethane.  
This was slowly added to a solution of pyridine, dichloromethane, and 3-chloroaniline, by 
means of a dropping funnel. The resulting reaction mixture was gently heated at 40 °C 
overnight, where after it was acidified with 2M hydrochloric acid, and the product was 
extracted with copious amounts of dichloromethane.  
The purification of product 5 was challenging, since the residue that was obtained did not 
easily dissolve in organic solvents. Therefore, the excess impurities were removed by means 
of column chromatography by using a large silica column. Compound 5 was finally purified 
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by recrystallisation from hot ethyl acetate, in a moderate yield of 41%, although this was of a 
crude product. 
Unfortunately, upon evaluating the 
1
H NMR and 
13
C NMR spectra, it was found that the 
product was still not pure. After many attempts of further purification, the desired product 
was not purified. With this product not being a final product, we considered it of sufficient 
purity to proceed with the subsequent step in the total synthesis of 2,7-dichloroquinoline, 
compound S2. 
 
Even though the 
1
H NMR and 
13
C NMR spectra indicated 
that an impure product was obtained, the result of the mass 
spectral analysis of 226.0606 amu correlated well with the 
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4.1.4.1.2 Synthesis of 2,7-dichloroquinoline - S2 
Compound S2 was finally synthesised from 5, where 5 was first cyclised to form a mixture of 
the quinolone intermediates 6 and 7. This was subsequently treated with phosphorus 









                                                    S2 S3  
 
Compound 5 was dissolved in a small amount of dichloromethane and was cooled by means 
of an ice-bath for the slow addition of glacial sulphuric acid, over a 15 minute period. The 
reaction was thereafter allowed to slowly warm to room temperature overnight. 
Upon completion, the reaction mixture was quenched with an aqueous ammonium chloride 
solution, whereupon the resulting waxy residue was filtered off and washed with hexane. The 
filtrate was extracted with ethyl acetate in order to ensure that all the product was isolated.  
Finally, this waxy solid was refluxed in phosphorus oxychloride overnight, whereupon the 
reaction was quenched on ice. The quinoline products were extracted with ethyl acetate and 
purified by means of column chromatography. Product S2 was obtained in a low 31% yield 
as the major product, while product S3 was obtained in a low 3% yield. 
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H NMR spectra, the absence of the signals corresponding to the 
ethyl chains was noticed, where the only peaks that were seen, were in 
the aromatic region. COSY and gHSQC NMR studies were performed 
in order to distinguish between compounds S2 and S3. Furthermore, 
thin layer chromatography analysis confirmed that the Rf value of 
compound S3 correlated with that of commercially obtained 





4.1.4.2 Synthesis pertaining to the carbazole compounds 
4.1.4.2.1 Synthesis of 2-nitrobiphenyl - 10 
Compound 10 was easily synthesised from 8, by performing a Suzuki coupling reaction 
(Scheme 10).
157
 The boronic acid 9 and compound 8 were dissolved in 
N,N-dimethylformamide, whereupon potassium carbonate was added, together with a small 
amount of water to dissolve the base. The reaction mixture was heated to 80 °C for five 
minutes, whereafter the palladium catalyst was added. 
Scheme 10 
 
8 9  10 
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Upon completion, the reaction was quenched with water and the product was extracted with 
ethyl acetate. The final product is purified by means of column chromatography, where it is 
obtained in a high yield of 91 %. 
 
This compound is found to be very unstable, with a melting point of 
40-45 °C. The 
1
H NMR spectrum integrated for two aromatic rings. 
A peak is observed at 149.4 ppm for C2 in the 
13
C NMR spectrum, 
indicating the presence of the nitro group. Also, an N=O stretch is 




        10 
4.1.4.2.2 Synthesis of 9-H carbazole - S6 
For the synthesis of compound S6 from 10, care was taken not to allow the reaction 
temperature to rise above 3 °C, and the reaction was performed under inert conditions 
(Scheme 11).
157
 The reaction was cooled in an ice-bath, and the reagents were added slowly. 
Scheme 11 
 
10  S6 
 
Compound 10 was dissolved in dry tetrahydrofuran. Phenylmagnesium bromide was slowly 
added over a period of 20 minutes, whereupon the reaction mixture was allowed to stir for 
another 10 minutes before it was quenched with an aqueous ammonium chloride solution.  
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The product was finally extracted with ethyl acetate and purified by means of column 
chromatography, to obtain S6 in a high yield of 86%. 
 
A new N-H peak at 11.22 ppm in the 
1
H NMR spectrum is indicative of 
the carbazole formation. Also, an N-H stretch is observed at 3416 cm
-1
 
in the IR spectrum. The result of the mass spectral analysis of 




4.1.4.2.3 Attempted synthesis of 4-chloro-2-nitrobiphenyl - 12 
For the synthesis of compound 12 from 11, the same procedure for the Suzuki coupling was 
performed as mentioned above (Scheme 12). Unfortunately, an inseparable mixture of 
compounds was obtained, where these had the same Rf value (Rf = 0.44, 2% EtOAc/Hexane), 
as determined by means of thin layer chromatography. It might be that the phenyl ring also 
coupled onto the 4-position of the nitro-containing ring, resulting in an inseparable mixture of 
4-chloro-2-nitrobiphenyl and 4-bromo-2-nitrobiphenyl. It was considered that by proceeding 
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Similarly as for compound 12, a peak is observed at 149.79 ppm 
for C2 in the 
13
C spectrum, where an N=O stretch is seen at 
1358 cm
-1
 in the IR spectrum. This indicates the presence of a nitro 
group at C2. Furthermore, the 
1
H NMR spectrum only showed the 
presence of aromatic rings. Unfortunately, these integrated for 
more than two aromatic rings, which revealed that a mixture of two 
aromatic products was obtained. 
 
            12 
 
4.1.4.2.4 Attempted synthesis of 2-chloro-9H-carbazole - S7 
For the synthesis of compound S7 from the impure mixture of 12, the same ring-closing 
procedure for the synthesis of compound S6 was performed (Scheme 13). Upon purification 
of the reaction mixture by means of column chromatography, a white crystalline powder was 
obtained. Unfortunately this product was light sensitive and turned into a blue powder within 
a period of 30 minutes. It decomposed into multiple compounds, as determined by means of 
thin layer chromatography. Consequently, the desired product S7 was not obtained. 
Scheme 13 
 
12  S7 
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With the complications encountered in purifying compound 12, by performing the Suzuki 
coupling under milder reaction conditions, this difficulty could be overcome, as a larger 
percentage of the major product would be obtained. However, the same problem might be 
encountered for the synthesis of compound S8, where coupling could once again occur on 
both the 2- and 4-position of compound 11.  
Therefore, also taking into account the complications encountered with the synthesis and 
purification of compound 12, the synthesis of compounds S7 and S8 were not pursued 
further. 
The bromine derivatives of both of these compounds were commercially available  
(Figure 84). Therefore, even though it would have been preferable to have chlorine atoms on 
the carbazole rings to match the other small molecular scaffolds that are investigated, the 
bromine derivatives could also provide us with the information that we require by 
determining the NP40 BHIC50 activities thereof. 
 
  
       S12 S13 
 
Figure 84: The chemical structures of compounds S12 and S13. 
 
Stellenbosch University  https://scholar.sun.ac.za





4.1.4.3 The synthesis pertaining to compound S11 
For the synthesis of compound S11, the same synthetic procedure is used as for the synthesis 
of compound L16 that would be discussed in detail in Section 4.2.4.1. 
 
4.1.4.3.1 Synthesis of 4-azido-7-chloroquinoline - 14 
Compound 14 was synthesised from 13 in the presence of sodium azide (Scheme 14).
165
 The 
starting reagent 13 was dissolved in dimethyl sulfoxide. The reaction mixture was heated to 
60 °C for 18 hours. 
Scheme 14 
 
13  14 
 
Upon completion, the reaction mixture was quenched with water and the product was 
extracted with ethyl acetate. Finally, upon purification by means of column chromatography, 
the desired product 14 is obtained in a high yield of 93%. 
 
 
The presence of the azide moiety was established by a N3 stretch at 
2250 cm
-1 
in the infrared spectrum. The 
1
H NMR and the IR 





             14 
Stellenbosch University  https://scholar.sun.ac.za





4.1.4.3.2 Synthesis of 4-amino-7-chloroquinoline - S11 
Compound S11 was synthesised by the reduction of 14 with freshly prepared Raney
®
-Nickel 
under a positive pressure of hydrogen gas (Scheme 15).  
Scheme 15 
 
14  S11 
   
This reaction was commenced by dissolving compound 14 in a small amount of dimethyl 
sulfoxide and dry ethanol, where a spatula scoop (approximately 5 mL) of freshly prepared 
Raney
®
-Nickel was added. This was repeated twice at 4 hour intervals, where after the 
reaction mixture was left to stir overnight. The reaction was kept at 30 °C and under a 
positive pressure of nitrogen in order to ensure the reduction of the azide in the 4-position of 
the quinoline. 
Upon completion, the reaction mixture was filtered through celite, whereupon the filtrate was 
washed with ethyl acetate. The solvent was removed in vacuo, whereupon the product was 
isolated by means of column chromatography, in a high yield of 77%. 
 
The presence of a broad singlet, integrating for 2 protons at 6.93 ppm in 
the 
1
H NMR spectra for H9, was indicative of the formation of the amine 
in the 4-position of the quinoline. Furthermore, the result of the mass 
spectral analysis of 179.0381 amu and 181.0342 amu correlated well   
                                   with the expected mass of 179.0376 amu and 181.0348 amu. 
 
            S11 
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Finally, with the desired small molecular fractions obtained, the NP40 BHIC50 activities 
could be determined. Thereby, structure-activity relationships for the adsorption of these 
small molecules into the primary adsorption site, could be evaluated. 
  
4.1.5 Investigating structure-activity relationships for the small molecular scaffolds 
Upon determining the NP40 BHIC50 activities of the small molecular scaffolds, it is found 
that these compounds were not all soluble in the buffer solution above a concentration of 
180 mM. Furthermore, some of these compounds precipitated out during the 4 hour 
incubation period, at a temperature of 37 °C. Therefore, NP40 BHIC50 activities were only 
determined for compounds that were soluble in the acetate buffer (Table 32). 
 
Table 32: The calculated Eads for the adsorption onto face {001}, and determined NP40 BHIC50 activity of 
the small molecular scaffolds, QC, and CQ. 
Compound scaffold Eads (kcal.mol
-1
) NP40 BHIC50 (μM) 
S1 quinoline -52.8 ± 0.01       
S2 quinoline -50.0 ± 0.01      
S3 quinoline -49.0 ± 0.9     
S4 quinoline -50.0 ± 1.3       
S5 indole -48.8 ± 0.01 2351 ± 138 
S6 carbazole -52.2 ± 0.01 7216 ± 3157 
S9 benzo(b)-(1-5)napthyridine -65.2 ± 2.4 59.7 ± 2.6 
S11 quinoline -49.4 ± 0.5 100.3 ± 2.0 
S12 carbazole -58.7 ± 0.01 6806 ± 631 
S13 carbazole -58.0 ± 0.01 6125 ± 877 
QC benzo(b)-(1-5)napthyridine -75.1 ± 0.01 6.28 ± 0.5 
CQ quinoline -67.0 ± 0.01 31.5 ± 2.0 
*
The small molecular fractions are present in the neutral speciation form, and compound S11, QC 
and  CQ, are present in the diprotic form, at pH 4.8.  
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For the determination of the NP40 BHIC50 activities, compounds S3, S6, S12 and S13 were 
found to be inactive, with large standard deviations. Based on the molecular modelling 
results, it is expected that the larger carbazole structures would be more active. It is found not 
to be the case when comparing the activity of compound S5 (indole) to that of compounds 
S3, S12 and S13 (carbazole). It might be that this inconsistent result is obtained due to the 
low solubility of these compounds in the buffer solution. Therefore, structure-activity 
relationships could not meaningfully be investigated for these compounds. 
Both the two benzo-(b)(1-5)napthyridine compounds S9 and QC are found to be active 
β-haematin inhibitors. However, even though these two compounds include the same 
benzo-(b)(1-5)napthyridine scaffold, these were found to adsorb differently into the primary 
adsorption site. Therefore, a direct structure-activity relationship could not be made. 
The NP40 BHIC50 activity of compound S11 could be compared directly to that of CQ, as 
these two compounds include the same 7-chloroquinoline scaffold, and these two compounds 
preferred the same adsorbed geometry inside the primary adsorption site. Both these 
compounds are 100% diprotic at pH 4.8. Even though compound S11 is considered as an 
active β-haematin inhibitor (NP40 BHIC50 activity of 100.3 ± 2.0 μM), CQ exerts three times 
the inhibition capacity (NP40 BHIC50 activity of 31.5 ± 2.0 μM). This again highlights that 
more than just the adsorption into the primary adsorption site should be considered for 
β-haematin inhibition, as adsorption does not only occur on the fastest growing crystal face.  
With water molecules being present in solution, it is known to manually include these in the 
molecular modelling studies. Therefore, as suggested by Buller et al.(Section 1.4.2),
54
 these 
could contribute in promoting hydrogen bonding interactions. It has been suggested that a 
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hydrogen bonding interaction forms between the amine in the side-chain and a water 
molecule, and then again between the same water molecule and a carbonyl group on the 
crystal surface (secondary adsorption site). However, for the purposes of this project, the 
manual alteration of the final molecular modelling results is not encouraged, as this would 
affect the final calculated Eads values that are used in evaluating structure-activity 
relationships. 
By performing this adsorption study, a noteworthy structure-activity relationship is found. 
With a determined NP40 BHIC50 activity of 6.28 ± 0.5 μM, QC is a significantly more potent 
β-haematin inhibitor than CQ, (31.5 ± 2.0 μM).  Moreover, considering that QC and CQ have 
the same side-chain, the contribution of a larger molecular scaffold for the adsorption into the 
primary adsorption site, is demonstrated. The benzo-(b)(1-5)napthyridine scaffold of QC is 
able to form more π-π interactions to the porphyrin structure inside the primary adsorption 
site than observed for the quinoline scaffold of CQ. It therefore seems reasonable that this 
additional intermolecular π-π interactions result in an improved β-haematin growth inhibition.    
Therefore, it is concluded that larger molecular structures, that are able to form an increased 
number of π-π interactions in the primary adsorption site, would be ideal for developing 
novel and more potent β-haematin inhibitors. 
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4.2 INVESTIGATING LINEAR MOLECULES THAT ADSORB INTO TWO NEIGHBOURING 
PRIMARY ADSORPTION SITES 
4.2.1 The larger bis-quinoline compounds investigated 
In Chapter 3 it is found that many of the larger non-quinoline inhibitors preferred adsorption 
geometries where two neighbouring primary adsorption sites were occupied. By combining 
the information obtained from the previous adsorption studies, new molecules could be 
designed with the purpose of improved adsorption into the two primary adsorption sites. 
However, with the focus of this project being on investigating the adsorption of β-haematin 
inhibitors onto β-haematin and evaluating structure-activity relationships, it was considered 
preferable to evaluate the adsorption of compounds of which the structure-activity 
relationships would contribute towards a greater understanding of the manner in which 
inhibitors adsorb into the primary adsorption site. The information obtained could then later 
be used to design active β-haematin inhibitors with the desired pharmacokinetics ADME 
properties (adsorption, digestion, metabolism, and excretion), as potential antimalarial drug 
candidates. 
As mentioned before, a favoured adsorption is obtained when an inhibitor is able to adsorb 
into both the primary and secondary adsorption sites on face {001}, as seen for QN and QD. 
However, this forms part of another PhD project, and therefore this adsorption geometry 
would not be discussed in this project. 
With compounds KW5 and FL2 showing the most favoured adsorption geometries for the 
adsorption into two neighbouring primary adsorption sites (Figure 85), similar compounds 
could be considered where these could be varied in length to optimise the adsorption 
Stellenbosch University  https://scholar.sun.ac.za





geometry. These results would strengthen the argument that a more favoured adsorption and 
thus an increased β-haematin inhibition activity is obtained when a compound is able to 




Figure 85: The adsorption of compound KW5 (left) and FL2 (right) in the crevice on face {001}. 
The adsorption of compound KW5 (left) in the diprotic form, and compound  FL2 (right) in the monoprotic 
form onto face {001}, as viewed perpendicular to the crystal face, is shown. Hydrogen bonding interactions are 
indicated by   , and π-π interactions are indicated by   . 
 
For instance, by cleaving compound FL2 at the amide nitrogen to obtain compound RM1, a 
smaller molecule would be obtained, which might result in a less favoured adsorption 
geometry, as only one primary adsorption site would be occupied (Table 33). Similarly, by 
replacing the phenyl ring with a quinoline moiety to obtain compound RM2, a more favoured 
adsorption geometry is expected, since an increased number of π-π interactions would form 
between the aromatic rings and the porphyrin structure on the crystal surface.  
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Table 33: Comparing the chemical structures of compounds RM1 and RM2 to that of FL2. 
Compound Chemical structure 
  
 











Alternatively, the length of the molecule could be altered systematically by forming a 
bis-quinoline compound with a linear chain in between, as seen for compounds RM3 - RM5 
(Table 34). The molecules would be able to extend into only one, and finally into two 
primary adsorption sites, where it could be lengthened even more until the molecule is too 
large to fit into two neighbouring primary adsorption sites.  
Table 34: The chemical structures of compounds RM3 - RM5 
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Unfortunately, the linear alkyl chains could also rotate into non-linear conformations, which 
would affect the final adsorption geometries. Therefore, the adsorption of more rigid 
structures was rather evaluated in this study.  
Moreover, with the growing malaria resistance against quinoline drugs (Section 1.3.2.1), 
indole scaffolds were also considered. It was suggested that an ester functional group could 
be utilised to connect the bis-indoles together (Table 35). However, when the adsorption of 
compounds RM6 and RM7 into the crevice was evaluated, the amide functional group is 
preferred, since the amide N-H forms a hydrogen bonding interaction to a carbonyl group on 
the crystal surface, as seen for FL2 in Figure 85. Also, the amide functional group would 
improve the water-solubility of the compound, which is an essential property needed to 
determine the NP40 BHIC50 activity.  
The location of the amide functional groups in the molecules could also be varied (Table 35). 
However, when comparing the adsorption of compounds RM7 and RM8, a more favoured 
adsorbed geometry is obtained for compound RM7, where the formation of the preferred 
hydrogen bonding interaction was consistently seen in the results of three consecutive 
simulations that were performed. The modelling results were found to be less consistent for 
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Table 35: The chemical structures of compounds RM6 - RM22 












In an attempt to synthesise compound RM7, it was realised that the 2,6-dichloroindole 
intermediate needed for the synthesis of the indole compounds, is unstable (Scheme 16). The 
preparation of this intermediate was attained by treating 6-chloroindolin-2-one with 
phosphorus oxychloride. However, upon purification, as well as in an attempt to stabilise the 
compound by introducing a tert-butyloxycarbonyl (Boc) protecting group on the indole 




R1 = -Cl, -NH2, or Phenyl 
R2 = Boc, or -H 
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Therefore, owing to the fact that quinoline drugs are known for their ability to act as 
β-haematin inhibitors and are still widely used in ACT treatments to combat malaria, as well 
as with the persisted activity of bis-quinoline compounds against CQ-resistant strains 
(Section 1.3.3), the synthesis of quinoline compounds was rather pursued in the remainder of 
this study (Table 36).  
Table 36: The chemical structures, and the speciation of compounds RM9 - RM13 at pH 4.8. 
Compound Chemical structure % Monoprotic % Neutral 
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It is considered that compound RM9 would occupy the two neighbouring primary adsorption 
sites in a similar geometry as compound FL2. Therefore, a chlorine atom could be introduced 
in the 7-position of the quinoline to obtain compound RM10, where a carbazole, being 
commercially available, could be introduced (RM11) in order to evaluate the adsorption of a 
larger aromatic ring system. 
Furthermore, by introducing different functional groups between the two quinoline scaffolds 
(compounds RM12 and RM13), the quinoline rings would be extended further apart. For 
these, more flexible molecules would be obtained, which might contribute to a more 
favourable adsorption geometry. When evaluating the two lowest energy conformations of 
compound RM12 and RM13, the conformations on the right in Figure 86 were found to be 
the absolute minimum energy conformations. Therefore, the adsorption of these 
conformations onto face {001} was evaluated.     
Also, in order to evaluate whether it is truly beneficial for a molecule to adsorb into both 
neighbouring primary adsorption sites, the adsorption of smaller molecules onto face {001} 
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Figure 86: Lowest energy conformations of compounds RM12 and RM13  
The two lowest energy conformations of compounds RM12 (top) and RM13 (bottom) are shown, where those on 
the right are found to be the absolute minimum energy conformations. 
 
 
Table 37: The chemical structures and the protic forms at pH 4.8, of compounds RM14-16 
Compound Chemical structure % Diprotic % Neutral 
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When evaluating the chemical structure of the bis-quinoline RM9, it is possible that by only 
having a phenyl ring on the one end (compound RM14), a less favoured adsorption into the 
crevice would be obtained, since the formation of fewer π-π interactions between the inhibitor 
and the porphyrin structure in the second primary adsorption site is expected. Similarly, this 
phenyl ring could be removed to evaluate the adsorption of the smaller compound RM15. 
Compound RM16 would only be able to occupy one primary adsorption site.  
Therefore, by evaluating the adsorption and structure-activity relationships of these 
compounds, it was reasoned that a greater understanding would be obtained as to whether a 
more favoured adsorption is gained when an inhibitor is able to adsorb into two primary 
adsorption sites. 
 
4.2.2 Adsorption of the bis-quinoline compounds onto face {001} 
Interestingly, the quinoline compounds preferred adsorption geometries where either the 
compounds adsorbed entirely into the two neighbouring primary adsorption sites where no 
hydrogen bonding interaction is formed, or the lengthier compounds were not able to adsorb 
entirely into the two neighbouring primary adsorption sites, where the formation of hydrogen 
bonding interaction between the amide N-H and a carbonyl group on the crystal surface is 
found. 
Compounds RM10 and RM12 had the most favoured adsorption geometries, where these 
molecules were able to fully occupy two neighbouring primary adsorption sites (Figure 87). 
The quinoline moieties on both ends of the molecules formed π-π interactions to the 
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porphyrin structures in both primary adsorption sites. However, for both of these compounds, 
the formation of hydrogen bonding interactions is not observed. 
 
  
Figure 87: Adsorption of compounds RM10 and RM12 onto face {001} 
The adsorption of compounds RM10 (left)in the neutral form and RM12 (right) in the monoprotic  form onto 
face {001}, as viewed from above, is shown. The π-π interactions are indicated by   . 
 
When evaluating the adsorbed geometries of the smaller compounds RM14-16, it is found 
that these were able to form fewer π-π interactions in the crevice (Figure 88). Compound 
RM16 only occupied one primary adsorption site, where both compounds RM14 and RM15 
were able to extend into the second primary adsorption site. Even though the quinoline 
moiety of compound RM15 adsorbed in the left corner of the primary adsorption site, and the 
quinoline moiety of compound RM14 adsorbed in the right corner of the primary adsorption 
site, these two adsorption geometries are considered comparable. For example, by rotating 
the quinoline moiety of compound RM15, it could also have adsorbed in the right corner, 
where the same intermolecular interactions would form between the inhibitor and the crystal 
surface. What is however significant, is the increased number of intermolecular interactions 
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formed between the additional phenyl ring of compound RM14. Moreover, when evaluating 
the adsorbed geometry of both compounds RM14 and RM15 more closely, additional alkyl-π 
(T-shape) interactions could form between the phenyl ring and alkyl groups in close 
proximity.  
It has been reported that dispersion effects have the greatest contribution in promoting these 
alkyl-π interactions, where the alkyl hydrogen atom acts as a weak hydrogen bond donor.
168
 
By performing DFT calculations, it has been demonstrated that the optimum calculated 




The measured alkyl-π interaction distances between compound RM15 and the porphyrin 
structure are between 3.5 and 4.2 Å. These are less favoured interaction distances, and the 
interactions between the alkyl C-H bond and the benzene ring do not occur at right angles 
(75-80°). Therefore, from a computational perspective, it is considered that these interactions 
do not contribute significantly to a more favoured adsorption geometry.  
Based on the number of intermolecular interactions formed, the adsorbed geometry of 
compound RM14 is considered more ideal, followed by that of compound RM15. Compound 
RM16 is considered to have the least favoured adsorbed geometry, since it is only able to 
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Figure 88: Adsorption of compounds RM14-16 onto face {001} 
The adsorption of compounds RM14 (a) and RM15 (c) in the neutral form, and RM16 (b) in the diprotic  form 
onto face {001}, as viewed from above, is shown. The π-π interactions are indicated by  , and are measured 
to be between 3.5 and 3.8 Å. The alkyl-π interactions are indicated by   , and are measured to be between  
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It is found that the larger compounds RM11 and RM13 are too long to adsorb into both 
primary adsorption sites, and a hydrogen bonding interaction between the amide N-H and the 
carbonyl group on the crystal surface is rather preferred. Consequently, adsorbed geometries 
are obtained where the molecules adsorb into both the primary and the secondary adsorption 
sites (Figure 89). 
Compound RM9 adsorbed in a similar manner as compounds RM11 and RM13 (Figure 90). 
It is possible that the chlorine atom in the 7-position of the second quinoline group of 





Figure 89: Adsorption of compounds RM11 and RM13 onto face {001} 
The adsorption of compounds RM11 (left) and RM13 (right) in the neutral form onto face {001}, is shown, as 
viewed from above. The hydrogen bonding interaction is indicated by  , and π-π interactions are  
indicated by   , and are measured to be between 3.5 and 3.8 Å. 
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Figure 90: Adsorption of compound RM9 onto face {001} 
The adsorption of compound RM9 in the neutral form onto face {001}, is shown, as viewed from above. The 
hydrogen bonding interaction is indicated by  , and π-π interactions are  
indicated by   , and are measured to be between 3.5 and 3.8 Å. 
 
With these larger molecules (RM9, RM11 and RM13) not being able to adsorb into the 
crevice, adsorption of these onto the second fastest growth face, face {011}, was also 
evaluated. Interestingly, for the adsorption of compound RM11, a more favoured Eads value 
was calculated for the adsorption onto face {011} than for the adsorption onto face {001}  
(Figure 91, Table 38).  
 
Table 38: Eads values for the adsorption of compound RM11 onto face {001} and face {011} 








       
RM11 -76.5 ± 0.02 -80.0 ± 0.001 
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Figure 91: Adsorption of compound RM11 onto face {011} 
The adsorption of compound RM11 in the neutral form onto face {011}, is shown, as viewed from above.  
The π-π interactions are indicated by   , and are measured to be between 3.5 and 3.8 Å. 
 
For the adsorption of the larger molecules onto face {011}, adsorption geometries were 
preferred where additional interactions formed between the inhibitor and the secondary 
adsorption site on the crystal surface. These additional interactions would contribute to an 
enhanced adsorption, and may therefore contribute to an improved NP40 BHIC50 activity. 
Since a more favoured adsorption is found for compound RM11 onto face {011} for 
example, it provides an opportunity to determine the relationship, if any, between adsorption 
and an overall improved NP40 BHIC50 activity.  
Therefore, with these larger compounds showing more favoured intermolecular interactions 
outside of the crevice, and also for the adsorption onto face {011}, these could not be used to 
evaluate adsorption into the two neighbouring primary adsorption sites on face {001}. 
It is therefore concluded that the smaller compounds RM10, RM12, and RM14-16 could be 
used to determine structure-activity relationships for the adsorption into two neighbouring 
primary adsorption sites. By this means, the ability of this adsorption protocol to predict the 
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activity of β-haematin inhibitors for the adsorption into two neighbouring primary adsorption 
sites, could be assessed. 
 
4.2.3 Towards the synthesis of the bis-quinoline compounds 
Yang et al. reported an Ullmann-type synthetic procedure for a one-pot copper-catalysed 
oxidative amination of aldehydes from 2-aminopyridines.
169
 Various reaction conditions were 
considered, where the optimum yield is obtained by using air or oxygen gas as an oxidant in 
the presence of 10 mol % copper iodide. This was heated to 80 °C in N,N-dimethylformamide 
for 24 hours. A reaction mechanism is proposed (Scheme 17), where the copper coordinates 
with the pyridine nitrogen and the aldehyde oxygen, thereby bringing the carbonyl bond in 
close proximity to the amine. The amine is able to act as a nucleophile and attack the 
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The reaction mechanism proposed by Yang et al. for the copper-catalysed oxidative amination, is shown.
169
 The 
copper-coordinates to the pyridine nitrogen and the carbonyl oxygen (a1-2), which results in the formation of 
the hemiaminal (b). Finally, this is then oxidised (c) to form the desired product. 
 
By using this Ullmann-type coupling procedure, an inconvenient acylation reaction could be 
avoided, and a coupling reaction could be performed directly between the aldehyde and the 
amine to achieve the formation of an amide.  
For this synthetic endeavour, the amine could be introduced in the 2-position of the quinoline 
by performing an Ullmann coupling reaction. This could be achieved by treating the 
2-bromoquinoline 15 with ammonium hydroxide at high temperatures to afford the 
2-aminoquinoline RM16 in one reaction (Scheme 18).  
Scheme 18 
 
15  RM16 
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Compounds RM10 and RM14 could be synthesised by performing a Suzuki coupling to 
obtain the intermediate aldehyde compounds, where after the Ullmann-type coupling could 







R =       or               
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By performing the Ullmann-type coupling between compound 16 and RM16, in the presence 
of atmospheric oxygen, only compound RM15 would be obtained (Scheme 20). 
Therefore, for the synthesis of compound RM12, a one-pot reaction could be considered, 
where an amination reaction and an Ullmann-type coupling could be performed (Scheme 20). 
By maintaining the reaction mixture under a positive pressure of nitrogen gas, only the 
amination reaction would proceed. Once the reaction mixture is exposed to atmospheric 










                                                                                                          RM12 
 
With the synthetic strategy outlined, the target molecules could be synthesised in order to 
determine the NP40 BHIC50 activities thereof, and to evaluate structure-activity relationships. 
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4.2.4 Synthesis of the bis-quinoline compounds 
4.2.4.1 Synthesis pertaining to 2-aminoquinoline - RM16 
4.2.4.1.1 Attempted synthesis of 2-aminoquinoline - RM16 
Compound RM16 could be synthesised by means of a Ullmann coupling upon exposing 
compound 15 to ammonium hydroxide at high temperatures, with copper iodide acting as a 
catalyst (Scheme 21). 
Scheme 21 
 
15  RM16 
 
In proceeding with the synthesis of compound RM16, compound 15 was dissolved in 
N,N-dimethylformamide, and an excess amount of ammonium hydroxide, 0.5 mL water, and 
copper iodide was added. This reaction mixture was refluxed for 5 hours, until the full 
consumption of the starting material was attained.   
Unfortunately, after quenching the reaction mixture on ice and by neutralising it with 2M 
hydrochloric acid, the desired product was not extracted with ethyl acetate. It is probable that 
the product RM16 is water-soluble. 
Another synthetic route was rather considered where the product could be formed in the 
absence of water. With the formation of an azide intermediate 17 from 16, it could be reduced 
in the presence of hydrogen gas in order to obtain the desired product RM16 (Scheme 22). 
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16  17  RM16 
 
4.2.4.1.2 Synthesis of 2-azidoquinoline - 17 
Compound 17 was synthesised from 16 in the presence of sodium azide (Scheme 23).
165
 The 
starting reagent 16 was dissolved in dimethyl sulfoxide. Sodium azide was added, which only 
dissolved in the solvent upon heating the reaction mixture above 80 °C. However, at this 




16  17 
 
Upon completion, the reaction mixture was quenched with water and the product was 
extracted with ethyl acetate. Finally, upon purification by means of column chromatography, 
the desired product 17 was obtained in a decent 75% yield. 
 
The presence of the azide moiety was established by a N3 stretch at 
2250 cm
-1 
in the infrared spectrum. Moreover, the result of the mass 
spectral analysis of 171.0652 amu correlated well with the expected mass of 
171.0671 amu.  
         17 
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4.2.4.1.2 Synthesis of 2-aminoquinoline - RM16 
Compound RM16 was finally synthesised by the reduction of 17 with freshly prepared 
Raney
®
-Nickel under a positive pressure of hydrogen gas (Scheme 24). The Staudinger 
reaction was also attempted for the reduction of the azide in the presence of 
triphenylphosphine, however the reaction did not proceed to completion. Therefore, the 
above mentioned method was rather preferred.  
Scheme 24 
 
17  RM16 
 
Compound 17 was dissolved in a small amount of dimethyl sulphoxide and dry ethanol, 
whereupon a spatula scoop (approximately 5 mL) of freshly prepared Raney
®
-Nickel was 
added twice a day over a period of three days. The reaction was kept at 30 °C and under a 
positive pressure of nitrogen in order to ensure the protonation of the nitrogen in the 
2-position of the quinoline. 
After full consumption of the starting reagent, the reaction mixture was filtered through 
celite, whereupon the filtrate was washed with ethyl acetate. The solvent was removed in 
vacuo, whereupon the product was isolated by means of column chromatography, in a high 
yield of 94%. 
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In the obtained 
1
H NMR spectrum, a singlet, integrating for 2 protons at 
6.41 ppm, was indicative of the secondary amine H9. Furthermore, a 
peak at 158.22 ppm for C2 is found in the 
13
C NMR spectra.          RM16 
 
With the successful synthesis of compound RM16, it was used to synthesise the other target 
compounds. 
 
4.2.4.2 Synthesis pertaining to compound RM14 
For the synthesis of the target molecules, it was deemed best to first synthesise the aldehyde 
intermediate 19, as this compound could be synthesised from commercially available 
reagents in one reaction step. This could then be used to evaluate and optimise the reaction 
conditions required for the Ullman-type coupling reaction, in order obtain the desired amide 
product RM14. These optimised reaction conditions could then be applied to synthesise the 
other remaining target compounds. 
 
4.2.4.2.1 Synthesis of biphenyl-4-carbaldehyde - 19 
Compound 19 was synthesised from commercially available 15 and 18 by means of a Suzuki 
coupling reaction (Scheme 25). 
Scheme 25 
 
18  15  19 
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The starting reagent 15 and the boronic acid 18 were dissolved in N,N-dimethylformamide, 
whereupon a small amount of water and potassium carbonate were added. The reaction 
mixture was refluxed for 10 minutes at 100 °C under a positive pressure of nitrogen, where 
after the air and light sensitive palladium catalyst was added. 
The reaction did not proceed to completion, and was quenched after 2 days with water. The 
product was extracted with ethyl acetate and finally purified by means of column 
chromatography to obtain the desired product in a reasonable 59% yield. 
 
The presence of the aldehyde was confirmed by a doublet integrating 
for 1 at 10.06 ppm in the 
1
H NMR spectrum for H5 and peak at 192.06 
ppm for C5 in the 
13
C NMR spectrum was observed. The aromatic 
signals integrated for 9 protons, which was indicative of the presence 




           19 
4.2.4.2.2 Synthesis of N-(quinolin-2-yl) biphenyl-4-carboxamide - RM14 
Upon performing the Ullmann-type coupling reaction, compound RM14 was synthesised 
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The two starting reagents RM16 and 19 were dissolved in N,N-dimethylformamide, 
whereupon the base in a trace amount of water, and copper iodide were added. The reaction 
mixture was heated to 100 °C for a period of two days.  
Finally, the reaction was quenched with water and the product was extracted with ethyl 
acetate. Upon purification by means of column chromatography, the product was isolated in a 
low 32% yield. 
Unfortunately, the reaction did not proceed to completion, and by allowing the reaction to 
reflux for a longer period of time, or by adding more reagents, a higher yield was not 
achieved. 
 
A singlet integrating for 1 at 11.15 ppm in the 
1
H NMR for 
H9, together with the peaks at 166.11 and 151.91 ppm for C10 
and C2 respectively, is indicative of the formation of the 
amide group. Moreover, the result of the mass spectral 
analysis of 325.1357 amu correlated well with the expected 
mass of 325.1341 amu. 
 
 
                RM14 
 
Having successfully performed the Ullman-type coupling between the aldehyde 19 and the 
amine RM16 to form the amide product RM14, this reaction could be used for the synthesis 
of the remaining target compounds.  
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4.2.4.3 Synthesis pertaining to compound RM10 
4.2.4.3.1 Attempted synthesis of 4-(7-chloroquinolin-2-yl)benzaldehyde - 21 
With the successful synthesis of compound 19 and finally RM14, the synthesis of 
compound 21 from previously synthesised S2 and commercially available boronic acid 20, 
was attempted (Scheme 27). 
Scheme 27 
 
S2 20  21 
 
The same Suzuki coupling procedure for the synthesis of compound 19 from 15 and 18 was 
used, where the reaction mixture was allowed to reflux for two days until the full 
consumption of the starting material S2 was obtained. 
Unfortunately, the Suzuki coupling occurred at both the 2-position, as well as at the 
7-position of the quinoline S2. This resulted in the formation of two inseparable products, 
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While it was not possible to unambiguously determine which 
compound (21 or 22) was favoured, the 
1
H NMR spectrum 
showed a singlet integrating for 1 at 10.08 ppm, as well as a 
singlet integrating for 2 at 10.07 ppm. This indicated that a  






It is expected that the coupling reaction would have been preferred at the more reactive 
2-position of the quinoline. However, this was not the case. The coupling reaction occurred 
on both ends of the quinoline S2.  
Unfortunately, even by performing the coupling reaction at lower temperature (60 °C) or for 
a shorter time period, these methods still did not overcome the problem of separating the two 
products that were isolated, and once again, a low yield was obtained. Therefore, with 
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4.2.4.4 Synthesis pertaining to compounds RM12 and RM15 
4.2.4.4.1 Attempted synthesis of N-(quinolin-2-yl)-4-(quinolin-2-ylamino)benzamide - 
RM12 
and the synthesis of 4-bromo-N-(quinolin-2-yl)benzamide - RM15 
A one-pot synthesis was attempted for the synthesis of compound RM12 from RM16 and 15 
(Scheme 28). By performing the first part of the reaction under inert reaction conditions, the 
amine bond would be introduced between RM16 and 15, where in the presence of oxygen 
and a trace amount of water, the amide bond would be introduced between the amine of 
RM16 and the aldehyde intermediate.  
Scheme 28 
 
15     RM16  RM12 
 
 
Therefore, 15 and RM16 were dissolved in dry N,N-dimethylformamide. Copper iodide and 
base were added and the reaction was refluxed under a positive pressure of nitrogen gas at 
100 °C. Unfortunately, after 2 days, the reaction did not proceed and only the starting 
reagents were present, as determined by means of thin layer chromatography. The reaction 
was gradually heated to 160 °C. Unfortunately, the amination reaction did not occur. 
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The reaction was repeated, open to atmospheric oxygen, whereupon a trace amount of water 
was added and the reaction was allowed to reflux for 2 days. Only the formation of product 
RM15 was observed, as determined by means of thin layer chromatography (Scheme 29). 
Scheme 29 
 
15 RM16  RM15 
 
Unfortunately, the reaction did not proceed to completion, and the starting reagents remained 
in the reaction mixture. The reaction mixture was quenched with water and the product was 
extracted with ethyl acetate. Afterwards, product RM15 was purified by means of column 
chromatography, upon which it was recovered in a low 19% yield.  
 
A singlet integrating for 1 at 11.23 ppm in the 
1
H NMR for 
H9, together with the peaks at 165.73 ppm for C10, is 
indicative of the formation of the amide group. Moreover, 
the result of the mass spectral analysis of 327.0133 amu and 
329.0116 amu correlated exactly with the expected mass of 
327.0133 amu and 329.0114amu. 
 
RM15 
From these reactions (synthesis of RM14 and RM15), it was apparent that the Ullmann-type 
coupling did not provide high yields when a 2-aminoquinoline RM16 was used to form the 
amide bond, as opposed to 2-aminopyridines that were originally used by  
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 It is suspected that the 2-aminoquinoline was not a strong enough nucleophile 
to bring about the formation of the desired secondary amine for the formation of 
compound RM12.  
Therefore, another synthesis approach was needed for the synthesis of these compounds, or 
different molecules had to be considered to evaluate the adsorption into the two neighbouring 
primary adsorption sites. 
Peng et al. reported the formation of the amine bond at the 2-position of a quinoline by means 
of an amination reaction, thereby treating substituted amino benzene rings with 
2-chloroquinoline.
170
 In proceeding with this alternative approach to form the amine bond, 
the quinoline moiety needs to act as an electrophile and would require a halogen in the 
2-position of the quinoline. However, in order to obtain compound 24, an extremely 
expensive reagent, 4-aminobenzaldehyde 23, is needed to act as the nucleophile (Scheme 30). 
Scheme 30 
 
                                                                               23 16  24 
 
 
Another approach could be used, where 4-aminobenzoic acid 25 is rather used to form the 
amine bond of compound 26 (Scheme 31). The benzoic acid 26 could be treated with thionyl 
chloride to obtain the acid chloride 27, which could again be reacted with 2-aminoquinoline 
RM16 to obtain the desired final product RM12. 
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25 16  26 
 
 
 26  27 
 
 
27 RM16  
 




Even though this suggested synthetic route is viable, the execution of the overall synthesis 
would depend on the initial amine formation, where 2-bromoquinoline 16 would be treated 
with the amine 25. With the carboxylic acid being a strong electron withdrawing group, it 
might cause the amine in the 4-position of compound 25 to be less nucleophilic. Therefore, it 
is less likely that the amination reaction would proceed.  
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The same trend in reactivity is observed in the results published by Peng et al., where slightly 




Table 39: Reaction yields reported by Peng et al.
170
 













The aim of this study is to evaluate the adsorption of compounds that would contribute in 
gaining a greater understanding of the adsorption of inhibitors into two neighbouring primary 
adsorption sites. Therefore, it was deemed more efficient to spend time and resources on 
obtaining such compounds, rather than to concentrate on the synthesis of specific compounds. 
To this end, with the amination reaction posing potential difficulties, the synthesis of new 
compounds was rather pursued, and the alternative synthesis of compound RM12 was set 
aside. 
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4.2.5 Introducing two new linear compounds for the adsorption onto face {001} 
With compounds RM14-16 in hand, the emphasis was set on designing molecules that would 
extend this data set, thereby contributing in gaining a greater understanding of the adsorption 
of these into the two neighbouring primary pockets. 
As mentioned above, compound RM14 adsorbs with one phenyl ring into the second primary 
adsorption site, where for compound RM15, only one bromine atom could form interactions 
at this position in the second primary adsorption site. Moreover, compound RM16 was only 
able to adsorb into a single primary adsorption site. For these compounds, the formation of 
hydrogen bonding interactions is not seen. Building on the structure-activity relationships that 
could be determined for these two compounds, compound RM17 and RM18 would also 
contribute to this study (Table 40).  
Upon evaluating the adsorption of these two compounds into the crevice on face {001}, it is 
found that compound RM17 adsorbs in a similar conformation as compound RM10 and 
RM12 investigated above, where the molecule is able to occupy both primary adsorption 
sites completely (Figure 92). Compound RM18 is not able to extend into a second primary 
adsorption site to form π-π interactions to the porphyrin structure, where the formation of a 
hydrogen bond between the primary amine and a carbonyl group on the crystal surface is 
seen, with a measured interaction distance of 2.7 Å. 
By synthesising these two compounds and by determining the NP40 BHIC50 activities 
thereof, structure-activity correlations could be evaluated. Moreover, the activity data of these 
two compounds could be compared to that of compounds RM14-16, where the extent of 
adsorption into the crevice on face {001} could be evaluated. 
Stellenbosch University  https://scholar.sun.ac.za






Table 40: The chemical structures of compounds RM17 and RM18. 
Compound Chemical structure % Diprotic % Monoprotic % Neutral 












Figure 92: Adsorption of compounds RM17 and RM18 onto face {001} 
The adsorption of compounds RM17 (left) and RM18 (right) in the diprotic form onto face {001}, is shown, as 
viewed from above. The hydrogen bonding interaction, with a measured interaction distance of 2.7 Å, is 
indicated by  , and π-π interaction, with measured interaction distances between 3.5 and 3.8 Å,  




Stellenbosch University  https://scholar.sun.ac.za





4.2.5.1. Towards the synthesis of compounds RM17 and RM18 
With the 2-aminoquinoline RM16 not being a strong nucleophile, the synthetic procedure for 
the formation of the amine bond that was attempted before, was not pursued. Instead, the 
amination reaction reported by Peng et al. was rather considered.
171
 
By heating an excess amount of 16 with 28 in dry ethanol, under a positive pressure of 
nitrogen gas, both compounds RM17 and RM18 would be obtained (Scheme 32). The 
formation of RM18 would be observed with the addition of 1 equivalent of 16. By allowing 
the reaction to proceed for a longer period of time, and by adding 2 equivalents of 16, a 
higher yield for RM17 would be obtained.  
Scheme 32 
 






       16 
 
                                                                       
 RM17  
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4.2.5.2 Synthesis of the two new quinoline compounds 




-di(quinolin-2-yl)benzene-1,4-diamine -RM17  
and N
1
-(quinolin-2-yl)benzene-1,4-diamine - RM18 
For synthesising compounds RM17 and RM18 from 16 and 28, the reagents were added to 
dry ethanol, where a small amount of N,N-dimethylformamide was added to ensure the 
solubility of reagent 16 (Scheme 33).
171
 
The reaction mixture was allowed to reflux under a positive pressure of nitrogen for three 
days. Unfortunately the reaction did not proceed to completion and a vast amount of starting 
reagent 16 was still present. Product formation was not seen at lower temperatures, and 
simultaneous formation of both products RM17 and RM18 was observed after refluxing the 
reaction mixture for 6 hours, as determined by means of thin layer chromatography analysis. 
Scheme 33 
 
16 28 RM18 
 
                                                            
 RM17 
 
Nevertheless, after the three day time period, the reaction mixture was allowed to cool to 
room temperature, whereafter the excess solvent was removed in vacuo. The desired products 
were purified by means of column chromatography.  
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Compound RM17 was obtained in a low 3% yield, and compound RM18 in a low 19% yield, 
where 30% of the starting reagent 16 was recovered.  
For compound RM17, the 
1
H NMR spectrum 
served as a confirmation of the successful 
synthesis of a symmetrical molecule with two 
identical secondary amines, where a peak 
integrating for 1 at 9.33 ppm for H9, was 
observed. Furthermore, the result of the mass 
spectral analysis of 363.1610 amu correlated 
exactly with the expected mass of 363.1613. For compound RM18, a peak integrating for 1 at 
8.89 ppm for H9, and a peak integrating for 2 at 4.76 ppm for H14 were observed in the 
1
H NMR spectrum, which indicated that the reaction only occurred once, where both a 
primary and a secondary amine are present. 
Unfortunately, these low yields could not be improved by allowing the reaction to proceed 
for longer, by adding more of compound 16, or with the addition of a strong base. By 
performing the reaction on a larger scale, the reaction did not proceed at all. However, a 
sufficient amount of product RM17 and RM18 was obtained in order to achieve full 
characterisation, and to determine the NP40 BHIC50 activities thereof. Furthermore, 
considering that a low yield was obtained for this reaction, the synthesis of compound RM12 
was not pursued. 
In retrospect, a more selective synthesis could have been achieved. By reacting compound 16 
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subsequently have been reduced to obtain compound RM18. Upon the further treatment of 
compound RM18 with 16, compound RM17 could have been isolated. 
Scheme 34 
 
16  29  30 
 
 
 30       
   
                                                                                                                  RM18 
 
 
RM18  +  16                                                              
 
                                                                                                                  RM17 
 
Even though compound RM17 was obtained in a low yield, it is an ideal target molecule for 
this study, as it is able to adsorb in such a geometry where the two quinoline moieties occupy 
two neighbouring primary adsorption sites simultaneously. Furthermore, with compound 
RM18 only being one quinoline moiety smaller than RM17, and with compound RM16 only 
comprising of one quinoline structure, the obtained structure-activity relationships would 
provide valuable insight as to whether the adsorbed geometry of compound RM17 is truly 
more favoured.  
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Therefore, with five final compounds in hand that were each observed to occupy the crevice 
in a different manner, the NP40 BHIC50 activities were determined in order to evaluate the 
structure-activity relationships of these compounds.  
4.2.6 Investigating structure-activity relationships for the synthesised quinoline 
compounds 
For the clinically-relevant quinoline, as well as for the non-quinoline compounds, a linear 
correlation was found between the calculated adsorption energies (Eads), and the NP40 
BHIC50 activities (Chapter 2 and 3). Furthermore, two main adsorbed geometries were found 
to be preferred for the adsorption onto face {001}. The molecules preferred adsorption into 
one primary adsorption site with the side-chains forming interactions on the crystal surface 
outside of the crevice, or an adsorption geometry is preferred where the compounds adsorb 
entirely into two neighbouring adsorption sites. 
In this Chapter, five final compounds with a novel structure were synthesised for the purpose 
of further evaluating structure-activity relationships for the adsorption into two neighbouring 
primary adsorption sites. The calculated Eads values for the adsorption onto face {001} are 
compared to the determined NP40 BHIC50 activities (Table 41, and Figure 93), and a linear 
correlation was found, with an R
2
 value of 0.87 and a P value of 0.02, when only taking into 
account the percentage speciation at pH 4.8. 





Table 41: The determined NP40 BHIC50 activity of the synthesised compounds, as well as the calculated Eads values for the adsorption onto face {001},  
















































































































































-62.3 ± 1.5 0 0 100 -62.3 318 ± 0.4 
 RM16 -46.8 ± 0.01       100 0 0 -46.8 453 ± 2.7 
 RM17 -99.4 ± 0.2 -99.8 ± 4.2 -90.8 ± 0.5 22 50 28 -97.2 10.5 ± 0.02 
 RM18 -66.4 ± 0.6 -65.5 ± 0.1 -66.0 ± 0.5 16 61 22 -65.8 155 ± 0.01 
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Figure 93: The calculated Eads values for the adsorption onto face {001}, by also taking into account the 




 value of 0.87 and a P value of 0.02 are obtained. 
 
This was indeed a pleasing result, which confirmed that the activities of new β-haematin 
inhibitors were successfully predicted by using the molecular modelling approach. 
Furthermore, this result has demonstrated that a greater NP40 BHIC50 activity is indeed 
obtained when an inhibitor is able to adsorb into two neighbouring primary adsorption sites, 
as opposed to adsorbing into a single primary adsorption site. 
Compound RM14 is able to adsorb with a phenyl ring into the second primary adsorption 
site, where compound RM15 only has a halogen atom adsorbed in this position, therefore it is 
expected for compound RM14 to be a significantly more active β-haematin inhibitor. This 
result is indeed found when comparing the determined NP40 BHIC50 activities, where 
compound RM14, with a NP40 BHIC50 activity of 148 ± 16 μM, is twice as active as 
compound RM15, with a NP40 BHIC50 activity of 318 ± 0.4 μM. 
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Furthermore, for compound RM16, which is only able to adsorb into one primary adsorption 
site, a significantly less favoured NP40 BHIC50 activity of 453 ± 2.7 μM is determined. 
Therefore, this result indicates that either the bromine atom or the benzene ring on compound 
RM15 might give rise to additional hydrophobic interactions (halogen-π, or alkyne-π 
interactions) to the porphyrin structures in the crevice, which results in an improved NP40 
BHIC50 activity, compared to that of compound RM16. 
In contributing to this argument, compound RM16 only adsorbed into one primary 
adsorption site, where compound RM18 has one more benzene ring that forms alkyne-π 
interactions in the second primary adsorption site. As a result, a more favoured NP40 BHIC50 
activity of 155 ± 0.01 μM is determined for compound RM18.  
The second quinoline of compound RM17 is able to extend further into the second primary 
adsorption site, forming additional π-π interactions to the porphyrin structure. Therefore, a 
considerably improved NP40 BHIC50 activity of 10.5 ± 0.02 μM is determined for this 
compound. 
This result adds merit to the argument that when two neighbouring primary adsorption sites 
are occupied simultaneously, enhanced adsorption (Eads), and more importantly, enhanced 
β-haematin growth inhibition (NP40 BHIC50 activity), is achieved. Furthermore, considering 
that the NP40 BHIC50 activity of AQ is 7.2 ± 0.05 μM, and that of CQ is 31.5 ± 2.0 μM, 
compound RM17 is regarded as an active β-haematin growth inhibitor. 
In reviewing the structure-activity relationships more closely, a more in-depth understanding 
is obtained with regards to the intermolecular interactions that form between the inhibitor and 
the crystal surface. According to computational results, compounds RM15 and RM18 are 
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predicted to be equally active β-haematin inhibitors, with calculated Eads values of   62.3 
and   65.2 kcal.mol
-1
, respectively. However, when comparing the determined NP40 BHIC50 
activities of these two compounds, it is found that compound RM18 is twice as active as 
compound RM15.  Upon inspecting the visual results more closely, compound RM18 only 
adsorbed into one primary adsorption site, where the protonated primary amine N-H was able 
to form a hydrogen bonding interaction to the carbonyl group on the crystal surface. 
Compound RM15 has a bromine atom extending into the second primary adsorption site. 
Therefore, it is suggested that the formation of a hydrogen bonding interaction to the 
carbonyl group on the outside of the crevice contributes significantly in promoting 
β-haematin growth inhibition. 
Additionally, compounds RM14 and RM18 are found to be equally active β-haematin 
growth inhibitors, even though the calculated Eads value of compound RM14 indicates a more 
favoured adsorption onto face {001}. Compound RM14 is able to adsorb with an additional 
phenyl ring into the second primary adsorption site, where compound RM18 only adsorbs 
into one primary adsorption site, forming a hydrogen bonding interaction to the crystal 
surface. With the NP40 BHIC50 activities of these two compounds being similar, this 
outcome indicates that the hydrogen bonding interaction and a π-π interaction in the primary 
adsorption site contributes equally in promoting β-haematin inhibition. Therefore, with 
compound RM17 being significantly more active than compounds RM14 and RM18, this 
result indicates that the additional π-π interactions formed between the quinoline ring and the 
porphyrin in the primary adsorption site, promotes β-haematin growth inhibition even more. 
This finding coincides with the notion that the formation of an increased number of 
interactions results in an improved adsorption, and thus enhanced β-haematin growth 
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inhibition. Therefore, it is suggested that both the visual results, as well as the calculated 
Eads values should be applied when predicting the β-haematin growth inhibition activity of a 
molecule. 
Overall, it could be concluded that the computational adsorption model for evaluating the 
adsorption of small inhibitors onto the fastest growing face of β-haematin, and thereby 
calculating the Eads values, is suitable for predicting the β-haematin inhibition activities of 
small compounds, as well as for the design of new antimalarial compounds.  
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4.3 INVESTIGATING STRUCTURE-ACTIVITY RELATIONSHIPS FOR ALL COMPOUNDS 
EXAMINED 
With the NP40 BHIC50 activities obtained in this chapter being more widespread, the results 
were combined with those obtained in the previous two chapters (non-quinoline and 
clinically-relevant quinoline inhibitors), in order to attain a more representative data set 
(Table 42). By performing the same multiple correlation calculation as in the end of the 




 are obtained (Table 43), which were consistent 
with the overall speciation distribution of the inhibitors at pH 4.8, where a slight preference 
for the adsorption onto face {011} in the diprotic form is found. 
When comparing the optimised Eads values for the adsorption onto β-haematin against the 
determined NP40 BHIC50 activities of all compounds investigated, an R
2
 value of 0.63 and a 
P value of <0.0001 are obtained for a significant linear correlation (Figure 94). However, 
with this data set also including the less active compounds synthesised in this chapter, it is 
apparent that the correlation that is obtained, is not strictly linear, and an exponential 
correlation is rather found. Therefore, by comparing the log of the NP40 BHIC50 activity 
against the log of the absolute value of the optimised Eads, for all compounds investigated 
(Table 44), an improved linear correlation is found, with an R
2
 value of 0.75 and a P value 
of <0.0001 (Figure 95).  

































































































































































































































100 0 0 -79.5 58.8 ± 3.8 







































-65.5 ± 0.7 -66.8 ± 0.7 0 52 46 -98.5 13.8 ± 0.4 








75 23 0 -101.1 13.3 ± 0.7 









-59.8 ± 0.0 -62.0 ± 0.0 0 27 73 -88.1 12.7 ± 1.4 



































-61.9 ± 0.0 -65.1 ± 0.0 0 70 30 -86.1 32.0 ± 1.4 


























-51.0 ± 0.0 0 0 100 -67.8 318 ± 0.4 
RM16 -46.8 ± 0.01       -28.5 ± 0.2       100 0 0 -52.2 453 ± 2.7 
RM17 -99.4 ± 0.2 -99.8 ± 4.2 -90.8 ± 0.5 -61.4 ± 0.5 -63.1 ± 0.0 -62.3 ± 0.1 22 50 28 -106.3 10.5 ± 0.02 
RM18 -66.4 ± 0.6 -65.5 ± 0.1 -66.0 ± 0.5 -43.0 ± 0.0 -44.0 ± 0.0 -43.8 ± 0.4 16 61 22 -71.8 155 ± 0.01 
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98 2 0 -94.5 7.2 ± 0.5 










































0 100 0 -73.9 304.8 ± 9.2 








14 86 0 -86.4 25.6 ± 2.0 








14 86 0 -75.8 61.8 ± 1.8 












100 0 0 -97.5 6.3 ± 0.5 
 
 
Table 43: Final variables calculated for all compounds investigated 
Variable Value Crystal face Speciation form 
    
v
1
 0.17 {001} Monoprotic 
v
2
 0.14 {011} Monoprotic 
v
3
 0.13 {001} Diprotic 
v
4
 0.26 {011} Diprotic 
v
5
 0.15 {001} Neutral 
v
6
 0.15 {011} Neutral 
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Figure 94: The best-fit Eads values for the adsorption onto β-haematin are compared to the determined 
NP40 BHIC50 activity of all compounds investigated. 
An R
2
 value of 0.63 with a P value of <0.0001 are obtained for a linear graph. 
The quinoline inhibitors are indicated in orange, the non-quinoline inhibitors are indicated in green, and the 








Stellenbosch University  https://scholar.sun.ac.za





Table 44: The log of  the NP40 BHIC50 activities and the log of the absolute value of the optimised 
Eads values for the adsorption onto β-haematin for all compounds investigated. 
Compounds Log |Eads| Log NP40 BHIC50 
KN6 1.901 1.769 
KN7 1.910 2.129 
KW1 1.913 1.105 
KW2 2.011 0.957 
KW3 1.933 1.122 
KW4 2.005 1.346 
KW5 1.911 1.164 
KW6 1.945 1.273 
KW7 1.947 1.141 
FL1 1.927 1.582 
FL2 1.954 1.390 
FL3 1.935 1.505 
S11 1.810 2.001 
RM14 1.898 2.171 
RM15 1.832 2.502 
RM16 1.717 2.656 
RM17 2.026 1.021 
RM18 1.856 2.189 
AQ 1.976 0.859 
CQ 1.912 1.498 
MQ-S 1.822 2.484 
MQ-R 1.869 2.484 
QD 1.937 1.409 
QN 1.880 1.791 
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 value of 0.73 with a P value of <0.0001 are obtained.  
The quinoline inhibitors are indicated in orange, the non-quinoline inhibitors are indicated in green, and the 
synthesised compounds and QC are indicated in blue. 
 
Now that an exponential correlation is obtained, it is clear why MQ and other less active 
β-haematin inhibitors were considered as outliers in a linear correlation (Section 3.2.2). With 
fewer data points, the correlations were thus incorrectly found to be linear. This outcome thus 
highlights the importance of evaluating a fully representative data set.  
However, with the new structure-activity evidence obtained, and with a greater understanding 
of the preferred intermolecular interactions formed between the inhibitor and the crystal 
surface, this information could be combined and used in future antimalarial drug 
development. 
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4.4 CONCLUDING REMARKS PERTAINING TO CHAPTER 4 
4.4.1 The significance of this chapter 
Chapter 4 mainly focused on obtaining a greater understanding of β-haematin growth 
inhibition by adsorption of inhibitors onto the fastest growing face, and more specifically the 
adsorption of inhibitors into the primary adsorption site.  
For investigating the small molecular scaffolds for the adsorption into a single primary 
adsorption site computationally, it is observed that the best adsorption is found for the 
carbazole and benzo(b)(1-5)napthyridine scaffolds. Unfortunately, as these compounds are 
not particularly soluble in the NP40 BHIC50 assay buffer solution, structure-activity 
relationships were not investigated for these compounds. 
However, upon evaluating the adsorption of these small molecular fractions into the primary 
adsorption site, the adsorption of CQ was compared to that of QC. As both of these active 
inhibitors have the same side-chain, and as these compounds adsorb in a similar geometry 
onto face {001}, it can be concluded that the greater β-haematin activity of QC is owing to 
the more favoured adsorption of its benzo(b)(1-5)napthyridine moiety into the primary 
adsorption site, as opposed to the quinoline moiety of CQ. Therefore, with an increased 
number of π-π interactions formed between the inhibitor and the porphyrin structures in the 
crevice, an improved adsorption is obtained (Eads value), which results in an improved 
β-haematin growth inhibition activity (NP40 BHIC50). 
The second part of this chapter was dedicated to the design and synthesis of compounds that 
would contribute in a greater understanding of the inhibition of β-haematin growth by 
adsorption onto face {001}, and more specifically, the adsorption into two neighbouring 
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primary adsorption sites. In the end, five molecules that were able to adsorb into the crevice 
were successfully synthesised, of which the NP40 BHIC50 activities were determined. 
It was found that both the formation of hydrogen bonding interactions, as well as 
π-π interactions between the inhibitor and the crystal surface are of great importance for 
enhanced adsorption, and thus β-haematin growth inhibition. It has been demonstrated that an 
increase in the number of these intermolecular interactions that form between the inhibitor 
and the crystal surface, results in an increase in the β-haematin growth inhibition activity 
(NP40 BHIC50). Consequently, it was demonstrated that a more favoured adsorption (Eads), 
and an improved β-haematin growth inhibition activity (NP40 BHIC50) is obtained when a 
molecule is able to adsorb entirely into two neighbouring primary adsorption sites.  
In the third and final part of this chapter, the results of the synthesised compounds were 
combined with that of the clinically-relevant quinoline inhibitors and the non-quinoline 
inhibitors, in order to evaluate structure-activity relationships. By applying the multiple 
correlation calculation, a significant linear correlation, with an R
2
 value of 0.63 and a P value 
of <0.0001, was obtained. However, by including less active β-haematin inhibitors into the 
data set, an exponential correlation is obtained when comparing the optimised Eads values for 
the adsorption of inhibitors onto β-haematin, and the determined NP40 BHIC50 activities. By 
comparing the absolute values of the log of the Eads to the log of the NP40 BHIC50 activity, 
an improved linear correlation with an R
2
 value of 0.73 and a P value of 0.0001 is found, 
which is considered to be significant. 
It can be concluded that more active β-haematin growth inhibitors would adsorb more 
favourably onto the fastest and second fastest growth faces of β-haematin. 
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4.4.2 Final conclusion 
In performing a more in-depth study of the adsorption of inhibitors into the primary 
adsorption site, it was concluded that with the formation of a larger number of intermolecular 
π-π or hydrogen bonding interactions between the inhibitor and the crystal surface, a 
subsequent improved adsorption and thus an enhanced β-haematin growth inhibition activity 
was obtained. 
Furthermore, by including additional less active β-haematin growth inhibitors into the overall 
data set of quinoline and non-quinoline inhibitors, an exponential correlation is found when 
the NP40 BHIC50 activities were compared to the adsorption onto β-haematin (Eads), thereby 
taking into account the adsorption of these inhibitors onto both the fastest and the second 
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OVERALL CONCLUSION AND FUTURE WORK 
5.1 CONCLUDING REMARKS PERTAINING TO THIS DISSERTATION 
As malaria is one of the most prevalent diseases known to mankind, this project was inspired 
to contribute towards the global fight against this epidemic. A substantial amount of research 
has been performed on gaining a more in-depth understanding of the mechanism of action of 
quinoline antimalarial drugs, where it is hypothesised that these drugs adsorb onto the crystal 
surface of β-haematin, thereby impeding further crystal growth. 
In preceding work, Solomonov et al. reported physical evidence for this phenomenon,
73
 and 
Buller et al. proposed adsorbed geometries in which the clinically-relevant inhibitors adsorb 
onto the fastest growing crystal face.
54
 For this, a universal force field was used, and the 
molecules were manually fitted onto the fastest growing face of β-haematin, followed by a 
geometry optimisation. Therefore, in the absence of a thorough computational investigation 
for the adsorption of clinically-relevant inhibitors onto β-haematin, a more in-depth study 
was needed. 
Upon parameterising a force field that is able to accommodate the high-spin Fe(III)-porphyrin 
complex, the adsorption of inhibitors onto both the fastest and the second fastest growth 
faces, was evaluated computationally. For the adsorption onto face {001}, similar adsorption 
geometries were obtained as previously reported by Buller et al., where less favoured 
adsorbed geometries were obtained for the adsorption of inhibitors onto the second fastest 
growth face. 
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By evaluating structure-activity relationships, it was demonstrated that multiple parameters 
need to be taken into account when assessing the adsorption of the clinically-relevant 
inhibitors onto β-haematin. Therefore, by taking into account the adsorption onto the fastest 
and the second fastest growth faces ({001} and {011}, respectively), as well as the 
percentage speciation at pH 4.8, a significant linear correlation is obtained when the 
adsorption of the inhibitors (Eads values) was compared to the determined lipid BHIC50 
activities. This result supports our research hypothesis that quinoline antimalarial drugs 
inhibit β-haematin formation by adsorbing onto the fastest growing faces of the crystal. In the 
absence of antimalarial activity data, this evidence does not point necessarily to the 
mechanism of action of quinoline antimalarial drugs. 
This adsorption study was subsequently further extended to evaluate the adsorption of 
non-quinoline inhibitors onto the two fastest growing crystal surfaces, where a new 
adsorption geometry was observed. For example, for the adsorption onto the second fastest 
growth face, the molecules were able to adsorb over two unit cells, thereby forming 
intermolecular interactions to two adjacent porphyrin structures. Furthermore, for the 
adsorption onto the fastest growing crystal face, these molecules were able to occupy two 
neighbouring primary adsorption sites.  
A linear correlation was found when comparing the adsorption of the non-quinoline inhibitors 
onto β-haematin (Eads values) to the determined NP40 BHIC50 activities. Moreover, by 
combining the two data sets of the clinically-relevant and the non-quinoline inhibitors, a 
linear correlation was again found. This result was indicative that these compounds adsorb 
onto the fastest growing crystal faces of β-haematin, and thereby inhibit further crystal 
growth. 
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To this end, it was concluded that two adsorption geometries are preferred for the adsorption 
of inhibitors on the fastest growing crystal face. The one adsorption geometry has previously 
been reported by Buller et al., where the inhibitor (QN and QD) was able to adsorb in such a 
manner that the formation of π-π interactions between the inhibitor and the porphyrin 
structures inside the primary adsorption site is observed, as well as the formation of a 
hydrogen bonding interaction between a hydrogen donor atom on the inhibitor and a free 
carbonyl group outside of the crevice. The second adsorption geometry was observed for the 
adsorption of the linear non-quinoline inhibitors, where the formation of multiple  
π-π interactions between the inhibitor and the porphyrin structures inside two neighbouring 
primary adsorption sites is observed, as well as the formation of a hydrogen bonding 
interaction between a hydrogen donor atom on the inhibitor and a free carbonyl group outside 
of the crevice. 
With a new adsorption geometry identified, which has not yet been reported in literature, the 
intermolecular interactions that form inside the two neighbouring primary adsorption sites, 
were evaluated more closely. It was found that an inhibitor which is able to fully occupy the 
two neighbouring primary adsorption sites, would be able to form a greater number of  
π-π interactions to the porphyrin structures, and would therefore be a more likely active 
β-haematin inhibitor than a compound that is only able to occupy one adsorption site. 
Consequently, it was demonstrated that a more favoured adsorption (Eads value) and also a 
greater inhibition activity (NP40 BHIC50) is obtained with the formation of an increased 
number of intermolecular interactions. 
In the end, all of the adsorption and activity data determined in this project were combined 
and the adsorption onto β-haematin (Eads) was compared to the determined β-haematin 
Stellenbosch University  https://scholar.sun.ac.za





growth inhibition (NP40 BHIC50). With this combined data set also including less active 
inhibitors, when once again considering adsorption onto both the fastest and the second 
fastest growth faces, and by taking into account the percentage speciation at pH 4.8, an 
improved exponential correlation was obtained. 
Overall, it has been demonstrated that the mechanism by which inhibitors cause β-haematin 
growth inhibition by adsorbing onto the β-haematin crystal, is a complex process. For crystal 
growth in the c direction, adsorption onto both the fastest and the second fastest growing 
faces needs to be accounted for, as well as the percentage speciation at pH 4.8. It has been 
demonstrated that a greater inhibition activity results from the formation of an improved 
number of intermolecular interactions between the inhibitor and the crystal surface, and that 
an exponential correlation exists between the modelled adsorption (Eads values) and the 
determined β-haematin inhibition activity (NP40 BHIC50), when taking into account the 
above mentioned parameters. 
The results obtained in this study strongly support, and greatly contribute to the 
understanding that clinically-relevant inhibitors execute their mechanism of action by 
adsorbing onto the fastest growing crystal faces of β-haematin, which brings about crystal 
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5.2 FUTURE WORK 
In this project, the adsorption of clinically-relevant quinoline inhibitors and a set of more 
rigid and linear non-quinoline inhibitors onto the fastest growing crystal faces of β-haematin, 
was evaluated. Considering that these inhibitors are not the only non-artemisinin compounds 
found to be active against malaria, this study could be extended to evaluate the adsorption of 
a significantly larger library of compounds onto β-haematin. By doing so, the following 
research outputs could be achieved: 
  The adsorption of a greater variety of molecular scaffolds onto β-haematin could be 
evaluated. Thereby, the preferred adsorption geometry for each class of molecular 
scaffold investigated could be identified. 
 This study could also be extended to evaluate whether a more flexible, as opposed to a 
more rigid scaffold, would contribute to an improved adsorbed geometry, and thus an 
enhanced inhibition activity. 
 Considering that the duration of a single adsorption simulation could extend up to 
5 days, a more high-throughput adsorption protocol would be needed to study a larger 
compound library. However, by knowing the preferred adsorption site on each of the 
two fastest growing crystal faces, the target sites could be specified prior to the 
simulation. This could, for example be achieved by applying a more selective 
grid-based docking simulation, or by using a smaller crystal surface. 
In Chapter 4, it has been demonstrated that for the adsorption to the primary adsorption site, 
the formation of an increased number of intermolecular interactions between the inhibitor and 
the crystal surface results in an enhanced β-haematin inhibition activity. Therefore, upon 
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identifying two preferred adsorption geometries for the adsorption of inhibitors onto the 
fastest growing crystal face, this combined information could be utilised to design novel and 
more active β-haematin growth inhibiting antimalarial drugs, with the required ADME 
properties (adsorption, digestion, metabolism, and excretion). In doing so, the following 
could also be considered: 
 For the adsorption geometry occupying the two neighbouring primary adsorption 
sites, enhanced activity could be obtained by the formation of the necessary π-π 
interactions, hydrogen bonding interactions, as well as possible C-H···X halogen 
bonding interactions, between the inhibitor and the crystal surface. 
 Also, for the adsorption geometry occupying both the primary and the secondary 
adsorption sites, improved activity could be obtained by the formation of the 
necessary π-π interactions and possible C-H···X halogen bonding interactions 
between the inhibitor and the crystal surface in the primary adsorption site, as well as 
hydrogen bonding interactions outside of the crevice. Furthermore, the molecule 
could be optimised to such an extent that the formation of π-π interactions between 
the inhibitor and the porphyrin structure in the secondary adsorption site could be 
achieved. 
A final challenge to consider is to design a more flexible molecule that is able to adsorb into 
both of these adsorption geometries, or which is able to occupy two neighbouring primary 
adsorption sites while being able to form a hydrogen bonding interaction outside of the 
crevice. 
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CHAPTER 6 – EXPERIMENTAL 
6.1 MOLECULAR MODELLING 
6.1.1 Theory of molecular modelling techniques used 
6.1.1 Density Functional Theory (DFT) 
Density Functional Theory (DFT) is one of the most widely used methods in quantum 
mechanics and calculates properties of molecules based on the three dimensional  electronic 
density thereof.
172
 This method is preferred to wave function theory (WFT) due to its better 
performance-to-time ratio. Wave function theory uses a wave function approximation to 
solve the Schrödinger equation in order to calculate the energy. Thus, as the number of 
electrons increases, the complexity of the wave function increases tremendously. By using 
the electron density, the calculation is less complex, resulting in a faster simulation.
172
  
DFT is a general, multi-purpose method, which is not only used for organic molecules, but is 
also optimised to apply to transition metals.
172
 Here, the functional and the basis set for 
representing the atomic orbitals would be chosen to represent the particular system on which 
the DFT calculation is performed. Local density approximation (LDA) functionals include 
PWC and VWN functionals,
173,174
 whereas generalised gradient approximations (GGA) 
includes, for instance, PW91, BP, PBE, BLYP, BOP, VWN-BP, RPBE and HCTH 
functionals.
173,175–179
 More recently, hybrid functionals were introduced, which are optimised 
for specific organic systems. These include functionals such as B3LYP. However, these are 
not optimal for the use on periodic systems.
172
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With such a vast range of DFT approximations available, it is thus important to use a 
functional and a basis set that would most accurately represent the system on which the DFT 
calculation is performed. For the purposes of this project, a simple GGA PW91 functional 
was used, with a DNP basis set, in order to accommodate the Fe(III) metal centre in the 
porphyrin. 
The DFT calculation was applied to optimise hydrogen atoms in crystal structures obtained 
from the Cambridge Structural Database (CSD).
180
 These optimised crystal structures were 
subsequently used to parameterise a force field, which was applied in molecular mechanics 
calculations. 
 
6.1.2 Molecular mechanics 
Molecular mechanics (MM) is an empirical model of molecular structure, where the nuclear 
coordinates are generated by internal variables that are defined within a force field. Each 
force field is specially parameterised for a specific system and is carefully chosen for each 
molecular calculation.
181
 Therefore, unlike quantum mechanical models, which use electrons 
in the calculations, parameterised molecular models cannot be used to calculate the energy 
distribution within any system.  
However, by choosing the appropriate force field, molecular mechanics is a significantly 
faster and more robust method for modelling the motion of larger molecules within sound 
accuracy.
181
 It is therefore the method of choice when performing molecular modelling 
calculations on large systems, such as protein-protein interactions, and protein-ligand 
interactions. 
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6.1.2.1 Force fields and the parameterisation thereof 
The force field, also known as the energy expression, is a sum of the potential energy terms, 
and specifies how the atoms within a molecule will behave in the presence of other atoms.
181
 
The internal variables that are defined within a force field consist of bonding and 
non-bonding interactions, where these are combined with energy terms to form the potential 
energy terms.  
The bonding interactions, are treated as a harmonic “ball-and-spring” model, where the 
molecular vibrations are derived from Hooke’s law (Displacement or extension is directly 
proportional to the force applied to bring about the change) and Newton’s second law (For a 
constant mass, the force applied is equal to the product of the mass and the acceleration of an 
object).
182,183
 Here, the atoms (represented as balls) are connected by bonds (represented as 
springs), where the size of the atoms and the rigidity of the bonds are defined by the force 
field. These internal variables taken into account are: bond lengths (rij), bond angles (θijk), 
torsion angles (τijkl), and inversion angles (γijkl), as shown in Figure 96.  
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Figure 96: Internal variables commonly examined during a force field optimisation 
This image was created with information obtained from images published by Machida,
183
 and Rappé and 
Casewit.
181
 The internal variables taken into account during a force field optimisation are: bond lengths (rij), 
bond angles  θijk), t rsi   a gl s  τijkl), a d i v rsi   a gl s  γijkl). At ms are represented as red balls and 
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The non-bonding interactions in the force field extend over the entire system, where these 
include van der Waals and electrostatic interactions. Van der Waals interactions involve polar 
or induced polar interactions between molecules, such as dipole-dipole, dipole-induced 
dipole, and induced dipole-induced dipole (London dispersion forces) interactions.
184,185
 





 or a Buckingham exponential-6 potential.
189,190
 For 
the Lennard-Jones 6-12 potential (V
LJ
) used in this project, this potential takes into account 
the non-bonded distance (ρ), the inner-wall repulsion (A), and the van der Waals 




     
 







In earlier force fields, which were designed for modelling hydrocarbons, electrostatic 
interactions were ignored. Kitaygorodsky first introduced the use of partial point charges or 
bond dipoles in 1960.
191,192
 Even though the benefit of applying these charges is still under 
debate, it is still largely considered to be more beneficial to include these charges.
193
 
Resultantly, modern force fields are rather parameterised to compensate for the limitations 
presented by applying partial point charges or bond dipoles.
194
 
Force fields are typically parameterised based on available experimental data. For this, 
information obtained from X-ray diffraction, electron diffraction, microwave spectroscopy, 
NMR spectroscopy, and IR vibrational frequencies, are frequently used.
181
 In the absence of 
physical experimental data, results from quantum mechanical calculations are applied, where 
these are also preferred to obtain more detailed potential energy curves. 
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With the force field being applied to represent molecules in a system, it has to be 
parameterised to fully mimic the natural state of the molecules investigated. For example, in 
parameterising the bond stretch harmonic potential (Vr in Equation 6.7), and the harmonic 
angle bend potential (V
θ
 in Equation 6.8), the representing force constants (kij and kijk, 
respectively) could be altered by means of an iterative process to represent the natural bond 
distance (rij) and bond angle (θijk).
181
 The optimisation of a force field is deemed adequate 
when the smallest root square deviation between the estimated and the natural bond angles 
and distances, is obtained. 
 
   
 
 




   
 
 
              
  
(6.8) 
   
Other terms that could be optimised, include the bond energy, the torsional potential, as well 
as the van der Waals potential terms. However, for the purposes of this project, only the 
above-mentioned force constants (kij and kijk) were optimised to account for the high-spin 
Fe(III) atom in the β-haematin porphyrin structure. 
 
6.1.2.2 Molecular modelling of Fe porphyrin structures and related transition metal 
complexes. 
A significant amount of work has been performed in parameterising force fields for high-spin 
Co(III) complexes, Cu(I) and Cu(II) complexes, as well as for high and low-spin Ni(II) 
complexes.
195
 In general, transition metal complexes are best modelled using quantum 
mechanical methods. However, with these methods being more time consuming, it has been 
Stellenbosch University  https://scholar.sun.ac.za





demonstrated that by knowing the spin state of the complex, the correct parameters could be 
applied to model these complexes using molecular mechanical methods. 
Unfortunately, this does not apply for porphyrin complexes containing high-spin Fe(III) or 
low-spin Fe(II) atoms. Marques et al. compared crystal structures obtained from the 
Cambridge Structural Database (CSD),
180
 upon which it was established that the N-Fe bond 
distances and angles depended upon the overall coordination geometry, and the oxidation and 
spin state of the Fe atom.
132
 In general, it was observed that the Fe-N bond lengths of low-
spin complexes were slightly shorter (2.001 ± 0.015 Å) than for high-spin complexes  
(2.046 ± 0.013 Å). Moreover, the coordination geometries varied depending on the 
coordinated ligands. Evidently, it was stated that separate force fields are required to 
efficiently model each of the different types of Fe(II) and Fe(III) porphyrin complexes.  
By separately defining the four nitrogen atoms in the cis and trans N-Fe-N angles in the 
porphyrin structure, a force field for Fe-containing complexes was optimised using structures 
obtained from the CSD, where the smallest allowed deviations between the natural and the 
modelled bond lengths, bond angles, and torsion angles, were 0.015 Å, 1.5°, and 4.0°, 
respectively.
132
 In the end, by comparing the modelling results to the original crystal 
structures, it was demonstrated that this force field is ideal for modelling hexa-coordinate 
low-spin Fe(III) porphyrin structures with imidazoles and pyridines as axial ligands. In 
addition to this work, Munro et al. ensued further refinement of this force field in order 
evaluate the structure of ruffled low-spin Fe(III) porphyrin complexes in more detail.
131
 
One challenge in modelling transition metal complexes, as opposed to performing quantum 
mechanical calculations, is to accurately mimic the electrostatic interactions between the 
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metal and the ligand. An argument was raised as to whether these interactions could be best 
described as covalent bonding or non-bonding interactions.
196
 However, by evaluating the 
total energies, the binding energies, and the molecular structures of octahedral coordination 
complexes of glyoxal diimine ligands of the ten first row transition metals, Xiong et al. was 
able to demonstrate that by using a suitable parameterised force field, this limitation could be 
overcome.
197
 The energy properties of these complexes were determined by means of DFT 
calculations, where after these results were compared to that of the parameterised force field. 
Resultantly, it was concluded that by treating the metal-ligand interactions as covalent 
bonding interactions, molecular mechanics studies were effectively able to mimic the energy 
results obtained from the DFT calculations. 
More recently, in relation to the Fe(III)-oxygen bond in β-haematin, Yapo-Kicho et al. 
reported the successful development of a force field to evaluate high-spin 
Fe(III)/Fe(II)-oxygen interactions specifically occurring between non-haemic iron and 
polyphenols found in tannins.
198
 Four model complexes containing Fe-water and Fe-catechol 
complexation, were evaluated by means of DFT calculations. The calculated geometry and 
vibrational results were combined with parameters previously reported in literature, upon 
which these results were applied to successfully parameterise the SPASIBA force field. 
Yapo-Kicho et al. demonstrated that high-spin Fe(III)-oxygen interactions could successfully 
be modelled by means of molecular mechanical calculations. 
With this relevant research performed on optimising force fields for high-spin Fe(III)-oxygen 
and low-spin Fe(II)-porphyrin complexes, the same procedure for optimising these force 
fields was applied in this project. Furthermore, the reported parameters were used as initial 
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guides for optimising a force field that is able to adequately model high-spin 
Fe(III)-porphyrin complexes, such as β-haematin.  
 
6.1.2 Software packages used 
6.1.2.1 Cambridge Crystallographic Data Centre   
The Cambridge Structural Database (CSD) is an online structural database that contains 
published single-crystal and powder X-ray refraction data of small organic and metal-organic 
molecules. This database was accessed through the Cambridge Crystallographic Data Centre 
(CCDC), by means of the Con Quest v1.16 software package.
180
 The crystal structures used 
in this project were obtained from this database. 
6.1.2.2 Marvin Sketch 
Marvin Sketch (version 6.3.1),
143
 a Java-based chemical drawing program, was utilised for 
the theoretical calculation of the pKa values of the molecules used in the computational 
studies. The pKa values gave a theoretical indication of the speciation of these molecules at 
pH 4.8. 
6.1.2.3 Accelrys Discovery Studio 
Accelrys Discovery Studio is a full comprehensive molecular modelling software package, 
specifically developed for protein-based drug discovery and ligand design.
144
 It includes 
software applications such as molecular mechanics, molecular dynamics and quantum 
mechanical simulations, as well as quantitative structure–activity relationship (QSAR) and 
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pharmacophore modelling. In this project Discovery Studio was primarily used to generate 
conformations of molecules, and for visualisation and image generation.  
6.1.2.3.1 Generate conformations 
The Generate conformations protocol in Discovery studio was used to generate 
conformations of the inhibitors used in this study.
144
 The default settings allow for a 
maximum number of conformations to be determined. However, for a more thorough search, 
the allowed degrees of rotation around bonds could be defined. 
 
6.1.2.4 Accelrys Materials Studio 
Accelrys Materials Studio is a software package specifically developed for materials science 
research in order to better understand the relationship between the molecular composition and 
the properties of the material.
123
 These include materials such as metallic and organic 
surfaces, polymers, crystals and mesoscale structures. As with Discovery Studio, various 
molecular mechanics, molecular dynamics and quantum mechanical tools are available for 







 is a module in Materials Studio that allows the modulation of the electronic structure 
and energetics of a system using Density Functional Theory (DFT).
123
 This module was 
utilised for the evaluation of a set of crystal structures, which was later used during the 
optimisation of the force field. The parameters that were applied are tabulated in Table 45. 
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Table 45: Energy parameters used for the DMol
3
 quantum mechanics calculations. 
Electronic  
        SCF tolerance  1 × 10
-6
  
        Maximum SCF cycles 50 000 
        Core treatment  DFT Semi-core Pseudopots 
        Basis set DNP 
 
Geometry optimisation  
        Quality  2 × 10
-5 
Ha 
        Maximum iterations 1 000 
        Functional GGA PW91 
        Use symmetry  No 
        Metal Yes 
 
6.1.2.4.2 Perl scripting 
Materials Studio allows for Perl scripting, an open source scripting language, by means of a 
script viewer.
123
 Here, new scripts could be written, or scripts generated from modules, could 
be edited. Not only does this allow for versatility within the software package, but it also 
simplifies the operation thereof, since simulations could be automated, or even be 
sequentially combined. Moreover, especially within the Adsorption locater and Forcite, 
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6.1.2.4.3 Force field viewer 
The force field viewer within Materials studio is designed to edit and view force fields for the 
use in molecular mechanics calculations.
123
 For this project, the cvff force field (version 2.4)  
was parameterised to accommodate the β-haematin porphyrin structure with a Fe(III) 
centre.
125
 In order to optimise the force field, the crystal structure of β-haematin, as well as a 
training set of eight similar published crystal structures, was used.
40,108,133–137,199
 The initial 




With the parameterised force field, a new atom type was defined for Fe (III). Special care was 
taken in the manual typing of the carbon atoms within the porphyrin structures, as these were 
incorrectly typed with the automatic typing in the Forcite module. The force field types used 
in the porphyrin are tabulated in Table 46. 
 
Table 46: Force field types used in the parameterised force field 




 n nitrogen, SP2, connected to heavy atoms 
 np nitrogen, SP2, aromatic 
 o oxygen, SP3, in ether or ester groups 
 c carbon, SP3, aliphatic 
 c1 carbon, SP3, bonded to 1H and heavy atoms 
 c3 carbon, SP3, in methyl group 
 c= carbon,  non-aromatic, doubly bonded 
 c=1 carbon, non-aromatic, doubly bonded, next to end 
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Forcite is a module in Materials Studio that holds a collection of molecular mechanics 
tools.
123
 This module was initially used for the parameterisation of the cvff force field, which 
was specifically optimised for the β-haematin crystal. Ligands were prepared for succeeding 
simulations, where the molecules were typed with the force field, the geometries were 
optimised, and the initial energies calculated. Most of these processes for large batches of 
molecules were automated by generated scripts. The final parameters used for the energy 
calculations and geometry optimisations are tabulated in Table 47 and Table 48, respectively. 
 
Table 47: Energy parameters used for the Forcite energy calculations. 
Energy  
        Force field cvff (parameterised for β-haematin) 
        Charges Charge using QEq 





        Summation method – electrostatics Ewald  
        Summation method – van der Waals Group based 
 
Table 48: Energy parameters used for the Forcite geometry optimisation calculations. 
Energy  
        Force field cvff (parameterised for β-haematin) 
        Charges Charge using QEq 





        Summation method – electrostatics Group based 
        Summation method – van der Waals Group based 
Geometry optimisation  
        Algorithm Conjugate gradient 





        Maximum iterations 20 000 
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The Morphology module within Materials Studio allows for the determination of the overall 
morphology of crystalline materials, as well as the investigation of the growth of the faces.
123
 
In this project, the morphology tool was utilised to determine the theoretical growth 
morphology of β-haematin and to locate the fastest and second-fastest growing faces. The 
parameters used are tabulated in Table 49.  
 
Table 49: Energy parameters used for the growth morphology calculations. 
Energy  
        Force field cvff (parameterised for β-haematin) 
        Charges Charge using QEq 





        Summation method – electrostatics Ewald  
        Summation method – van der Waals Group based 
 
6.1.2.4.7 The adsorption locator 
The Adsorption locator module in Materials studio is designed to find low energy adsorption 
sites on substrates, or to investigate the preferential adsorbed geometries of compounds.
123
  
Either single molecules or mixtures could be adsorbed onto a substrate. Possible adsorption 
geometries were determined by means of Monte Carlo simulations, while the temperature 
was slowly decreased. This process was then repeated several times in order to obtain the 
lowest energy adsorbed geometry.  
In order to obtain the best adsorption results, the ligands adsorbed and the substrate were 
prepared by means of a Forcite geometry optimisation, at the same quality as required in the 
adsorption calculation. Moreover, the calculation was optimised to obtain the best time 
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efficiency, and output quality. The results were deemed optimised, when a standard deviation 
of 1 kcal.mol
-1
 was obtained over three calculations, and when a higher quality and more 
timely calculation produced the same result. The final parameters used are tabulated in 
 Table 50. 
Table 50: Energy parameters used for the adsorption molecular mechanics calculations. 
Energy  
        Force field cvff (parameterised for β-haematin) 
        Charges Charge using QEq 





        Summation method – electrostatics Ewald  
        Summation method – van der Waals Group based 
Simulated annealing  
        Number of cycles  5 
        Steps per cycle 500 000
*
 
Geometry optimisation  
        Algorithm Conjugate gradient 





        Maximum iterations 20 000 
*
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6.1.2.4.8 The Forcite Anneal Dynamics protocol 
The Forcite Anneal Dynamics protocol is designed to overcome energy barriers in a 
computational system.
123
 For this protocol a specified number of annealing cycles was 
performed where the temperature was increased to a chosen mid-cycle temperature and then 
slowly decreased back to the chosen initial temperature (Table 51). For each of these 
temperature steps, a specified number of dynamics steps were performed. In the end, an 
ultra-fine geometry optimisation was applied in order to refine the final output geometry. 
 
Table 51: Annealing parameters used for the final adsorption minimisation calculations. 
Annealing  
        annealing cycles 100 
        Initial temperature 300 K 
        Mid-cycle temperature 500 K 
        Heating ramps per cycle 5  
        Dynamics steps per ramp 100 
Dynamics  
        Ensemble  NVE 
        Initial velocities random 
        Time step  1.5 fs 
        Integration tolerance  50 000 kcal.mol
-1
 
Geometry optimisation  
        Algorithm Conjugate gradient 





        Maximum iterations 20 000 
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6.2.1 General procedures 
6.2.1.1 Purification of solvents and reagents. 
All chemicals used in these experiments were purchased from Merck, Kimmix Chemicals, or 
Sigma Aldrich. Solvents used for thin layer and column chromatographic purposes were 
distilled by means of conventional distillation procedures. Tetrahydrofuran was distilled from 
sodium metal, using benzophenone as indicator, and ethanol was distilled from magnesium 
turnings and iodine. Both of these solvents were distilled under a positive pressure of 
nitrogen gas. All other solvents used were pre-dried over molecular sieves (pore 
diameter 4 Å) for a minimum of three days. 
6.2.1.2 Chromatography 
The chromatography techniques utilised in this project are tabulated in Table 52, where 
compounds on the TLC plates were viewed under UV light and if necessary stained using 
prepared solutions of KMnO4, or ninhydrin, followed by heating. 
 
Table 52: Chromatography techniques utilised 
Chromatography Materials used 
  
Thin layer chromatography Merck silica gel 60 F254 coated on aluminium sheets. 
Column chromatography Merck silica gel (particle size 0.063-0.200 mm, 60 Å) 
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6.2.1.3 Spectroscopic and physical data 
The relevant techniques applied to achieve full characterisation of synthesised compounds, 
are tabulated in Table 53.  
 
Table 53: Techniques applied to achieve full characterisation of synthesised compounds 
Techniques applied Instruments 
  






C, COSY and gHSQC) 
300 MHz Varian VNMRS (75 MHz for 
13
C) 
400 MHz Varian Unity Inova (101 MHz for 
13
C) 




Infrared spectroscopy (FTIR) 
 
Thermo Nicolet Nexus 470, 




Mass spectrometry (MS) 
 
Waters SYNAPT G2 




Melting points Gallenkamp Melting Point Apparatus 
 
6.2.1.4 Other general procedures 
Reactions were performed under a positive pressure of nitrogen gas, unless water was used as 
a solvent, or when atmospheric oxygen was needed as an oxidant. The glassware was 
pre-dried at 120 °C for a minimum of two hours. 
Solvents were removed in vacuo, where the bulk of the solvent was removed by using a 
rotary evaporator, followed by removal of trace amounts of solvent using a high vacuum 
pump at ca. 0.08 mm Hg. 
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6.2.2 Experimental work pertaining to Chapter 4.1 
6.2.2.1 Towards the small quinoline inhibitor -S2 
6.2.2.1.1 3,3-Diethoxypropanoic acid - 2 
A 250 mL two-neck round bottom flask was fitted with a reflux condenser. This was charged 
with sodium hydroxide (1.5 equivalents, 1.58 g, 39.4 mmol), which was dissolved in water 
(20 mL). Ethyl 3,3-diethoxypropanoate (4.90 mL, 5.00 g, 26.3 mmol) was added to this, 
whereupon the reaction mixture was refluxed at 110 °C for 4 hours. 
Upon completion, the reaction was allowed to cool to room temperature, where after the starting 
material was extracted with ethyl acetate (3 x 30 mL). The basic water layer was neutralised with 
a 2M solution of hydrochloric acid, whereupon the product was extracted with ethyl acetate  
(3 x 30 mL). The organic layer was washed with brine, dried over magnesium sulphate and 
filtered. The filtrate was concentrated in vacuo to yield the crude polar title compound 2 (3.65 g, 




):  3427 (O-H str), 3090 - 2563 (C-H str), 1667 (C=O 
str), 1601 (C=C str), 1426, 1305, 1211.
 1
H NMR (300 MHz, CDCl3) 
δ 7.69 (m, J = 12.5, 4.5 Hz, 1H, H3), 5.18 (d, J = 12.6 Hz, 2H, H2), 
3.95 (q, J = 7.0 Hz, 4H, H4), 1.36 (t, J = 7.1 Hz, 6H, H5). 
13
C NMR 
(75 MHz, CDCl3) δ 173.5 (C1), 164.6 (C3), 95.7 (C4), 67.3 (C2), 14.5 (C5). HRMS: The 
molecular ion was not found. 
 
 
             2 
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6.2.2.1.2 (E)-N-(3-Chlorophenyl)-3-ethoxyacrylamide - 5 
3,3-Diethoxypropanoic acid (10.0 g, 61.7 mmol) was dissolved in dichloromethane (5 mL) 
and added to a 250 mL two-neck flask, fitted with a reflux condenser. Thionyl chloride 
(30 mL) was slowly added to this, whereupon the reaction mixture was heated to 80 °C 
overnight. 
After 18 h, the thionyl chloride was evaporated off and the crude product (Rf = 0.36, 
10% EtOAc/Hexane) was dissolved in dichloromethane (10 mL), whereafter this mixture was 
transferred into a dropping funnel. A 250 mL two-neck flask was fitted with the dropping 
funnel and was charged with 3-chloroaniline (0.6 equivalents, 3.9 mL, 4.74 g, 37.2 mmol), 
dichloromethane (10 mL), and pyridine (10 mL). The crude product obtained above was then 
added drop-wise to the 3-chloroanaline mixture, where after the reaction mixture was heated 
to 40 °C overnight. 
Upon completion, the reaction was quenched with water and slowly acidified with a 2M 
hydrochloric acid solution. The product was extracted with dichloromethane (3 x 100 mL) 
and the organic layer was washed with brine, dried over magnesium sulphate and filtered. 
The filtrate was concentrated in vacuo to yield the residue that was further purified by 
column chromatography (5% EtOAc/Hexane). The product was recrystallised from hot ethyl 
acetate, to afford the title compound 5 (3.47 g, 15.4 mmol, 41% (crude)) (Rf = 0.29, 
20% EtOAc/Hexane), as white needles. 
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Mp 75-80 °C. IR (ATR, cm
-1
): 3281 (C-H str),  
2978 (C-H str), 1658 (C=O str), 1589 (C=C str), 1525, 
1406, 1342, 1281. 
1
H NMR (600 MHz, DMSO-d6) 
δ 9.90 (s, 1H, H7), 7.85 (t, J = 2.0 Hz, 1H, ArH), 7.50 (d, J = 12.3 Hz, 1H, H10), 7.42 (ddd, 
J = 8.3, 2.0, 0.9 Hz, 1H, ArH), 7.30 (t, J = 8.1 Hz, 1H, ArH), 7.06 (ddd, J = 7.9, 2.2, 0.9 Hz, 
1H, ArH), 5.49 (d, J = 12.3 Hz, 1H, H9), 3.96 (d, J = 7.0 Hz, 2H, H11), 1.27 (t, J = 7.1 Hz, 
3H, H12). 
13
C NMR (150 MHz, CDCl3) δ 165.4 (C8), 161.8 (C10), 139.6, 134.7, 130.1, 124.1, 
120.13, 118.0, 98.8 (C9), 67.7 (C11), 14.8 (C12). HRMS: calcd for C11H13NO2Cl [M+H]
+
, 
226.0635 and 228.0608, found 226.0606 and 228.0608. (100 and 33% MS peak ratio) 
 
6.2.2.1.2 2,7-Dichloroquinoline - S2 
(E)-N-(3-Chlorophenyl)-3-ethoxyacrylamide (3.27 g, 14.5 mmol) was dissolved in 10 mL 
dichloromethane in a 250 mL two-neck round bottom flask. The reaction mixture was cooled 
to 0 °C by means of an ice bath, whereupon concentrated sulphuric acid (21 mL) was slowly 
added over a period of 15 minutes. This was allowed to slowly heat to room temperature 
overnight. 
The resulting mixture was quenched with aqueous ammonium chloride and filtered, 
whereupon the resulting residue was washed with hexane. The water layer was extracted with 
ethyl acetate (3 x 80 mL). The organic layer was washed with brine, dried over magnesium 
sulphate and filtered. The filtrate was combined with the previously obtained residue and 
concentrated in vacuo to afford a waxy orange residue. 
 
5 
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A 250 mL two-neck flask was fitted with a reflux condenser, and was charged with the waxy 
orange residue and phosphorus oxychloride (10 mL). The reaction mixture was refluxed at 
110 °C overnight.  
After the 18 h time period, the reaction was quenched on ice and the product was extracted with 
ethyl acetate (3 x 80 mL). The organic layer was washed with brine, dried over magnesium 
sulphate and filtered. The filtrate was concentrated in vacuo to yield the residue that was purified 
by column chromatography (2% EtOAc/Hexane) to afford compound S3 (80 mg, 0.404 mmol, 
3%) (Rf = 0.75, 20% EtOAc/Hexane), as a white solid, and the title compound S2 (887 mg, 
4.48 mmol, 31%) (Rf = 0.83, 20% EtOAc/Hexane), as a white solid with a purity of 98.4% as 
determined by means of LC-MS. 
 
Mp 98-101 °C. IR (ATR, cm
-1
): 3050 (C-H str), 1605 (C=C str), 
1580, 1479 (C=C str), 1412, 1328, 1281. 
1
H NMR (400 MHz, 
CDCl3) δ 8.53 (d, J = 8.8 Hz, 1H, H4), 7.96 (dd, J = 7.5, 2.0 Hz, 1H, 
H5), 7.69 – 7.61 (m, 2H, H8 and H6), 7.50 (d, J = 8.8 Hz, 1H, H3). 
13
C NMR (101 MHz, 
CDCl3) δ 151.8, 148.7, 136.1 (C4), 131.6 (C8), 130.6 (C5), 127.9(C6), 127.3, 125.3 (C3), 
123.4. HRMS: calcd for C9H6NCl2 [M+H]
+
, 197.9877 and 199.9848, found 197.9875 and 
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Mp 81-83 °C. IR (ATR, cm
-1
): 3081 (C=C), 1581, 1558, 1490, 1454, 
1388, 1289. 
1
H NMR (400 MHz, DMSO-d6) δ 8.08 (d, J = 8.6 Hz, 1H, 
H2), 8.02 (d, J = 1.9 Hz, 1H, H8), 7.76 (d, J = 8.7 Hz, 1H, H5), 7.52 (dd, 
J = 8.6, 2.0 Hz, 1H, H6), 7.39 (d, J = 8.5 Hz, 1H, H3). 
13
C NMR 
(101 MHz, CDCl3) δ 152.0, 148.3, 138.7 (C2), 136.8, 128.9 (C6), 128.2 (C5),  
127.8 (C8), 125.3 (C3), 122.7.  
The 
1
H NMR and the IR characterisation of compound S3 are in agreement with that reported 




6.2.2.2 The synthesis of the carbazole compounds 
6.2.2.2.1 2-Nitrobiphenyl - 10 
A 50 mL two-neck round bottom flask, fitted with a reflux condenser, was charged with 
N,N-dimethylformamide (20 mL) and water (4 mL). To this was added 1-bromo-2-
nitrobenzene (300 mg, 1.49 mmol), phenylboronic acid (1.5 equivalents, 272 mg, 
2.23 mmol), potassium carbonate (2 equivalents, 410 mg, 2.97 mmol), and palladium-
tetrakis(triphenylphosphine) (5 mol %, 85.5 mg, 0.0743 mmol). The reaction mixture was 
heated to 80 °C for 5 hours under a positive pressure of nitrogen gas. 
Upon completion, the reaction was quenched with water and the product was extracted with ethyl 
acetate (3 x 30 mL). The organic layer was washed with brine, dried over magnesium sulphate 
and filtered. The filtrate was concentrated in vacuo to yield the residue that was purified by 
column chromatography (5% EtOAc/Hexane) to afford the title compound 10 (248 mg, 
1.35 mmol, 91%) (Rf = 0.63, 10% EtOAc/Hexane), as yellow crystals. 
 
S3 
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Mp 40-45 °C. IR (ATR, cm
-1
): 2922 (C-H str), 2853 (C-H str), 1519 
(C=C str), 1470 (C=C str), 1354 (N=O str). 
1
H NMR (300 MHz, 
CDCl3) δ 7.89 – 7.83 (m, 1H, H3), 7.65 – 7.59 (m, 1H, H4), 7.52 – 7.40 
(m, 5H, ArH), 7.36 – 7.31 (m, 2H, ArH). 
13
C NMR (101 MHz, CDCl3) 
δ 149.4 (C2), 137.5, 136.4, 132.4, 132.1, 128.8, 128.3, 128.3, 128.0, 
124.2. HRMS: calcd for C12H10NO2 [M+H]
+
, 200.0712, found 200.0717. 
 
6.2.2.2.2 9-H Carbazole - S6 
A 50 mL round bottom flask was charged with dry tetrahydrofuran (15 mL) and 
2-nitrobiphenyl (200 mg, 1.09 mmol) under a positive pressure of nitrogen gas. The reaction 
mixture was cooled to 0 °C by means of an ice bath. Phenylmagnesium bromide (1M in 
tetrahydrofuran) (4.5 equivalents, 6,0 mL, 5.90 mmol) was slowly added to the reaction 
mixture over a period of 20 minutes. 
The reaction mixture was allowed to stir for another 10 minutes, whereupon it was quenched 
with aqueous ammonium chloride. Subsequently, the product was extracted with ethyl acetate 
(3 x 30 mL), where after the organic layer was washed with brine, dried over magnesium 
sulphate and filtered. The filtrate was concentrated in vacuo to yield the residue that was purified 
by column chromatography (5% EtOAc/Hexane) to afford the title compound S6 (157 mg, 
0.939 mmol, 86%) (Rf = 0.17, 2% EtOAc/Hexane), as light brown crystals with a purity of 99.8% 




        10 
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Mp 235-239 °C. IR (ATR, cm
-1
): 3416 (N-H str), 3048 (C-H str), 1596, 
1449, 1323. 
1
H NMR (600 MHz, DMSO-d6) δ 11.22 (s, 1H, H9),  
8.10 (d, J = 7.8 Hz, 2H, H4 and H5), 7.48 (d, J = 8.1 Hz, 2H, H2 and H7),  
7.37 (ddd, J = 8.2, 7.1, 1.2 Hz, 2H, H3 and H6), 7.19 – 7.05 (m, 2H, H1 
and H8). 
13
C NMR (150 MHz, CDCl3) δ 139.6, 126.0, 123.5, 120.5, 119.6, 110.7.  
HRMS: calcd for C12H10N [M+H]
+
, 168.0813, found 168.0816. 
 
6.2.2.2.3 Attempted synthesis of 4-chloro-2-nitrobiphenyl - 12 
The same procedure was used as for preparing compound 10 in Section 6.2.2.2.1.  
 
 
The equivalents used were as follows: N,N-dimethylformamide (20 mL), water (4 mL), 
1-bromo-4-chloro-2-nitrobenzene (350 mg, 1.49 mmol), phenylboronic acid (1.5 equivalents, 
272 mg, 2.23 mmol), potassium carbonate (2 equivalents, 410 mg, 2.97 mmol), and 
palladium-tetrakis(triphenylphosphine) (5 mol %, 85.5 mg, 0.0743 mmol). 
Upon completion, the reaction was quenched with water and the product was extracted with ethyl 
acetate (3 x 30 mL). The organic layer was washed with brine, dried over magnesium sulphate 
and filtered. The filtrate was concentrated in vacuo to yield the residue that was purified by 
column chromatography (5% EtOAc/Hexane). Unfortunately, the title compound was not 
isolated, as another product co-eluted with the final compound. This additional product might 
have been 4-bromo-3-nitrobiphenyl, where the coupling reaction occurred at the 3-position of the 
benzene ring. This mixture of compounds was isolated (269 mg) (Rf = 0.44, 2% EtOAc/Hexane) 
as a yellow powder. 
 
        S6 
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Mp 95-98 °C. IR (ATR, cm
-1
): 2924 (C-H str), 1527 (C=C str),  
1474 (C=C str), 1358 (N=O str). HRMS: calcd for C12H9ClNO2 
[M+H]
+
, 234.0322 and 236.0296, found 234.0968 and 236.1191. (100 
and 33% MS peak ratio) 
 
6.2.2.2.4 Attempted synthesis of 2-chloro-9H-carbazole - S7 
The same procedure was used as for preparing compound S6 in Section 6.2.2.2.2.  
 
 
The equivalents used were as follows: dry tetrahydrofuran (15 mL), 4-chloro-2-nitrobiphenyl 
(297 mg, 1.27 mmol), and phenylmagnesium bromide (1M in tetrahydrofuran) 
(4.5 equivalents, 5.7 mL, 5.72 mmol). 
The reaction was quenched with aqueous ammonium chloride. The product was extracted with 
ethyl acetate (3 x 30 mL), whereupon the organic layer was washed with brine, dried over 
magnesium sulphate and filtered. The filtrate was concentrated in vacuo to yield the residue that 
was purified by column chromatography (5% EtOAc/Hexane). 
This product decomposed from white crystals, in the presence of light within a time period of 
30 minutes, to a light blue powder. Unfortunately, the formation of multiple compounds was 
observed when analysed by means of thin layer chromatography. 
 
 
       12 (crude) 
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6.2.2.3 Towards the 4-amino-7-chloroquinoline - S11 
6.2.2.3.1 4-Azido-7-chloroquinoline - 14 
A 50 mL two neck round bottom flask, fitted with a reflux condenser, was charged with 
dimethylsulfoxide (10 mL), sodium azide (1.2 equivalents, 790 mg, 12.2 mmol), and 
4,7-dichloroquinoline (2.0 g, 10.1 mmol). The reaction was heated to 60 °C for 18 hours, 
under a positive pressure of nitrogen. 
Upon completion, the reaction was quenched with water and the product was extracted with ethyl 
acetate (3 x 30 mL). The organic layer was washed with brine, dried over magnesium sulphate 
and filtered. Afterwards, the filtrate was concentrated in vacuo to yield the residue that was 
purified by column chromatography (10% EtOAc/Hexane) to afford the title compound 14 (1.9 g, 
9.43 mmol, 93%) (Rf = 0.74, 40% EtOAc/Hexane), as a white powder.  
 
Mp 92-95 °C. IR (ATR, cm
-1
): 3070 (C-H str), 2325, 2250 (N3 str), 
1612 (C=C bend), 1560, 1535, 1447, 1322. 
1
H NMR (300 MHz, 
DMSO-d6) δ 8.85 (d, J = 5.0 Hz, 1H, H3), 8.07 – 8.03 (m, 1H, H6),  
7.99 (dd, J = 8.6, 5.5 Hz, 1H, H8), 7.63 (dd, J = 8.9, 2.2 Hz, 1H, H5), 
7.48 (d, J = 5.0 Hz, 1H, H2). 
13
C NMR (75MHz, DMSO-d6) δ 152.0, 148.9, 145.7, 135.1, 
127.6, 127.3, 124.1, 119.4, 110.3. 
The 
1
H NMR and the IR characterisation are in agreement with that reported by Pereira et al. 
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6.2.2.3.2 4-Amino-7-chloroquinoline - S11 
A 50 mL round bottom flask, fitted with a rubber septum, was charged with dimethyl 
sulphoxide (2 mL), dry ethanol (10 mL), and 4-azido-7-chloroquinoline (1.9 g, 9.43 mmol). 
To this was added one table spoon of activated Raney
®
-Nickel, three times, at 4 hour 
intervals (12 hours in total), while the reaction was kept under a positive pressure of 
hydrogen gas. After the last addition of Raney
®
-Nickel, the reaction was left to stir overnight. 
Upon the full consumption of the starting material, the reaction mixture was filtered through 
celite, and washed with ethyl acetate. The filtrate was concentrated in vacuo to yield the residue 
that was purified by column chromatography (40% EtOAc/Hexane) to afford the title compound 
S11 (1.3 g, 7.23 mmol, 77%) (Rf = 0.00, 40% EtOAc/Hexane), as a yellow solid with a purity of 
92.0% as determined by means of LC-MS. 
 
Mp 70-75 °C. IR (ATR, cm
-1
): 3422 (C-N str), 3255 (C-H str), 1644 
(N-H bend), 1562, 1507, 1481, 1430, 1288. 
1
H NMR (400 MHz, 
DMSO-d6) δ 8.30 (d, J = 5.2 Hz, 1H), 8.18 (d, J = 9.0 Hz, 1H), 7.76 (d, 
J = 2.2 Hz, 1H), 7.39 (m, 1H), 6.93 (s, 2H, H9), 6.52 (dd, J = 19.9, 
5.3 Hz, 1H, H3). 
13
C NMR (101 MHz, DMSO-d6) δ 151.7, 151.6, 149.5, 133.5, 127.4, 
124.7, 123.8, 117.1, 102.7. HRMS: calcd for C9H8N2Cl [M+H]
+
, 179.0376 and 181.0348, 
found 179.0381 and 181.0342 (100 and 33% MS peak ratio) 
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6.2.3 Experimental work pertaining to Chapter 4.2 
6.2.3.1 Towards the 2-aminoindole  
The synthesis of the 2-aminoindole was briefly mentioned in Chapter 4.2. Unfortunately, this 
compound was not successfully isolated and the quinoline scaffold was rather used in this 
project. Therefore, this section is only included for the curious reader. 
 
6.2.3.1.1 Attempted synthesis of 2,6-dichloro-1H-indole  
A 250 mL two-neck flask was fitted with a reflux condenser, and charged with  
6-chloroindolin-2-one (500 mg, 2.98 mmol) and phosphorus oxychloride (10 mL). The 
reaction mixture was refluxed at 110 °C and monitored over a period of 5 hours.  
Upon completion, the reaction was quenched on ice and the product was extracted with ethyl 
acetate (3 x 80 mL). The organic layer was washed with brine, dried over magnesium sulphate 
and filtered. The filtrate was concentrated in vacuo to yield the residue that was purified by 
column chromatography (5% EtOAc/Hexane) to afford a compound (Rf = 0.69, 
20% EtOAc/Hexane), as white crystals. Unfortunately, this compound turned dark of colour 
within 30 minutes, and decomposed into multiple compounds as determined by means of thin 
layer chromatography analysis. 
Therefore, the desired product was not isolated and the compound that formed was used 
immediately for the subsequent reactions without purification. 
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6.2.3.1.2 Attempted synthesis of 6-chloro-1H-indol-2-amine  
A 50 mL two-neck round bottom flask, fitted with a reflux condenser, was charged with 
N,N-dimethylformamide (10 mL). To this was added the crude 2,6-dichloro-1H-indole 
product  obtained in Section 6.2.3.1.1, ammonium hydroxide (10 mL), potassium carbonate 
(2 equivalents, 824 mg, 5.97 mmol), and copper (I) iodide (10 mol%, 56.8 mg, 0.298 mmol). 
The reaction was heated to 110 °C, and monitored over a period of 5-24 hours. 
Unfortunately, by monitoring the reaction by means of thin layer chromatography, the 
formation of multiple compounds was observed, and neither the final amine product, nor the 
starting indole reagent, were isolated. 
The reaction conditions were considered to be too harsh, and a milder synthesis route was 
considered via the formation of the azide intermediate, with the azide in the 2-position of the 
indole. 
A 50 mL two neck round bottom flask, fitted with a reflux condenser, was charged with 
dimethylsulfoxide (10 mL), sodium azide (1.2 equivalents, 233 mg, 3.58 mmol), and the 
crude 2,6-dichloro-1H-indole product obtained in Section 6.2.3.1.1. The reaction was heated 
to 100 °C under a positive pressure of nitrogen, whereupon it was monitored over a period of 
5- 24 hours. 
To our dismay, by monitoring the reaction by means of thin layer chromatography, the 
formation of multiple compounds was observed, and as before, neither the final amine 
product nor the starting reagent were isolated. 
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6.2.3.1.3 Attempted synthesis of tert-butyl 2,6-dichloro-1H-indole-1-carboxylate 
The crude 2,6-dichloro-1H-indole  product obtained in Section 6.2.3.1.1 and di-tert-butyl 
dicarbonate (1.3 equivalents, 0.9 mL, 3.87 mmol) were added to 20 mL anhydrous 
tetrahydrofuran in a 50 mL two-neck round bottom flask at 30 °C. A catalytic amount of  
4-dimethylaminopyridine was added and the reaction mixture was left to stir for 30 minutes. 
The decomposition of the 2,6-dichloro-1H-indole compound was observed, as monitored by 
means of thin layer chromatography. The desired Boc-protected indole product was thus not 
obtained. 
By performing these reactions, especially by attempting a Boc protection, it was clear that 
this 2,6-dichloro-1H-indole product was too unstable to use as the primary aromatic scaffold 
in this project.  
 
6.2.3.2 Towards the amide target compounds  
6.2.3.2.1 Attempted synthesis 2-aminoquinoline - RM16 
A 50 mL two-neck round bottom flask, fitted with a reflux condenser, was charged with 
N,N-dimethylformamide (10 mL). To this was added 2-bromoquinoline (200 mg, 
0.961 mmol), ammonium hydroxide (10 mL), and copper (I) iodide (10 mol%, 18.3 mg, 
0.0961 mmol). The reaction was heated to 110 °C, and monitored over a period of 
5-24 hours. Upon full consumption of the starting material, the reaction was quenched on ice, 
and the reaction mixture was neutralised with 2M hydrochloric acid. 
Unfortunately, the product was not extracted, as it was found to be water soluble. 
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6.2.3.2.2 2-Azidoquinoline - 17 
A 50 mL two neck round bottom flask, fitted with a reflux condenser, was charged with 
dimethyl sulphoxide (10 mL), sodium azide (1.2 equivalents, 113 mg, 1.73 mmol), and 
2-bromoquinoline (300 mg, 1.44 mmol). The reaction was heated to 100 °C for 2 days, under 
a positive pressure of nitrogen gas. 
Upon completion, the reaction was quenched with water and the product was extracted with ethyl 
acetate (3 x 30 mL). The organic layer was washed with brine, dried over magnesium sulphate 
and filtered. The filtrate was concentrated in vacuo to yield the residue that was purified by 
column chromatography (10% EtOAc/Hexane) to afford the title compound 17 (183 mg, 
1.07 mmol, 75%) (Rf = 0.21, 20% EtOAc/Hexane), as a white powder.  
 
Mp 130-134 °C. IR (ATR, cm
-1
): 3070 (C-H str), 2325, 2250 (N3 str), 
1612 (C=C bend), 1560, 1535, 1447, 1322. 
1
H NMR (300 MHz, 
DMSO-d6) δ 8.64 (d, J = 8.3 Hz, 1H), 8.28 (dd, J = 15.3, 8.7 Hz, 2H), 
8.10 (d, J = 9.4 Hz, 1H), 8.00 (m, 1H), 7.83 (dd, J = 8.0, 7.3 Hz, 1H). 
13
C NMR (75 MHz, 
DMSO-d6) δ 134.1, 131.5, 129.5, 128.2, 123.8, 116.2, 112.4. HRMS: calcd for C9H7N4 
[M+H]
+
, 171.0671, found 171.0652. 
Not all of the 13C peaks are accounted for. However, the mass spectrometry and infrared 
spectroscopy results indicate that compound 17 was indeed isolated. 
 
6.2.3.2.3 2-Aminoquinoline - RM16 
A 50 mL round bottom flask, fitted with a rubber septum, was charged with dimethyl 
sulphoxide (2 mL), dry ethanol (10 mL), and 2-azidoquinoline (1.2 g, 7.21 mmol). To this 
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was added one table spoon of activated Raney
®
-Nickel, twice a day for 3 days. The reaction 
was kept under a positive pressure of hydrogen gas. 
Upon full consumption of the quinoline starting material, the reaction mixture was filtered 
through celite, and washed with ethyl acetate. The filtrate was concentrated in vacuo to yield 
the residue that was purified by column chromatography (40% EtOAc/Hexane) to afford the title 
compound RM16 (977 mg, 6.78 mmol, 94%) (Rf = 0.10, 40% EtOAc/Hexane), as a yellow 
powder with a purity of 91.3% as determined by means of LC-MS. 
Mp 70-74 °C. IR (ATR, cm
-1
): 3422 (C-N str), 3255 (C-H str), 1644 
(N-H bend), 1562, 1507, 1481, 1430, 1288. 
1
H NMR (400 MHz, 
DMSO-d6) δ 7.87 (d, J = 8.8 Hz, 1H, H4), 7.61 (d, J = 7.8 Hz, 1H), 
7.48 – 7.42 (m, 2H), 7.17 – 7.08 (m, 1H), 6.75 (d, J = 8.8 Hz, 1H, H3), 6.41 (s, 2H, H9).  
13
C NMR (75 MHz, DMSO-d6) δ 158.2 (C2), 148.0, 136.8, 129.0, 127.5, 125.1, 122.7, 
121.1, 112.4. HRMS: calcd for C9H9N2 [M+H]
+
, 145.0759, found 145.0766. 
 
6.2.3.2.4 Biphenyl-4-carbaldehyde - 19 
A 50 mL two-neck round bottom flask, fitted with a reflux condenser, was charged with 
N,N-dimethylformamide (20 mL) and water (4 mL). To this was added 4-bromobenzaldehyde 
(300 mg, 1.62 mmol), phenylboronic acid (1.2 equivalents, 237 mg, 1.95 mmol), potassium 
carbonate (2 equivalents, 447 mg, 3.24 mmol), and palladium-tetrakis(triphenylphosphine) 
(5 mol%, 112 mg, 0.0810 mmol). The reaction mixture was heated to 100 °C for 2 days under 
a positive pressure of nitrogen gas. 
The reaction was quenched with water and the product was extracted with ethyl acetate  
(3 x 30 mL). The organic layer was washed with brine, dried over magnesium sulphate and 
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filtered. The filtrate was concentrated in vacuo to yield the residue that was purified by column 
chromatography (5% EtOAc/Hexane) to afford the title compound 19 (175 mg, 0.960 mmol, 
59%) (Rf = 0.43, 5% EtOAc/Hexane), as a white powder.  
 
Mp 65-70 °C. IR (ATR, cm
-1
): 3030-2737 (C-H str), 1695 (C=O str), 
1601 (C=C str), 1562, 1484, 1450, 1412, 1288. 
1
H NMR (300 MHz, 
CDCl3) δ 10.06 (d, J = 0.6 Hz, 1H, H5), 8.03 – 7.88 (m, 2H, C3), 
7.74 (ddd, J = 7.7, 4.6, 2.2 Hz, 2H, C2), 7.66 – 7.59 (m, 2H, C7),  
7.52 – 7.35 (m, 3H, C8 and C9). 
13
C NMR (75 MHz, CDCl3) δ 192.1 (C5), 147.3, 139.9, 





6.2.3.2.5 N-(Quinolin-2-yl) biphenyl-4-carboxamide - RM14 
A 50 mL two-neck round bottom flask, fitted with a reflux condenser, was charged with 
N,N-dimethylformamide (10 mL) and water (0.5 mL). To this was added biphenyl-4-
carbaldehyde (150 mg, 0.823 mmol), 2-aminoquinoline (1.2 equivalents, 142 mg, 
0.988 mmol), potassium carbonate (2 equivalents, 302 mg, 1.65 mmol), and copper (I) iodide 
(10 mol%, 15.7 mg, 0.0823 mmol). The reaction was heated to 100 °C, for 2 days. 
Once the aldehyde starting material was consumed, the reaction was quenched with water and the 
product was extracted with ethyl acetate (3 x 30 mL). The organic layer was washed with brine, 
dried over magnesium sulphate and filtered. The filtrate was concentrated in vacuo to yield the 
residue that was purified by column chromatography (10% EtOAc/Hexane) to afford the title 
compound RM14 (86.7 mg, 0.267 mmol, 32%) (Rf = 0.43, 20% EtOAc/Hexane), as a yellow 
powder with a purity of 99.4% as determined by means of LC-MS.  
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Mp 135-140 °C. IR (ATR, cm
-1
): 3350-3330 (N-H str), 
2831-2733 (C-H str), 1680-1695 (C=O str, N-H bend), 1596 
(C=C str), 1567, 1492, 1423, 1315. 
1
H NMR (300 MHz, 
DMSO-d6) δ 11.15 (s, J = 19.5 Hz, 1H, H9), 8.40 (m, 
2H), 8.23 – 8.17 (m, 2H), 7.96 (dd, J = 8.1,  
1.1 Hz, 1H), 7.90 (d, J = 8.1 Hz, 1H), 7.87 – 7.81 (m, 2H), 
7.81 – 7.73 (m, 3H), 7.57 – 7.48 (m, 3H), 7.46 – 7.40 (m, 1H). 
13
C NMR (75 MHz,  
DMSO-d6) δ 166.1 (C10), 151.9, 146.4, 143.6, 139.0, 138.1, 132.7, 130.0, 129.1, 128.9, 
128.2, 127.8, 127.1, 126.9, 126.6, 125.8, 125.2, 115.5. HRMS: calcd for C22H16N2O [M+H]
+
, 
325.1341, found 325.1357. 
 
6.2.3.2.6 Attempted synthesis of 4-(7-chloroquinolin-2-yl) benzaldehyde - 21 
The same procedure was used as for preparing compound 19 in Section 6.2.3.2.4.  
 
 
The equivalents used were as follows: N,N-dimethylformamide (20 mL), water (4 mL), 
4-formylphenylboronic acid (1.2 equivalents, 540 mg, 2.92 mmol), 2,7-dichloroquinoline 
(482 mg, 2.44 mmol), potassium carbonate (2 equivalents, 673 mg, 4.87 mmol), and 
palladium-tetrakis(triphenylphosphine) (5 mol %, 141 mg, 0.122 mmol). 
Upon completion, the reaction was quenched with water and the product was extracted with ethyl 
acetate (3 x 30 mL). The organic layer was washed with brine, dried over magnesium sulphate 
and filtered. The filtrate was concentrated in vacuo to yield the residue that was purified by 
column chromatography (10% EtOAc/Hexane) to afford a mixture of compounds 21 and 22 
(32.0 mg, 0.120 mmol, 5%) (Rf = 0.50, 10% EtOAc/Hexane), as a white powder.  
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The reaction was repeated at 60 °C, but the formation of the same products was observed, as 
determined by means of thin layer chromatography analysis. 
When integrating the two aldehyde protons in the 1H NMR (10.08 and 10.07 ppm), a 2:1 ratio is 
obtained. It is most likely that compound 21 is the major product, since the 2-position of the 
quinoline is deemed more reactive than the 7-position. However, without separating these two 
compounds, this could not be resolved.   
 
Mp 58-62 °C. IR (ATR, cm
-1
): 3029-2731 (C-H str), 1696 
(C=O str), 1591 (C=C str), 1211. 
1
H NMR (300 MHz, 
DMSO-d6) δ 10.08 (s, J = 2.4 Hz, 1H), 10.07 (s, 2H),  
8.01 – 7.93 (m, 7H), 7.81 – 7.63 (m, 12H), 7.60 – 7.37 (m, 




6.2.3.2.7 Attempted synthesis of N-(quinolin-2-yl)-4-(quinolin-2-ylamino) benzamide - 
RM12, 
 and synthesis of 4-bromo-N-(quinolin-2-yl) benzamide - RM15 
A 50 mL two-neck round bottom flask was fitted with a reflux condenser and charged with 
N,N-dimethylformamide (10 mL). To this was added 4-bromobenzaldehyde (96.3 mg, 
0.520 mmol), 2-aminoquinoline (2 equivalents, 150 mg, 1.04 mmol), potassium carbonate 
(2 equivalents, 193 mg, 1.40 mmol), and copper (I) iodide (10 mol%, 19.8 mg, 0.104 mmol). 
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Unfortunately, the reaction did not proceed and the starting material was isolated. The 
reaction was repeated whereupon water (0.5 mL) was added, and the reaction was heated to 
100 °C. This reaction mixture was left open to the atmosphere. 
Upon completion, the reaction was quenched with water and the product was extracted with ethyl 
acetate (3 x 30 mL). The organic layer was washed with brine, dried over magnesium sulphate 
and filtered. The filtrate was concentrated in vacuo and the compounds that had formed were 
separated by column chromatography (40% EtOAc/Hexane). The title compound was not 
obtained. The intermediate, compound RM15 (32.0mg, 0.0978 mmol, 19%) (Rf = 0.57, 
80% EtOAc/Hexane), was however isolated as orange crystals with a purity of 92.0% as 
determined by means of LC-MS.  
 
Mp 133-135 °C. IR (ATR, cm
-1
): 3345 (N-H str), 3133-2852 
(C-H str), 1692 (C=O str), 1598 (C=C str), 1537 (N-H bend), 
1499 (N-H bend), 1426, 1333. 
1
H NMR (600 MHz, DMSO-d6) 
δ 11.23 (s, 1H), 8.37 (dd, J = 52.6, 8.9 Hz, 2H), 8.06 – 7.82 (m, 
4H, H12 and H13), 7.74 (m, 3H), 7.53 (dd, J = 11.0, 3.9 Hz, 1H).  
13
C NMR (150 MHz, DMSO-d6) δ 165.7, (C10), 151.8, 146.4, 
138.2, 137.3, 133.2, 131.4, 130.3, 130.1, 130.1, 127.9, 127.1, 126.0, 125.9, 125.3, 115.5. 
HRMS: calcd for C16H11BrN2O [M+H]
+
, 327.0133 and 329.0114, found 327.0133 and 
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-di(quinolin-2-yl)benzene-1,4-diamine - RM17 
and N
1
-(quinolin-2-yl)benzene-1,4-diamine - RM18 
A 50 mL two-neck round bottom flask was fitted with a reflux condenser and charged with 
dry ethanol (15 mL), N,N-dimethylformamide (2 mL), 2-bromoquinoline (2.2 equivalents, 
250 mg, 1.20 mmol), and benzene-1,4-diamine (59.0 mg, 0.546 mmol), whereupon the 
reaction was refluxed at 80 °C for 3 days under a positive pressure of nitrogen. 
Upon completion, the solvent was removed in vacuo and the compounds that formed were 
purified by column chromatography (20% EtOAc/Hexane) to afford the title compound RM17 
(5 mg, 0.0138 mmol, 3%) (Rf = 0.57, 40% EtOAc/Hexane), as a light brown powder with a purity 
of 98.7 %, and compound RM18 (25 mg, 0.106 mmol, 19%) (Rf = 0.37, 40% EtOAc/Hexane), as 
a light brown powder with a purity of 97.8% as determined by means of LC-MS. The remaining 
starting material, 2-bromoquinoline (74.0 mg, 0.356 mmol, 30%), was recovered.  
In several attempts to improve the product yield, the reaction was allowed to proceed for a longer 
time period, more of compound RM16 was added (3 equivalents), and potassium carbonate was 
added (1.3 equivalents, 100 mg, 0.724 mmol). Unfortunately, a higher product yield was not 
obtained. 
Mp 210-213 °C. IR (ATR, cm
-1
): 3411-3390 
(N-H str), 3045 (C-H str), 1619 (C=C str), 1538, 
1509, 1392. 
1
H NMR (300 MHz, DMSO-d6) δ 
9.33 – 9.27 (m, 1H, H9), 8.04 – 7.97 (m, 1H),  
7.95 – 7.90 (m, 2H), 7.73 – 7.64 (m, 2H), 7.60 – 7.51 (m, 1H), 7.30 – 7.21 (m, 1H),  
7.06 – 7.00 (m, 1H). 
13
C NMR (75 MHz, DMSO-d6) δ 154.8, 147.4, 143.6, 136.4, 130.6, 
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129.2, 127.4, 125.9, 123.2, 121.7, 121.0, 114.2, 113.6. HRMS: calcd for C24H19N4 [M+H]
+
, 
363.1613, found 363.1610. 
Mp 150-155 °C. IR (ATR, cm
-1
): 3404-3331 (N-H str), 
3045-3195 (C-H str), 1608 (C=C str), 1538, 1510, 1475, 
1400, 1249. 
1
H NMR (300 MHz, DMSO-d6) δ 8.89 (s, 
1H, H9), 7.99 – 7.82 (m, 1H), 7.64 (d, J = 7.8 Hz, 1H), 
7.52 (ddd, J = 6.7, 3.6, 1.5 Hz, 4H), 7.23 – 7.14 (m, 1H), 6.91 (d, J = 9.0 Hz, 1H),  
6.60 – 6.53 (m, 2H), 4.76 (s, 2H, H14). 
13
C NMR (75 MHz, DMSO-d6) δ 155.2, 147.9, 
144.0, 136.8, 131.0, 129.5, 127.8, 126.3, 123.6, 122.2, 121.4, 114.6, 114.0. HRMS: calcd for 
C15H14N3 [M+H]
+
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6.3 β -HAEMATIN INHIBITION ASSAYS 
6.3.1 General procedures 
6.3.1.1 Solvents and reagents used 
Chemicals used in these assays were purchased from Sigma Aldrich, where the solvents were 
either purchased from Sigma Aldrich or Kimix Chemicals. 
 
6.3.1.1.1 General procedure for converting inhibitors into the free base form 
Amodiaquine dihydrochloride dihydrate (300 mg, 0.645 mmol)(Table 54) was dissolved in 
hot distilled water (6 mL). This was slowly added to a 6M sodium hydroxide solution 
(20 mL) and heated for 2 min in a boiling water bath. This was allowed to cool to room 
temperature for the product to precipitate out, and left to stand for an additional 2 hours.  
The precipitate was filtered, washed with a cold 1M sodium hydroxide solution (2 x 5 mL), 
and dried over phosphorus pentoxide (5.00 g, 17.7 mmol) in a desiccator for 3 days. 
Table 54: Inhibitors converted into the free base form and the yields obtained 
Inhibitor Amount used Free base obtained % Yield 
    
Amodiaquine dihydrochloride dihydrate 300 mg, 0.645 mmol 216 mg, 0.606 mmol 94% 
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6.3.1.2 Spectroscopic data 
UV-visible single wavelength readings (405 nm), were collected on a Thermo Scientific 
Mulitskan
TM
 GO UV-visible spectrophotometer. 
 
6.3.1.3 Measuring pH  
A Mettler Toledo FE20 pH meter was used to measure the pH of buffer solutions. The 
electrode was calibrated using pH buffer solutions (pH 4.0 and pH 7.0) purchased from 
Crison Instruments. 
 
6.3.1.4 Temperature regulated incubation 
The experiments were performed in a temperature regulated laboratory at 23 °C. The samples 
were incubated in a fan-assisted oven at 37 °C. 
 
6.3.1.5 IC50 determination 
The data that were obtained were analysed using the GraphPad Prism v.6.0 software 
package.
202
 A sigmoidal dose response curve was obtained by plotting the measured 
absorbance (nm) against the log of the concentration (μM). The required IC50 data with the 
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6.3.2 Lipid β-haematin inhibition IC50 
6.3.2.1 Stock solutions prepared 
6.3.2.1.1 50 Stock solution of citrate buffer (50 mM), pH4.8 
Citric acid monohydrate (5.26 g, 25.0 mmol) was dissolved in distilled water (450 mL) in a 
600 mL beaker. The pH was adjusted to 4.8 by the slow addition of a 6M sodium hydroxide 
solution. The solution was transferred to a 500 mL volumetric flask, where it was made to 
volume with distilled water. 
 
6.3.2.2 Solubility testing 
3,6-Dibromocarbazole (1.63 g, 0.500 mmol) and 4,7-dichloroquinoline (0.990 g, 
0.500 mmol) were dissolved separately in various mixtures of the 50 mM citrate buffer stock 
solution (Section 6.3.2.1.1) and dimethyl sulfoxide, in 12 mL polytop glass vials (Table 55). 
The samples were incubated at 37 °C and monitored for 6 hours, where after it was left 
overnight. 
 
Table 55: The time to precipitation of 0.5 mM drug solution in mixtures of acetate buffer and dimethyl 
sulfoxide were investigated. 
Time to precipitation (h): Ratio of dimethyl sulfoxide to acetate buffer 
      
 
0:10 1:9 2:8 3:7 4:6 
3,6-dibromocarbazole (0.5 mM) 0 0 0 0.5 >24 
4,7-dichloroquinoline (0.5 mM) 0 4 >24 >24 >24 
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6.3.3 NP40 β-haematin inhibition IC50 
6.3.3.1 Stock solutions prepared 
6.3.3.1.1 NP40 solution  
Distilled water (7.00 mL), dimethyl sulfoxide (1.00 mL), and NP40 (306 μM, 2.00 mL) were 
added to a 15 mL Falcon conical centrifuge tube. This was vortexed for 30 seconds. This 
solution was stored in the refrigerator. 
 
6.3.3.1.2. Acetate buffer (1.0M), pH 4.8 
Sodium acetate (8.20 g, 0.0100 mmol) was dissolved in distilled water (10.0 mL) in a 100 mL 
volumetric flask. Glacial acetic acid was added (2.40 mL), and the solution was made to 
volume with distilled water. 
 
6.3.3.1.3 Haemin solution  
Haemin (10.0 mg, 0.0153 mmol)) was dissolved in dimethyl sulfoxide (613 μL) in a 5 mL 
polytop glass vial and vortexed for 1 minute. This solution was freshly prepared daily. 
 
6.3.3.1.4 Haemin in acetate buffer solution 
The sodium acetate buffer (Section 6.3.3.1.2)(10.0 mL) was added to a 15 mL Falcon conical 
centrifuge tube. The haemin solution (Section 6.3.3.1.3)(72.0 μL) was added to this and the 
solution was vortexed for 1 minute. This was used without further delay. 
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6.3.3.1.5 2M HEPES and pyridine solution  
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (4.77 g, 20 mmol) was 
dissolved in water (30.0 mL) in a 100 mL volumetric flask. Acetone (20.0 mL) was added 
and the solution was made to volume with pyridine.  
 
6.3.3.1.6 Inhibitor stock solution 
In order to prepare an inhibitor stock solution, the inhibitor was dissolved in dimethyl 












Stellenbosch University  https://scholar.sun.ac.za





Table 56: Inhibitor concentrations prepared for the NP40 assay. 
Inhibitor Concentration (mM) Mass (mg) Dimethyl sulfoxide (μL) 
    
CQ free base 10.0 2.5 782 
AQ free base 10.0 2.5 703 
QC 10.0 2.5 529 
KN6 10.0 2.5 900 
KN7 10.0 2.5 805 
S1 180 10 340 
S2 180 7.0 196 
S3 180 10 366 
S4 180 10 281 
S5 180 15 393 
S6 180 6.0 199 
S9 180 15 273 
S10 180 15 300 
S11 20 2.0 559 
S12 180 15 339 
S13 180 20 342 
RM14 20 1.0 161 
RM15 20 1.0 153 
RM16 20 2.0 812 
RM17 20 1.0 138 
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6.3.3.2 Determining the NP40 β-haematin inhibition IC50 
6.3.3.2.1 General procedure for performing the NP40 assay 
This general procedure was reported by Dr Kathryn Wight.
122
 
A 96-well plate was prepared by adding inhibitor stock solution (20.0 μL)(Section 6.3.3.1.6), 
NP40 solution (40.0 μL) (Section 6.3.3.1.1), and distilled water (140 μL) to 4 of the wells in 
the 12
th
 column (Figure 97). NP40 solution (100 μL) (Section 6.3.3.1.1) was added to the 
remaining wells in the 4 rows. 
 
Figure 97: An illustration of the 96-well plate  
 
A serial dilution was performed by transferring 100 μL of the mixture in the 12
th
 column to 
the 11
th
 column in the same row, halving the concentration. This was repeated down till the 
2
nd
 column, from which the 100 μL was discarded and not added to the 1
st
 column. 
A fresh solution of haemin (Section 6.3.3.1.4) was prepared and 100 μL was added to each of 
the wells of the first three rows. The 96-well plate was incubated with a lid for 5 hours. 
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After the 5 hour incubation period, 2M HEPES and pyridine solution was added (32.0 μL) 
(Section 6.3.3.1.5), followed by the addition of acetone (60.0 μL).  This was allowed to stand 
for 5 minutes, where after the absorbance was measured at 405nm. 
 
6.3.3.2.2 Determining the NP40 β-haematin inhibition IC50 
Using the GraphPad Prism 6.0 software package, the measured absorbance at 405 nm was 
plotted against the log of the concentration (μM). A sigmoidal dose response curve was fitted 
to the graph, from which the IC50 value (μM) was readily determined. This value is reported 
as the EC50 value in the software. 
The standard deviation was calculated from the reported standard deviation log EC50 and 
standard deviation EC50 values by using Equation 6.3 
                            
               (6.3) 
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